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No importa el lugar, el sol es siempre 
igual, no importa si es recuerdo 
o es algo que vendra. No importa 
cuanto hay en tus bolsillos hoy, sin 
nada hemos venido y nos iremos 
igual. No importa donde estas, si 
vienes o si vas, la vida es un camino, 
un camino para andar. Si hay algo 
que esconder o hay algo que decir, 
siempre sera un amigo el primero en 
saber! Porque siempre estaran en mi 
esos buenos momentos que pasamos 
sin saber: que un amigo es una luz, 
brillando en la oscuridad, siempre 
seras mi amigo, no importa nada 
mas... 
Los Enanitos Verdes                
It doesn’t matter the place, the sun 
will always be the same, it doesn’t 
matter if it is a remembering or 
something that still has to happen. 
It doesn’t matter how much money 
there is in your pockets today, we 
came with nothing and with nothing 
we will leave. It doesn’t matter 
where you are, if you are going or 
coming, life is a journey  to keep 
going. If there is something to tell or 
something to hide it will always be a 
friend the first one to know! Because 
those moments we spent together 
without knowing that a friend is 
like a light burning in the dark will 
always be in me, you will always be 
my friend, nothing else matters...
“The Green Dwarfs”
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One of the most significant contributions to our understanding of the phenomenon 
of life was made by the research of the famous physiologist Claude Bernard (1813-
1877). Bernard came to the insight that the role of physiological processes is to control 
the organism’s internal environment, the ‘milieu intérieur’, and he understood that this 
control, essential to life, depends on the laws of chemistry and physics. The tendency 
to maintain the constancy of this internal environment (cells and body fluids) is called 
homeostasis, a term introduced by Walter Cannon in ‘The Wisdom of the Body’ (1932) 
and derived from the Greek ‘homoios’, meaning ‘similar’, and ‘stasis’, ‘to stand still’. 
The maintenance of this internal condition allows animals to survive in spite of their 
ever changing and sometimes harsh environments (Bernard’s ‘milieu extérieur’). To 
achieve this, many physiological processes have to be regulated, for example feeding, 
cardiovascular activity, hydromineral balance, growth, reproduction, development 
and metabolism. Moreover, these processes must be co-ordinated in an integrative 
way, so that they allow the organism to function as one unit. The scientific study of 
the regulation and co-ordination of these physiological processes is often named 
‘Adaptation Physiology’ or ‘Integrative Physiology’. 
All organ systems participate in these regulatory processes, but the nervous and 
the endocrine systems are the main regulators, by sensing information signals about 
the external conditions and translating these signals into appropriate physiological 
adaptive responses. To enable an organism to react adequately to the changes in the 
environment, a tight communication between the nervous and endocrine systems 
is essential. This integration mainly takes place in the neuroendocrine system, an 
important component of which is the hypothalamo-hypophyseal system. The unifying 
way by which the nervous, endocrine and neuroendocrine systems function, both 
intrinsically and in collaboration with each other, is by neurochemical messengers 
(neurotransmitters, hormones and neurohormones) that act via specific receptors to 
control the activity of target cells. 
In classical handbooks about physiology, individual physiological processes and the 
nervous, neuroendocrine and endocrine systems, are typically described in separate 
chapters. In this thesis these various aspects of organismal functioning are treated in 
an integrated form. This integrated physiological approach serves the aim of this thesis 
research: to unravel basic mechanisms at the central, endocrine and neuroendocrine 
level that are responsible for the co-ordination of separate physiological processes, 
effectuating co-ordinated behavior and adaptation. More specifically, it is being 
studied what kind(s) of neurochemical messenger release is/are responsible for this co-
ordination. This has been done especially in an animal that has been studied in much 
detail with regard to its nervous and (neuro)endocrine system and as to the regulation 
of its physiology, i.e., the South African clawed toad Xenopus laevis. Emphasis has been 
put on the processes of background adaptation, feeding and stress adaptation, as 
controlled by the brain and, especially, by the hypothalamo-hypophyseal system.
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In this General Introduction, first some basic information will be given about the 
various types of release of neurochemical messengers. Subsequently, attention will 
be paid to the control centres and the physiological processes they regulate, and 
finally it will be indicated which studies have been carried out to reach the aim of this 
research.
Modes of neurochemical communication
Generally, four ways of release of neurochemical messenger are distinguished: a) 
hormonal release from endocrine cells, b) neurotransmitter release from neuronal 
synapses, c) neurohormone release from neurosecretory cells, and d) release of 
neurochemical messengers into the interneuronal space or into the cerebrospinal fluid 
(‘paracrine’ or ‘non-synaptic communication’ or ‘volume transmission’). In the first way 
of release (a) endocrine cells release their messengers, hormones, into the circulation 
to act over long distances on distant targets that possess the appropriate receptors (see 
e.g. Iversen et al., 2000). In the second way of release (b) a nerve impulse elicits the 
release of the neurochemical messenger from the neuronal synapse into the synaptic 
cleft. From here the messenger diffuses to reach specific receptors on the postsynaptic 
cell membrane that induce a rapid response. Below more detailed attention will be 
paid to neurohormone release (c) and volume transmission (d).
Neurohormone release. The generalised neuroendocrine system has a neurosecretory 
centre of neuronal cell bodies that synthesise neurohormones and form efferent axons 
that transport the neurohormone within secretory granules to a release site, typically a 
specialised neurohemal area/organ that facilitates diffusion of the neurohormone into 
the blood vascular system. The various hypothalamic neurosecretory cells of vertebrates 
release their neurohormones mainly from two neurohemal areas: the external zone of 
the hypothalamic median eminence situated at the bottom of the third ventricle, and 
the neural lobe of the pituitary gland. Neurosecretory neurons of the hypothalamic 
supraoptic and paraventricular nuclei have long axons that run via the internal zone 
of the median eminence to the neural lobe, where their widened axon terminals end 
near fenestrated capillaries. The axon terminals act as neurohormone storage sites that, 
upon appropriate stimulation, release their neurohormones (in particular oxytocin and 
vasopressin) by exocytosis into the general circulation to reach their distant targets 
(classically, for vasopressin: the kidney, and for oxytocin: smooth muscles of the milk 
glands and the uterus). Other hypothalamic neurosecretory cells send their terminals 
to the external zone of the median eminence and release their contents (releasing 
and inhibiting factors) into portal vessels that carry these ‘neurosecretions’ to their 
endocrine target cells in the anterior lobe of the pituitary gland, to control the release 
of various hormones into the general circulation. It should be noted that endocrine cells 
located in the intermediate lobe of the pituitary gland (especially melanotrope cells) 
and in fishes, all endocrine cells in the distal pituitary lobe, are synaptically controlled 
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by hypothalamic neurons. This type of synaptic control of endocrine cells, which is 
similar to the synaptic control of muscle cells, has been called ‘neurosecretomotor 
control’ (Bargmann and Knoop, 1960).
Volume transmission. Neurochemical communication occurs not only between neurons 
and endocrine cells, but also between neurons themselves. Several authors have 
proposed the revision of the classical concept that communication responsible for 
interneuronal communication in the central nervous system (CNS) occurs exclusively 
by synapses (wiring transmission; WT; Agnati et al., 1986), making the point that 
there is another mode for interneuronal communication in the CNS besides synaptic 
transmission. This alternative mode of communication has been named nonsynaptic 
communication or volume transmission (VT; see e.g. Beaudet and Descarries, 1978; 
Nieuwenhuys, 1985; Agnati et al., 1995; Zoli et al., 1998). WT is a fast, one-to-one, 
‘private’ intercellular communication process in the local intercellular space, whereas 
VT is a slow, one-to-many, widespread communication process that takes place via 
the extensive extracellular space (ECS) or cerebrospinal fluid (CSF) (Agnati et al., 
1995; Zoli et al., 1999). Evidence for the existence of VT in the brain has been obtained 
from morphological studies in both vertebrates and invertebrates, where the release 
of substances outside specialized junctions such as synapses has been observed 
(Buma and Roubos, 1986; Schmidt and Roubos, 1987; Buma and Nieuwenhuys, 1988) 
and from studies describing a mismatch in the distribution of the ligands and their 
receptors (Hamel and Beaudet, 1984; MacMillan et al., 1998; Jansson et al., 2002). 
The diffusion of high molecular weight compounds was demonstrated in the brain 
extracellular microenvironment (Nicholson and Tao, 1993) and evidence was obtained 
for intracranial pressure waves (Agnati et al., 2005) that can help generate convection 
fluid movements in the brain  supporting signal migration (Rennels et al., 1990; 
Abbot, 2004). More recently, ligand-receptor mismatches have been related to local 
temperature gradients created by brain uncoupling protein 2, which uncouples oxidative 
phosphorylation from ATP synthesis, thereby generating heat and contributing to a 
dynamic regulation of VT (Fuxe et al., 2005). In fact, communication in the CNS via 
VT in the brain appears similar to the brain homologue of endocrine communication 
in the body by ‘true hormones’, as in both processes multiple targets are controlled in 
a remote communicative way, and the selectivity of the communication is based on 
specific ligand (messenger)-receptor interaction (‘chemical addressing’).
Amphibians as models to study the ways physiological processes are integrated
Amphibians make good models to study the regulation and integration of different 
physiological processes, such as osmoregulation (e.g. Uchiyama and Konno, 2005), 
background adaptation (e.g. Roubos et al., 2005), temperature regulation (Tonosaki 
et al., 2004), stress adaptation (Boorse and Denver, 2004) and feeding (Ewert et al., 
2001). The interaction between the nervous and the endocrine system has been largely 
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studied in two anuran species, namely the South African clawed toad Xenopus laevis 
and the frog Rana esculenta (Tonon et al., 1983, 1986), revealing the tight and elaborate 
cooperation between the two regulatory systems. Therefore, in this thesis the regulation 
of the integration of physiological processes, in particular of background adaptation, 
stress adaptation and feeding, has been investigated in X. laevis and R. esculenta, and 
in the following paragraphs a general overview of the current knowledge regarding 
these processes in these amphibians will be presented.
Background adaptation 
Optimal functioning of an organism requires adequate adaptation to changes in 
environmental conditions, such as adaptation of skin colour. In amphibians the 
sensory information concerning light intensity is perceived by the retina, translated 
into electrical and chemical signals, and transmitted to different visual centres in 
the brain. After processing, the information is passed on to hypothalamic centres 
that subsequently stimulate or inhibit the production, storage and secretion of α-
melanophore-stimulating hormone (α-MSH) by the endocrine melanotrope cells 
situated in the intermediate lobe of the pituitary gland. After being released into the 
circulation, α-MSH evokes the blackening of the skin by stimulating dispersion of the 
black melanin pigment in dermal melanophores. Particularly in Xenopus laevis and 
Rana esculenta, the process of background adaptation has been described in much detail 
(e.g. Tonon et al., 1983, 1986; Lamacz et al., 1989; de Rijk et al., 1992; Jenks et al., 1993a,b; 
Tuinhof et al., 1994a,b; Berghs et al., 1997; Roubos, 1997; Ubink et al., 1998; Kramer 
et al., 2001; Kolk et al., 2002; Roubos et al., 2002). Several neurochemical messengers 
have been described that control the release of α-MSH from the melanotrope cells 
(Roubos et al., 1997, 2005), some having a stimulatory action, such as corticotropin-
releasing factor (CRF), sauvagine (Verburg-van Kemenade et al., 1987a), thyrotropin-
releasing hormone (TRH; Verburg-van Kemenade et al., 1987b) and brain-derived 
neurotrophic factor (BDNF; Kramer et al., 2002), whereas others are inhibitory, such 
as dopamine, neuropeptide Y (NPY) and γ-aminobutyric acid (GABA; de Rijk et al., 
1992; Tuinhof et al., 1993a,b). Stimulatory factors such as CRF and TRH are present in 
the hypothalamic magnocellular nucleus (Mg; Verburg-van Kemenade et al., 1987b; 
Tuinhof et al., 1994a), the homologue of the mammalian paraventricular nucleus (PVN) 
and supraoptic nucleus (SON), which has neurohemal terminals in the neural lobe of 
the pituitary gland. The type of external information that controls the activity of the Mg 
is unknown, with the exception of vasotocin-, mesotocin- and TRH-producing cells in 
the Mg (Tonosaki et al., 2004). The first two ‘classical’ neurohormones (homologues of 
the mammalian vasopressin and oxytocin) act on peripheral hydromineral regulatory 
organs, such as kidney and bladder (Pang and Sawyer, 1978; Warburg, 1995), probably 
as a response to osmotic stimulation of the Mg (Ubink et al., 1997). Regarding TRH, 
lowering the temperature from 20 ° to 5 ° C, stimulates the Mg to release TRH from 
the neural lobe. This TRH probably reaches the melanotrope cells, and activates them 
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to release α-MSH, which in turn induces skin darkening (Tonosaki et al., 2004). The 
inhibitory factors NPY, dopamine and GABA are produced in another hypothalamic 
centre called suprachiasmatic nucleus (SC; de Rijk et al., 1992), which sends axons 
to the pituitary gland to make synaptic contacts with the melanotrope cells (Tuinhof 
et al., 1994a). Their release is probably under control of the external light condition 
and a direct retino-suprachiasmatic pathway (e.g. de Rijk et al., 1991, 1992; Tuinhof 
et al., 1994a; Kramer et al., 2001). Two other brain centres, the locus coeruleus, which 
produces noradrenalin (Tuinhof et al., 1994a) and the raphe nucleus, which makes 
serotonin (Ubink et al., 1999), are likely to make synaptic contact with the melanotrope 
cells in the intermediate lobe of the pituitary gland (Tuinhof et al., 1994a), but the nature 
of the information that controls the activity of these centres is not known (Ubink et al., 
1999; Kolk et al., 2002).
Stress adaptation
When the homeostatic balance of an organism is disturbed as a result of external 
or internal stimuli (stressors), the animal’s physiological state is defined as ‘stressed’ 
and consequently the organism builds up a stress response (e.g. Sapolsky, 1994). The 
physiological meaning of the stress response is to distribute energy to those tissues 
and organs that are required to resolve the homeostatic challenge event. Much of the 
organismal stress response occurs via the hypothalamus-pituitary-adrenal (HPA) axis. 
CRF is the primary neuroregulator of the vertebrate stress response (Vale et al., 1981). 
After appropriate stimulation, CRF is secreted by the hypothalamus into the portal 
system and subsequently induces the anterior pituitary corticotrope cells to release 
adrenocorticotropic hormone (ACTH) into the systemic circulation (Vale et al., 1981). 
As a result, ACTH stimulates the synthesis and release of steroid hormones from the 
adrenal gland (James and Few, 1985). These glucocorticoids act on various organs and 
stimulate metabolism in such a way that the animal obtains enough energy to ‘cope’ 
with the stressful situation. Not only CRF, but also other neurochemical messengers, 
such as the neuropeptides belonging to the CRF/urocortin family (Ucn1, Ucn2 and 
Ucn3), have been implicated in mediating autonomic and behavioral responses to 
stress (Skelton et al., 2000; Kozicz et al., 2004; Kórösi et al., 2005). Recently, CRF, Ucn1 
and Ucn3 have been identified in Xenopus laevis (Stenzel-Poore et al., 1992; Boorse et 
al., 2005), as have their receptors: CRF receptor type 1 (CRF1) and CRF receptor type 
2 (CRF2) (Dautzenberg et al., 1997, 1998, 2001, 2002; Boorse and Denver, 2006). The 
functions of CRF and Ucn1 in amphibians have been investigated less well than in 
mammals, but CRF in the Mg exerts its ‘traditional’ role as controller of the HPA-axis 
(Boorse and Denver, 2004; Yao et al., 2004; Boorse et al., 2005). Ucn1-peptide distribution 
has been described in the brain of R. esculenta (Kozicz et al., 2002) but its possible role 
in the regulation of stress in amphibians awaits confirmation. 
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Feeding
Besides their importance for studying neurochemical mechanisms to adapt to 
different environmental conditions, amphibians also make good research models 
for the study of feeding-related processes (e.g. Crespi and Denver, 2004). Several 
investigations on amphibians have focused on prey-catching behavior (Ewert et al., 
2001; Carr et al., 2002; Crespi and Denver, 2004; Carr, 2005) and on metabolic changes 
in response to changed physiological conditions such as fasting/estivation and 
hibernation (Hervant et al., 2001; Hervant and Renault, 2002; Secor, 2005). With the 
identification in the amphibian brain of several neuropeptide systems known to be 
involved in feeding control in mammals, recently attention was focused on the central 
regulation of feeding, especially in Xenopus laevis. In this amphibian species CRF, 
Ucn1 and NPY seem to regulate food intake (Crespi et al., 2004; Boorse et al., 2005), 
suggesting an evolutionary conservation of these peptides and their functions in both 
lower vertebrates and mammals.
Aim of this thesis
In this thesis we aim to test our hypothesis that the regulations of different 
physiological processes are tightly interconnected, and involve the use of the same 
(families of) neurochemical messengers. In view of the importance of this integration 
of communication for the maintenance of homeostasis, the regulation of different 
physiological processes such as background adaptation, stress adaptation and feeding-
related processes has been investigated at the brain and pituitary level, using X. laevis 
and R. esculenta as research models, with special attention to the modes and sites at 
which these regulations take place.
Outline of the thesis
A main aspect of this research is the mode of release of neurochemical messengers 
involved in physiological regulations. In Chapter 2 we have studied the presence in the 
X. laevis brain of cerebrospinal fluid-contacting neurons containing the stress-related 
peptides CRF and Ucn1 and the opioid peptides β-endorphin, met-enkephalin (ENK) 
and endomorphin. A second way of communication is represented by the release of 
neurochemical messengers into the blood. This process of ‘neurosecretion’ is tested in 
Chapter 3 and Chapter 4 for BDNF and Ucn1. BDNF is a member of the nerve growth-
factor family of peptides, and is involved in growth, differentiation and maintenance 
of neuronal systems. 
In Chapter 3, we describe the distribution of BDNF in the X. laevis brain and 
pituitary gland, compare it to the distribution of the classical amphibian neurohormone 
mesotocin, and test if BDNF is present in axon terminals in the neural lobe together 
with mesotocin. Furthermore, it is investigated if mesotocin stimulates α-MSH release 
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from the melanotrope cells in the pituitary gland. 
In Chapter 4 we describe the distribution of CRF and Ucn1 in the Xenopus brain and 
pituitary gland, and test if Ucn1 is present in terminals in the pituitary neural lobe. 
Furthermore, it is studied if Ucn1 stimulates the release of α-MSH from the pituitary 
melanotrope cells. The actions of CRF and Ucn1 are mediated by the G-protein-coupled 
receptors CRF1 and CRF2 (Chen et al., 1993; Perrin and Vale, 1999). In Xenopus and in 
mammals, both CRF and Ucn1 have a high affinity for the CRF1 (Dautzenberg et al., 
1997). 
In Chapter 5, attention is directed towards the distribution and physiological 
regulation of CRF1 mRNA in the X. laevis brain and pituitary gland, in relation to the 
distribution of CRF- and Ucn1-positive neurons and their processes. Moreover, the role 
of the background light condition in the regulation of the expression of CRF1 mRNA in 
the pituitary intermediate lobe is investigated.
Chapter 6 deals with another important physiological process analysed in this thesis, 
namely the regulation of feeding. First, the distribution of cocaine and amphetamine-
regulated transcript (CART), an established messenger in the regulation of feeding 
in mammals (Kristensen et al., 1998), is described in the brain and spinal cord of the 
hibernating frog R. esculenta and compared to its distribution in the rat CNS, with 
special attention to brain areas regulating feeding behavior. 
Then, in Chapter 7, the distribution of CART is described in the CNS of Xenopus and 
compared to the central distribution in Rana and rat. In mammalian species, besides 
CART, also CRF and Ucn1 are important regulators of feeding-related processes. 
In Chapter 8, the hypothesis is tested that in X. laevis, CRF and Ucn1 in the Mg 
are involved in the regulation of feeding-related processes. The effect of long-term 
starvation on the expression of the neuronal activity marker Fos and on CRF- and 
Ucn1-expressions in different brain structures and in the pituitary gland of Xenopus 
is also investigated. For comparison, CART, ENK and NPY, all implicated in feeding 
control, have been studied as well. 
Finally, in Chapter 9 the results of the thesis are discussed with regard to the aim of 
the thesis research.

Chapter 2
Opioid Peptides, CRF and Urocortin in 
Cerebrospinal Fluid-Contacting Neurons 
in Xenopus laevis
Marinella Calle, Ilse E.W.M. Claassen, Jan G. Veening,               
Tamás Kozicz, Eric W. Roubos, Henk P. Barendregt
In: Trends in Comparative Endocrinology and Neurobiology (H. Vaudry, E.W. Roubos,         
L. Schoofs, G. Flik, D. Larhammar eds.), 2005, New York Academy of Sciences,                    
 New York, 1040: 249-252
Ucn1 in LCN@ Mg
Enk in LCN@ SC ∩ TP
CRF in LCN@ SC ∩ PCN
END in LCN@ SC ∩ PVN ∩ VH
EM in LCN@ SC 
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Abstract
The presence of the opioids β-endorphin, met-enkephalin and endomorphin and of corticotropin-
releasing factor (CRF) and the CRF-family member urocortin 1 (Ucn1) is described in 
cerebrospinal fluid-contacting neurons in the brain of the amphibian Xenopus laevis. 
Opioid peptides, CRF and Ucn1 in CSF-contacting neurons
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Introduction
Intercellular communication in the brain can be divided into two types: wiring 
transmission, via synaptic contacts, and volume transmission, by the diffusion of 
chemical messengers via the intercellular space or the cerebrospinal fluid (CSF). 
Since communication via the CSF is a relatively slow process, volume transmission 
may particularly control delayed-onset processes like emotion and stress adaptation 
(Roubos et al., 2001). Various peptides have been implicated in such processes, like 
opioids (Herckenham, 1991) and peptides from the corticotropin-releasing factor (CRF) 
family (Rothman et al., 2002). 
One of the intriguing questions as to volume transmission concerns the mechanism 
by which such neuropeptides are released into the CSF. Likely candidates are dendrites 
of CSF-contacting neurons (CSFcn), which occur throughout the vertebrate phylum but 
are particularly numerous in lower vertebrates (Vigh et al., 2004). Here we describe the 
presence of the opioids β-endorphin, met-enkephalin and endomorphin and the CRF-
family members CRF and urocortin 1 (Ucn1) in CSFcn in the brain of the amphibian 
Xenopus laevis. 
Material and Methods
Xenopus laevis (aged 6 months), reared under standard laboratory conditions were 
anaesthetised and brains were processed for light and immuno-electron microscopy 
using high-pressure freezing and cryosubstitution, as described elsewhere (Kramer 
et al., 2003; Wang et al., 2004). Primary antisera were against rat met-enkephalin, 
β-endorphin and endomorphin, all raised in rabbit (dilution 1:1,000), Xenopus CRF 
(dilution 1:15; R.J. Denver, Ann Arbor, MI, USA, personal communication; the CRF 
serum was his generous gift) and rat Ucn1 (1:30,000; generous gift from Dr J. Vaughan, 
La Jolla, CA, USA). 
No immunopositivity was observed when a first antiserum was omitted from the 
reaction. All studies were performed according to the guidelines of the Declaration 
of Helsinki and the Dutch law concerning animal welfare, as tested by the ethical 
committee for animal experimentation of Radboud University Nijmegen.
Results and Discussion
β-Endorphin. Immunopositive CSFcn were observed in the caudal part of the 
suprachiasmatic nucleus (SC), in the paraventricular organ (PVN) and in the ventral 
hypothalamic area. They send their dendritic processes in between the ependymal 
cells to the CSF (Fig. 1a).
Met-enkephalin. Some immunoreactive CSFcn were seen in the SC and in the tuberculum 
posterior, showing long, slender dendritic processes that contact the CSF (Fig. 1b).
Chapter 2
22
Endomorphin. Numerous moderately positive CSFcn are present in the SC (Fig. 1c), 
some of them located directly beneath the ependymal cell layer of the ventricle and 
protruding with their dendrites into the CSF.
CRF. A few immunopositive CSFcn occur in the SC and numerous immunoreactive 
CSFcn are present in the PVN. Some show short dendrites that run towards the 
ventricle, passing through the ependymal layer to contact the CSF (Fig. 1d).
Ucn1. Numerous immunoreactive CSFcn are situated in the anterior preoptic nucleus. 
They are small, pyriform or fusiform, and their processes run in between the ependymal 
cells to contact the CSF. In the magnocellular nucleus of the hypothalamus (Mg), 
many small, strongly stained CSFcn are situated near the border of the ventricle. They 
generally are fusiform, with many ramifying dendrites contacting the CSF (Fig. 1e).
Conclusion
Our immunocytochemical data show that both opioids and members of the CRF-
peptide family are present in CSFcn in the brain of Xenopus laevis, including in their 
dendrites. The ventricular location of these dendrites strongly suggests that the peptides 
are released into the CSF. We assume that the peptides are transported via the CSF to 
other parts of the ventricular system to become either bound to selective receptors in 
neuronal elements located in the ventricular wall or to diffuse into the brain to control 
specific targets situated at some distance from the CSF.
Fig 1. Arrows indicating CSFcn in the Xenopus laevis brain, immunopositive to β-endorphin in SC (a), 
met-enkephalin in SC (b), endomorphin in SC (c), CRF in PVN (d) and Ucn1 in Mg (e). Arrows point to 
dendrites contacting the CSF. Bar = 20 µm.
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Abstract
Brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, occurs 
abundantly in the brain, where it exerts a variety of neural functions. We previously demonstrated 
that BDNF also exists in the endocrine melanotrope cells in the intermediate lobe of the pituitary 
gland of the amphibian Xenopus laevis, suggesting that BDNF, in addition to its neural actions 
within the brain, can act as a hormone. In the present study, we tested if BDNF, in addition 
to its neural and hormonal roles, can be released as a neurohormone from the neural pituitary 
lobe of X. laevis. We show by light immunocytochemistry that BDNF is present in perikarya 
and in ventrolaterally projecting axons of the hypothalamic magnocellular nucleus, and in the 
neural lobe of the pituitary gland, and that it coexists in these structures with the amphibian 
neurohormone, mesotocin. The neural lobe was studied in detail at the ultrastructural level. 
Two types of neurohemal axon terminals were observed, occurring intermingled and in similar 
numbers. Type A is filled with round, moderately electron-dense secretory granules with a 
mean diameter of ca. 145 nm. Type B terminals contain electron-dense and smaller, ellipsoid 
granules (long and short diameter ca. 140 and 100 nm, respectively). BDNF is exclusively 
present in secretory granules of type A axon terminals. Double gold-immunolabelling revealed 
that BDNF coexists in these granules with mesotocin. We furthermore demonstrate in an 
in vitro superfusion study, that mesotocin stimulates peptide release from the endocrine 
melanotrope cells. On the basis of these data we propose that BDNF can act on these cells as a 
neurohormone.
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Introduction
In the mammalian brain, brain-derived neurotrophic factor (BDNF) is an abundant 
member of the nerve growth factor family. By binding specific receptors like TrkB 
and P75NTR, BDNF plays important roles in the control of a variety of brain processes, 
including growth, differentiation and maintenance of neuronal systems, plasticity of 
neurons and modulation of neurotransmitter-mediated actions (for reviews, see Chao 
and Hempstead, 1995; McAllister et al., 1999; Chao, 2003). For long it has been assumed 
that the brain is the exclusive endogenous source of BDNF and that this factor is 
locally released within the brain to have paracrine or autocrine neural actions (Kokaia 
et al., 1993). However, recently, a considerable level of BDNF was demonstrated in 
mammalian serum (Yamamoto and Gurney, 1990; Radka et al., 1996) including that 
of humans, where it may be related to the occurrence of mental disorders (Karege et 
al., 2002; Shimizu et al., 2003). This raises the question as to the source of circulating 
BDNF. One possibility is that it is produced within the brain and diffuses through the 
blood-brain barrier to reach the blood (Pan et al., 1998), but such a diffusion has not 
been shown in vivo. Another possibility is that BDNF is produced outside the brain. 
Infantile mouse ovary (Paredes et al., 2004) as well as human eosinophils express 
BDNF (Noga et al., 2003) but whether this BDNF is released into the blood in vivo 
is unknown. A more likely candidate BDNF source outside the brain is the pituitary 
gland. BDNF has been demonstrated in the rat anterior, intermediate and posterior 
pituitary lobe (Kononen et al., 1994; Conner et al., 1996; Hopker et al., 1997) and 
recently we found that the endocrine melanotrope cells in the intermediate pituitary 
lobe of the amphibian Xenopus laevis produce and release BDNF to stimulate their 
own biosynthetic and secretory activity in an autocrine fashion (Kramer et al., 2002; 
Wang et al., 2004). Most likely, BDNF acts on the melanotrope cells via TrkB receptors, 
as shown in the pars intermedia by RT-PCR (Kidane et al., 2005). These data indicate 
that BDNF, in addition to acting as a neural factor within the brain, can act as a true 
hormone, after being released from pituitary cells into the circulation. In the present 
study we elaborate on the possible properties of BDNF, by investigating if, in addition 
to the brain and the pituitary pars intermedia, the hypothalamo-neurohypophyseal 
system (HNS) of Xenopus laevis is a source of circulating BDNF. This animal model 
was chosen because its neuroendocrine system is known in much detail (de Rijk et 
al., 1992; Jenks et al., 1993a,b; Tuinhof et al., 1994a,b; Scheenen et al., 1995; Berghs et 
al., 1997; Roubos, 1997; Ubink et al., 1998; Roubos et al., 2001, 2002; Kolk et al., 2002; 
Wang et al., 2005a,b). We have tested the hypothesis that in X. laevis BDNF is produced 
by neurosecretory neurons in the hypothalamus and is present in neurohemal axon 
terminals in the pituitary neural lobe, to be released as a neurohormone. We have 
applied light immunocytochemistry and immuno-electron microscopy with the high-
pressure freezing-cryosubstitution method, to obtain optimal tissue preservation 
combined with strong immunoreactivity (Wang et al., 2005b). The distribution of BDNF 
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has been compared to that of the classical amphibian neurohormone in the amphibian 
HNS system, mesotocin (Vandesande and Dierickx, 1976; Dierickx and Vandesande, 
1977; van Vossel-Daeninck et al., 1979; Gonzáles and Smeets, 1992). We show by in 
vitro superfusion, that mesotocin activates the release of α-MSH from the melanotrope 
cells in the pituitary intermediate lobe, and propose a similar role for BDNF after its 
neurohormonal release from the neurohypophysis.
Methods
Animals 
Thirty young-adult (age 6 months) specimens of Xenopus laevis, with a body weight 
of 28-32 g, were raised in our Nijmegen laboratory under 24-h illumination, on a black 
background, at a water temperature of 22 ± 1 °C, and fed weekly on ground beef heart 
(Janssen, Nijmegen, The Netherlands) and Trouvit trout pellets (Trouvit, Trouw, Putten, 
The Netherlands). Ten were used for in vitro superfusion studies (see below). The others 
were deeply anaesthetised by immersion in a solution of 0.1% tricaine methane sulfonate 
(MS222; Novartis, Basel, Switzerland) in tap water, and transcardially perfused with 
ice-cold 0.6% sodium chloride, for 5 min, to wash out blood cells, and further processed 
for light or electron microscopical immunocytochemistry. Experiments were carried 
out according to the Declaration of Helsinki and the Dutch law concerning animal 
welfare, as tested by the ethical committee for animal experimentation of Radboud 
University Nijmegen. 
Light microscopic immunocytochemistry
Twenty animals were perfused with 250 ml ice-cold Bouin’s fixative, for 15 min. 
After dissection, brains with the pituitary gland attached were postfixed in the same 
fixative, for 16 h at 4 °C, and then washed in 70% alcohol, to eliminate excess of picric 
acid, for 24 h. 
Cryostat immunocytochemistry. Ten fixed brains were rinsed and cryoprotected in 30% 
sucrose in sodium phosphate-buffered saline 10 mM (PBS; pH 7.6) and subsequently 
frozen in tissue tek (Sakura, Tokio, Japan). Coronal sections (20 µm) were mounted 
on poly-L-lysine-coated slides (Sigma Chemicals, St. Louis, CA, USA) and dried at 
37 °C for 16h. The tyramide signal amplification (TSA) technique was applied and 
immunodetection was performed as follows. To quench endogenous peroxidase, 
sections were incubated with 1% hydrogen peroxide (H2O2) in 0.1 M PBS for 15 min. 
After rinsing in PBS containing 0.02% Triton X-100 (PBS-T; Sigma Chemicals), sections 
were incubated in 0.5% TSA blocking reagent (NEN Life Science Products, Boston, 
MA, USA) in PBS (PBS-BT) for 20 min to prevent aspecific binding. Subsequently, they 
were incubated in rabbit-anti-BDNF serum (1:200; N-20, Santa Cruz Biotechnology, 
Santa Cruz, CA, USA) or rabbit-anti-mesotocin (1:10,000; refs Vandesande and 
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Dierickx, 1976 and van Vossel-Daeninck et al., 1979) in PBS-BT for 16 h, rinsed in PBS-
T and incubated in biotinylated secondary goat-anti-rabbit antibody (1:200; Vector 
Laboratories, Burlingame, CA, USA). Sections were then rinsed in PBS-T and incubated 
with streptavidin conjugated to HRP (1:100; NEN Life Science Products) for 30 min. 
After rinsing in PBS-T, sections were incubated in fluorescein-conjugated tyramide 
solution (1:50 in Amplification Diluent; NEN Life Science Products) for 10 min, rinsed 
in PBS, coverslipped in Fluorsave (Calbiochem, La Jolla, CA, USA) and studied with a 
Leica DMRBE light microscope (Leica Microsystems, Heerbrugg, Switzerland).
Paraffin immunocytochemistry. Ten brains were dehydrated through a graded series of 
ethanol and embedded in paraffin. Coronal sections (8 µm) were mounted on poly-
L-lysine-coated slides (Sigma Chemicals) and allowed to air-dry, for 16 h at 45 °C, 
deparaffinized and rehydrated. For five fixed brains the TSA method was applied 
as described above for the cryostat sections. For the other five brains the subsequent 
staining procedure was carried out, at 20 °C. Endogenous peroxidase activity was 
quenched with 0.1% H2O2 in PBS, for 30 min. Then, to prevent unspecific binding, 
sections were rinsed for 1 h in PBS-T and a combination of 2.5% normal goat serum 
(NGS; Vector Laboratories) and 2.5% normal horse serum (NHS; Vector Laboratories). 
Sections were then rinsed in an avidine/biotine blocking solution (Vector Laboratories), 
for 15 min, and incubated with anti-BDNF (1:200) or anti-mesotocin (1:10,000) diluted 
in PBS-T, for 16 h at 20 °C. Immunodetection was carried out with a Vectastain ABC 
elite kit (rabbit; Vector Laboratories). After rinsing the sections in PBS and in Tris-HCl 
buffer for 30 min, the reaction product was visualized with 0.04% 3-3’-diaminobenzidine 
(DAB; Sigma) and 0.015% H2O2 in Tris-HCl buffer containing 0.5% nickel-ammonium 
sulphate, for approximately 10 min. The reaction was controlled under a microscope 
and was stopped with several rinses in Tris-HCl buffer. In some cases, intensification 
of the staining was achieved with 0.5% nickel-ammonium sulfate in the DAB solution. 
Then sections were rinsed once in PBS, mounted with Entellan (Merck, Darmstadt, 
Germany) and studied with the Leica microscope.
High-pressure freezing and cryosubstitution
Ten animals were perfused with 250 ml 0.2% ice-cold glutaraldehyde in PBS (pH 
7.4), for 5 min, and prepared for immuno-electron microscopy using our high-pressure 
freezing and cryosubstitution method (Wang et al., 2005b). In short, after decapitation, 
neurointermediate lobes of the pituitary gland were dissected and postfixed in the 
same fixative, for 1 h at 4 °C, washed in PBS, and mounted under 1-hexadecene 
(Merck, Hohenbrunn, Germany) into the cavity of an aluminum planchette (ALU Ø 
3 X 0.5 mm and an inner cavity of Ø 2X 0.15 mm; Waldner, Uetliburg, Switzerland) 
for high pressure freezing. The planchette was covered with the flat side of another 
planchette coated with lecithin (3-sn-phosphatidyl choline; Fluka, Buchs, Switzerland) 
to ease opening of the planchette sandwich. The sandwich was placed into a high-
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pressure freezing apparatus (Leica HPF, Leica Microsystem, Vienna, Austria) in which 
the tissue was rapidly cryofixed at 2100 bar (Wang et al., 2005b). Under liquid nitrogen, 
the planchette sandwiches were opened and the 1-hexadecene was removed with 
forceps and a dissection needle. Then the frozen lobes were put into microtubes (Saf-
T-Seal, Biozym, Landgraaf, The Netherlands) containing 0.5% uranyl acetate and 0.2% 
glutaraldehyde in methanol, and kept at -90 °C in a cryosubstitution unit (CS Auto; 
Leica). Next, a substitution program was performed: after 50 h at -90 °C, the temperature 
was raised in steps by 4 °C/h and maintained at -40 °C for 6 h. Then samples were 
washed with precooled methanol and embedded at -40 °C into Lowicryl HM20 resin 
(Electron Microscopy Science, Fort Washington, PA, USA). Polymerisation of the resin 
was performed under UV irradiation at -40 °C for 16 h and at 20 °C for another 24 h 
(Wang et al., 2005b). Thick (about 2 µm) sections were made with a Reichert OMU4 
ultramicrotome (Reichert, Vienna, Austria) to locate with a light microscope the neural 
and intermediate lobe. Then ultrathin, pale-gold sections were cut. 
Immunolabelling for electron microscopy
For single labelling, ultrathin sections were first incubated in 0.01 M PBS (pH 7.4), for 
2 x 5 min. Aspecific protein binding sites were blocked by phosphate-buffered gelatine 
(PBG; 0.5% BSA, fraction V and 0.045% teleostean gelatin, both from Sigma Chemicals) 
in PBS, for 2 x 15 min. Then, they were incubated in rabbit anti-mesotocin (1:10,000) 
or rabbit anti-BDNF (1:200) in PBG, for 16 h. After washing in PBG for 6 x 5 min, 
sections were incubated with 5 or 10 nm gold-conjugated secondary antibodies (goat 
anti-rabbit; BB International, Cardiff, UK), for 2 h, washed with PBG and PBS, each 
for 4 x 5 min, postfixed in 1% glutaraldehyde in PBS, for 15 min, and contrasted with 
2% uranyl acetate and lead citrate, each for 6 min. Sections were examined with a Jeol 
1010 electron microscope (Jeol, Tokyo, Japan). For immunodouble-labelling, the same 
procedure as for single-labelling was followed, but labelling was executed on both 
faces of the ultrathin section. Rabbit anti-BDNF and the secondary goat anti-rabbit IgG 
(5 nm gold particles) were applied on one face. After postfixation in glutaraldehyde, 
the section was thoroughly rinsed and the second immunolabelling was performed on 
the other face of the section with rabbit anti-mesotocin and goat anti-rabbit IgG (10 nm 
gold particles).
Specificity of immune reactions
All immune reactions were tested for specificity by (1) omitting the first antiserum 
and (2) using sera that had been preabsorbed with the respective antigens. Rabbit 
anti-BDNF was preabsorbed with excess (50 µg/ml) of recombinant rh human BDNF 
(Promega, Leiden, The Netherlands), and rabbit anti-mesotocin was preabsorbed with 
excess (50 µg/ml) of synthetic mesotocin (Bachem, Bubendorf, Switzerland). 
In no case any immunoreactivity was found in such test preparations. 
BDNF in the brain of X. laevis
31
Superfusion
Twelve animals were decapitated, their neurointermediate pituitary lobes dissected, 
and melanotrope cells dissociated as described before (Scheenen et al., 1995). In short, 
lobes were incubated for 45 min in Ringer’s solution without CaCl2 to which 0.25% (w/v) 
trypsin (Gibco, Renfrewshire, UK) had been added. Cells were subsequently dispersed 
in Leibovitz’s L15 medium (Life Technologies, Paisley, UK) adjusted to X. laevis blood 
osmolality (XL15: ultrapure water = 2:1) and containing 10% foetal calf serum (Gibco), 
by gentle trituration of the lobes with a siliconised Pasteur’s pipette. After washing, 
cells were resuspended in lysine-free XL15 and in dialyzed foetal calf serum (FCS; 
Life Technologies). After centrifugation, cells were resuspended in lysine-free XL15 
containing 250 µCi 3H-labelled lysine (Amersham, Buckinghamshire, UK) and plated 
onto poly-L-lysine-coated 15 mm Ø glass cover slips. After the cells had been allowed 
to attach for 1 h, they were cultured for two days at 22 °C in humidified atmosphere in 
lysine-free XL15 containing 10% dialyzed FCS. For superfusion, cells were rinsed with 
X. laevis Ringer’s four times and placed in a 4-well plate (Nuclon, Roskilde, Denmark). 
This was followed by superfusing the cells with Ringer’s at a rate of 75 µl/min for 1.5 
h, after which mesotocin (Bachem, Bubendorf, Switzerland) was added in pulses of 
10 min, in different concentrations (for protocol, see Results). Fractions were collected 
every 2 min, and 160 µl scintillation fluid (Optiphase Supermix; Wallac, Loughborough, 
UK) was added. The amount of radiolabelled peptides in each fraction was determined 
with a scintillation counter (Wallac) and data were collected with Microbeta software 
(Wallac). For each experiment the average of the first 20 fraction values was considered 
as the control release level and set as 100%. It was previously shown that about 30-50% 
of the radioactivity in the superfusate is unincorporated (3H)lysine (Scheenen et al., 
1995).
Results
General remarks
Light microscopic immunocytochemistry was carried out on cryostat and paraffin 
sections. All data presented are essentially the same for both types of technique. 
However, the cryostat technique yielded a more intense immunostaining and the 20-
µm-thick sections permitted us to study the course of stained fibres over relatively 
long distances, whereas in the 8-µm paraffin sections, individual neuronal cell bodies 
and thin fibre tracts could be identified more accurately. In order to enhance the signal 
intensities of BDNF-positive fibres and cell bodies, the TSA method was applied. The 
occurrence of immunoreactive cell bodies in X. laevis brain structures was assessed 
through the analysis of serial sections (Fig. 1), and semiquantitatively expressed in 
Table 1. 
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The brain
In the X. laevis brain, BDNF-immunoreactivity has a wide distribution (Fig. 1; Table 
1). In the telencephalon, many neuronal perikarya are present in the medial pallium 
(Fig. 2a) and fibres occur in the medial olfactory tract, lateral septum (Fig. 2b), diagonal 
band of Broca, medial and lateral part of the amygdala, and the anterior commissure. 
In the diencephalon, some positive cell bodies were observed in the suprachiasmatic 
nucleus (Fig. 2c) and posterior thalamic nucleus, a few perikarya occur in the posterior 
tubercle, and many stained cells are present in the ventral hypothalamic area (Fig. 
2d). Immunoreactive fibres run in the preoptic area, in the ventromedial, central 
and posterior thalamic nucleus, suprachiasmatic nucleus, lateral hypothalamus 
and posterior tubercle. In the mesencephalon, a few positive neurons were found 
in the anterior and dorsal tegmental nucleus (Fig. 2e), whereas many long, beaded 
fibres run in the tectum mesencephali (Fig. 2f) and a few in the Edinger-Westphal 
nucleus, anteroventral and dorsal tegmental nucleus and posterior commissure. In 
the diencephalon, staining appears in perikarya in the ventral and, especially, in the 
medial part of the magnocellular nucleus, the latter revealing about 10 moderately 
immunopositive cells (Fig. 2g). From this part of the brain, axons can be traced into 
the ventrolateral direction (Fig. 2h), running towards the internal zone of the median 
eminence of the hypothalamus. 
The distribution of mesotocin-immunoreactivity in the Xenopus brain confirms 
previous descriptions (van Vossel-Daeninck et al., 1979; Gonzáles and Smeets, 
1992). In short, in the telencephalon, fibres occur in the internal granule cell layer of 
the olfactory bulb, postolfactory eminence, medial septum, medial pallium, lateral 
septum, striatum, nucleus accumbens, diagonal band of Broca, medial and lateral 
part of the amygdala, and anterior commissure (Fig. 1). In the diencephalon, some 
mesotocin-positive perikarya are present in the ventromedial thalamic area (Fig. 
3a) and in the suprachiasmatic nucleus (Fig. 3b), whereas fibres run in the preoptic 
area, central and ventromedial thalamic nucleus, suprachiasmatic nucleus, nucleus of 
the paraventricular organ and the lateral hypothalamic area. In the mesencephalon, 
Fig. 1. Top left: schematic dorsal view of the brain of X. laevis, with A-L indicating the levels of 
transverse sections used to determine the presence of BDNF and mesotocin throughout the brain. In 
panels A to L, BDNF distribution is schematically indicated on the left and mesotocin distribution on 
the right. Immunoreactive perikarya are indicated by black dots and immunoreactive main axon tracts 
by lines. Ac, anterior commissure; Acc, nucleus accumbens; Ad, anterodorsal tegmental nucleus; Apl, 
amygdala, pars lateralis; Apm, amygdala, pars medialis; Av, anteroventral tegmental nucleus; C, central 
thalamic nucleus; DB, diagonal band of Broca; EW, Edinger-Westphal nucleus; igl, internal granule 
cells of the olfactory bulb; LH, lateral hypothalamic nucleus; ls, lateral septum; lv, lateral ventricle; 
me, median eminence of the hypothalamus; Mgd, dorsal part of magnocellular nucleus; Mgm, medial 
part of magnocellular nucleus; Mgv, ventral part of magnocellular nucleus; mot, medial olfactory 
tract; mp, medial pallium; ms, medial septum; NPv, nucleus of the paraventricular organ; ON, optic 
nerve; P, posterior thalamic nucleus; pc, posterior commissure; pd, pituitary pars distalis; pe, post-
olfactory eminence; pi, pituitary pars intermedia; pn, pituitary pars nervosa; Poa, preoptic area; SC, 
suprachiasmatic nucleus; Str, striatum; tect, mesencephalic tectum; TP, posterior tubercle; VH, ventral 
hypothalamic nucleus; VM, ventromedial thalamic nucleus (see abbreviations list).
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Fig. 2. Brain sections of Xenopus laevis, showing BDNF-immunoreactive perikarya and fibres (arrowheads) 
in (a) medial pallium, (b) lateral septum, (c) suprachiasmatic nucleus, (d) ventral hypothalamic area, (e) 
anterodorsal tegmental nucleus, (f) tectum mesencephali, (g) medial part of the magnocellular nucleus, 
and (h) magnocellular region with fibres running towards median eminence. In a, c, d and h bar = 20 
µm, in b, e, f and g bar = 10 µm.
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fibres occur only in the tectum mesencephali and posterior commissure. We focused 
especially on the magnocellular nucleus and found immunoreactivity in all three of its 
areas: many immunopositive perikarya are present in the ventral, in the medial and in 
the dorsal area, and from each area axons run into ventrolateral direction towards the 
median eminence (Fig. 3c). 
The median eminence
BDNF staining was found in both the external and internal zone of the median 
eminence (Fig. 4a). In the external zone, which has neurohemal axon terminals 
contacting the hypothalamo-hypophyseal portal system, BDNF appears to be present 
as small immunoreactive dots, whereas in the internal zone strongly BDNF-positive 
fibres run into the direction of the pituitary neural lobe. 
Strong mesotocin-immunoreactivity occurs in the internal zone of the median 
eminence whereas in the external zone no appreciable staining was seen (Fig. 4b). 
The pituitary gland
Light microscopically, strong dot-like BDNF-immunoreactivity, indicating the 
presence of BDNF in neurohemal axon terminals, was seen throughout the neural lobe 
(Fig. 4c). Similarly, anti-mesotocin stains the neural lobe in a dotted pattern (Fig. 4d). 
In the intermediate lobe of the pituitary gland, BDNF is present in the melanotrope 
cells (Fig. 4c), whereas no immunoreactivity was observed in these cells for mesotocin 
(not shown). In the distal lobe of the pituitary gland, BDNF-immunoreactivity occurs 
in scattered endocrine cells with varying staining intensities, but especially in a rostral 
endocrine cell group (Fig. 4e). No cells in the distal lobe stain with the anti-mesotocin 
serum (not shown).
Fig. 3. Brain of Xenopus laevis, showing mesotocin-immunoreactive perikarya in (a) ventromedial 
thalamic area, (b) suprachiasmatic nucleus, and (c) medial (Mgm) and ventral (Mgv) part of the 
magnocellular nucleus; arrowheads indicate fibres running towards the median eminence. In a and b 
bar = 10 µm, in c bar = 30 m.
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Special attention was paid to the neural lobe of the pituitary, using immuno-
electron microscopy after high-pressure freezing and cryosubstitution, which yields 
superior ultrastructure compared to conventional electron microscopy preparation 
techniques (Wang et al., 2005b). In this lobe, neurohemal axon terminals appear to 
be filled with secretory granules of various size, shape and electron-density. Based 
on these morphological characteristics, two types of axon terminal are distinguished. 
These types occur intermingled and contact widened intercellular spaces (Fig. 5a) 
and capillaries. The first type (type A) contains large (mean diameter about 145 nm) 
round secretory granules with a moderately electron-dense core, while the other type 
(type B) is characterized by the presence of strongly electron-dense, ellipsoid granules 
Fig. 4. Median eminence of Xenopus laevis, stained with (a) anti-BDNF or (b) anti-mesotocin, with 
arrowheads indicating fibres running via internal zone (iz) towards neural lobe, and BDNF-
immunoreactive neurohemal axon terminals in external zone (ez). (c) BDNF-immunoreactivity of 
neurohemal axon terminals (arrowheads) in neural lobe (nl) and of melanotrope cells in intermediate lobe 
(il) of the pituitary gland. (d) Mesotocin-immunoreactivity of neurohemal axon terminals (arrowheads) 
in neural lobe (nl). (e) BDNF-immunoreactive endocrine cells in distal lobe (dl) of pituitary gland. In a, 
b, d, e bar = 20 µm, in c bar = 40 µm. 
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Fig. 5. Immunogold electron microscopy of the pituitary neural lobe of Xenopus laevis, with type A 
and type B neurohemal axon terminals. (a) Type A terminals with large and round secretory granules 
covered with gold particles to indicate BDNF-immunoreactivity. (b) Type B terminals with smaller and 
ellipsoid secretory granules and type A terminals immunoreactive to mesotocin. (c) Immunodouble-
labelling showing coexistence in type A neurohemal axon terminals, with large gold particles (10 
nm; arrowheads) revealing immunoreactivity to anti-BDNF and small gold particles (5 nm; arrows) 
indicating immunoreactivity to mesotocin. Asterisks in panel a and c indicate intercellular space. Bar a 
= 400 nm, b = 500 nm, c = 250 nm.
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with a mean long diameter of ca. 140 nm and a mean short diameter of ca. 100 nm 
(Fig. 5). BDNF-immunoreactivity is exclusively present in type A terminals, and is 
restricted to secretory granules. The number of immunogold particles is high (Fig. 
5a), demonstrating the high affinity of the antiserum for BDNF. Mesotocin is also 
exclusively seen over secretory granules in type A terminals (Fig. 5b). Immunodouble 
labelling using different gold particle sizes for the two different antisera, reveals that 
BDNF and mesotocin coexist within the secretory granules of type A neurohemal axon 
terminals (Fig. 5c). 
The effect of mesotocin on α-MSH release 
An in vitro superfusion study was conducted to test if mesotocin can stimulate α-
MSH release from melanotrope cells. Exposure to mesotocin evoked a clear, dose-
dependent stimulation of radiolabelled peptide release (Fig. 6). At a concentration  of 
10-7 M, mesotocin stimulated peptide release by ca. 36%, whereas at 10-6 M mesotocin 
this stimulation was ca. 45%. To test the viability and reactivity of the melanotropes after 
mesotocin stimulation, the potent inhibitor of melanotrope α-MSH release, dopamine 
(DA; Verburg-van Kemenade et al., 1986) was applied. Exposure to 10-8 M DA strongly 
inhibited melanotrope cell release of radiolabelled peptides, viz. by 50%. 
Fig. 6. Effect of two concentrations of mesotocin (meso; 10-7 M and 10-6 M) on the release of radiolabelled 
peptides (mainly α-MSH; Scheenen et al., 1995) from dissociated Xenopus melanotrope cells superfused 
in vitro. Vertical bars indicate 10-min fractions during which mesotocin or the inhibitor dopamine (DA; 
10-8M) was given. Secretion is expressed as a percentage of control release level, set at 100% (n=4).
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Discussion
Occurrence of BDNF
In this study we present the first detailed description of the distribution of BDNF 
in the brain and pituitary gland of an amphibian, viz. the South African clawed toad 
Xenopus laevis. It appears that BDNF has a widespread distribution, occurring in various 
brain centres as well as in the three lobes of the pituitary gland. The broad distribution 
of BDNF in the X. laevis brain is in line with the occurrence of BDNF in various brain 
centres in mammals and suggests that, like in mammals, BDNF may exert various 
trophic and modulatory neural actions in amphibians (cf. Chao and Hempstead, 1995; 
McAllister et al., 1999; Chao, 2003). Furthermore, the demonstration of BDNF in the 
pituitary pars intermedia confirms our previous conclusion that BDNF can act as a 
hormone, being released from the endocrine melanotropes into the blood (Kramer et 
al., 2002; Wang et al., 2004). In the present study we have focused on the possibility 
that BDNF can have a third way of action, viz. as a neurohormone, being produced 
by neurons in the Mg and being transported to neurohemal axon terminals in the 
pituitary neural lobe.
BDNF may be released as a neurohormone from the neural pituitary lobe
We show the presence of BDNF-immunoreactivity in the HNS of X. laevis. The 
light microscope data strongly indicate that especially neurons in the medial part of 
the magnocellular nucleus produce BDNF and transport the factor via their axons to 
the external zone of the median eminence and also further, via the internal zone of 
the eminence, to the neural lobe of the pituitary gland. The magnocellular nucleus 
of amphibians is considered to be homologous with the mammalian supraoptic and 
paraventricular nuclei (Tuinhof et al., 1994a). In both nuclei, BDNF has been shown to 
be present, whereas BDNF was also demonstrated in the rat neural lobe (Kononen et al., 
1994; Conner et al., 1996). The present study is the first to reveal the presence of BDNF in 
the HNS of a non-mammalian vertebrate, highlighting the neuroendocrine importance 
of this evolutionary apparently well-conserved protein. Moreover, we demonstrate at 
the ultrastructural level that BDNF is present within secretory granules in neurohemal 
axon terminals in the neural lobe. The immuno-electron microscopical double labelling 
study reveals that these granules also contain the classical neurohormone mesotocin. 
This neurohormone is released in a neurohemal fashion into the blood (Rodriguez, 
1984). Its granular coexistence with BDNF in neurohemal axon terminals strongly 
suggests that BDNF will also be released from these terminals in a neurohemal fashion, 
which would be the first evidence that BDNF can act as a neurohormone. 
The functional role of BDNF released from the X. laevis neural lobe is not known, 
but in view of the fact that the neural lobe is closely apposed to the intermediate lobe, 
neurohormonally released BDNF might reach the melanotrope cells to stimulate or 
modulate their cellular activity. This routing and action of BDNF is the more feasible, 
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Brain region BDNF Mesotocin
Cells Fibres Cells Fibres
Telencephalon
Olfactory bulb, mitral cells (ml)
Olfactory bulb, internal granule cells (igl) +
Medial olfactory tract (mot) +
Postolfactory eminence (pe) +
Medial septum (ms) +
Lateral septum (ls) + +
Medial pallium (mp) +++ +
Dorsal pallium (dp)
Striatum (Str) +
Nucleus accumbens (Acc) +
Diagonal band of Broca (DB) + +
Amygdala pars medialis (Apm) + +
Amygdala pars lateralis (Apl) + +
Anterior commissure (ac) + +
Diencephalon
Ventromedial thalamic nucleus (VM) + ++ +
Anterior thalamic nucleus (A)
Central thalamic nucleus (C) + +
Posterior thalamic nucleus (P) ++ +
Magnocellular nucleus, ventral part (Mgv) + +++ +
Magnocellular nucleus, medial part (Mgm) +++ + +++ +
Magnocellular nucleus, dorsal part (Mgd) ++ +
Suprachiasmatic nucleus (SC) ++ + + +
Nucleus of the paraventricular organ (Npv) +
Lateral hypothalamic area (LH) + +
Posterior tubercle (TP) + +
Ventral hypothalamic nucleus (VH) +++
Median eminence zona interna + +
Median eminence zona externa +
Pituitary pars nervosa (pn) + +
Pituitary pars intermedia (pi) +++
Pituitary pars distalis (pd) ++
Mesencephalon
Tectum mesencephali (tect) + +
Edinger-Westphal nucleus (EW) +
Anteroventral tegmental nucleus (Av) + +
Anterodorsal tegmental nucleus (Ad) + +
Posterior commissure (pc) + +
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because we here show that mesotocin, present in the same granules as BDNF, also has 
a clear action on the melanotropes, at least in vitro. The fact that BDNF stimulates both 
POMC biosynthesis and α-MSH release by X. laevis melanotrope cells in vitro (Kramer 
et al., 2002), as well as our recent demonstration by RT-PCR of TrkB receptor mRNA 
in the neurointermediate lobe of the X. laevis pituitary (Kidane et al., 2005) is also in 
support of the idea that BDNF acts on melanotropes. 
BDNF and other messengers in the neural lobe
In addition to BDNF, previously various neuropeptides were demonstrated in 
the amphibian neural lobe. The first of these peptides, together with vasotocin, 
was mesotocin (Vandesande and Dierickx, 1976; Dierickx and Vandesande, 1977; 
van Vossel-Daeninck et al., 1979; Gonzáles and Smeets, 1992), which has a diuretic 
action, most likely acting peripherally on kidney, skin and bladder (Pang and Sawyer, 
1978; Warburg, 1995). In our study we not only confirm the widespread occurrence 
of mesotocin in the Xenopus brain, but we also show that it is in neurohemal axon 
terminals in the neural lobe together with BDNF, and that it may stimulate peptide 
secretion from the melanotrope cells in the pituitary pars intermedia. Therefore, like 
BDNF, mesotocin seems to be a neurochemical messenger with multiple roles, both as 
a neural factor in the brain and as a neurohormone released from the pituitary after 
which it may act peripherally, as well as more locally on the pars intermedia. 
As to the external zone of the median eminence, we did not find any appreciable 
staining of mesotocin-immunoreactive fibres, in contrast to the situation in the 
external zone of the median eminence in the frog  where immunopositive fibres have 
been described (Dierickx and Vandesande, 1977; van Vossel-Daeninck et al., 1979). 
Ultrastructural studies may reveal whether mesotocin is absent from the external zone 
in the Xenopus median eminence, or that the number of secretory granules stored in the 
axon terminals is too low to be detected by light immunocytochemistry. 
The stimulatory action of mesotocin on the Xenopus melanotrope cells is in contrast 
with the situation in the frog Rana ridibunda, where mesotocin does not affect α-MSH 
release from the pituitary intermediate lobe in vitro (Tonon et al., 1986; Lamacz et al., 
1989). Thus, differences may exist among different amphibian species as to the diverse 
roles of mesotocin. The ultrastructural location of mesotocin, however, seems to be 
very similar among amphibians. Mesotocin was immunocytochemically demonstrated 
at the ultrastructural level in secretory granules in the neural lobe of the frog, Rana 
ridibunda (Lamacz et al., 1989). These granules occur in a subpopulation of neural lobe 
axons, measure ca. 160 nm in diameter, and face capillaries. Similar observations were 
Table 1. Semiquantitative distribution of BDNF- and mesotocin-immunoreactive perikarya and fibres 
in the X. laevis brain and pituitary gland, visualized by cryostat and paraffin immunocytochemistry of 
sections made at the levels A-L, as indicated in Fig. 1. The numbers of positive cell bodies are expressed 
as follows: 1 - 4: + (‘few’); 5 - 8: ++ (‘some’); 9 or more: +++ (‘many’). Immunoreactive fibres are always 
indicated by +.
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made in the bullfrog Rana catesbeiana (Shioda et al., 1989). Possibly, these frog axons 
are homologous with the type A terminals that we show to contain both BDNF and 
mesotocin in the toad X. laevis. In frog, a subpopulation of the mesotocin-containing 
axons also contains thyroid-stimulating hormone (TRH) (Lamacz et al., 1989; Shioda 
et al., 1989), which is known to stimulate α-MSH release from frog and from X. laevis 
melanotrope cells (Vaudry et al., 1977; Verburg-van Kemenade et al., 1987b; Galas 
et al., 1998; Galas et al., 1999). We have not been able to detect TRH in the X. laevis 
neural lobe at the ultrastructural level (L.C. Wang, unpubl. res.). On the other hand, 
by light microscopical immunocytochemistry of the neural lobe the presence has been 
demonstrated of TRH, corticotropin-releasing hormone, urocortin 1 and vasotocin, 
and ultrastructurally the presence was shown of urocortin 1 in both type A and type B 
terminals (Conway and Grainer, 1987; Verburg-van Kemenade et al., 1987a,b; Gonzáles 
et al., 1995; Calle et al., 2005b/Chapter 4). These chemical messengers are all known to 
stimulate α-MSH release by the X. laevis melanotrope cells (Verburg-van Kemenade et 
al., 1987a,b; Tonosaki et al., 2004; Calle et al., 2005b/Chapter 4). 
Taken these data together, we propose that the X. laevis neural lobe is an important 
site of neurohormonal control of the melanotrope cells, being responsible for the 
neurohormonal release of multiple stimulatory messengers of melanotrope cell activity. 
This sheds a new light on the functional significance of the close anatomical association 
between the neural and intermediate lobe of the pituitary gland. 
As retrograde tracing of the neural lobe only labels the magnocellular nucleus 
(Tuinhof et al., 1994a), all messengers present in the neural lobe are likely produced in 
the magnocellular nucleus. Detailed colocalization studies will have to show possible 
coexistences of these factors in various subpopulations of magnocellular neurons and 
in their neurohemal axon terminal types.
BDNF and the distal pituitary lobe
In our study, the dot-like immunostaining of the external zone of the median 
eminence suggests that BDNF occurs in neurohemal axons terminals of this neurohemal 
organ and, therefore, can be released as a neurohormone into the portal system of 
the hypothalamo-hypophyseal system. This idea would seem to be in contrast with 
the situation in mammals, because in the rat median eminence BDNF is essentially 
located in astrocytes and tanycytes and not in neurohemal axon terminals (Givalois et 
al., 2004). Since selective antibodies have labelled TrkB receptors in various cell types 
of the median eminence, it is likely that BDNF is not released as a neurohormone from 
the rat median eminence into the circulation but rather has a local, paracrine action 
(Givalois et al., 2004). Detailed ultrastructural observations on the median eminence 
of X. laevis may support our assumption that BDNF in amphibians is released as a 
neurohormone from the external zone of the median eminence. BDNF released as a 
neurohormone into the portal system would readily reach endocrine cells in the distal 
lobe of the pituitary gland. In mammals, TrkB receptors are expressed in this lobe 
BDNF in the brain of X. laevis
43
(Kononen et al., 1994) and in Xenopus laevis, TrkB receptor mRNA is present in clusters 
of, yet unidentified, endocrine cells in the distal lobe of the pituitary gland (Kidane et 
al., 2005).
In the rat distal pituitary lobe, varying degrees of BDNF-immunoreactivity have 
been observed, suggestive of BDNF acting as a hormone after being released from 
this lobe into the circulation (Conner et al., 1996; Hopker et al., 1997). This situation 
is consistent with our present observation of BDNF-immunoreactivity in the X. laevis 
distal pituitary lobe, and suggests that in addition to the intermediate lobe, the neural 
lobe and the median eminence, also the distal pituitary lobe in this amphibian can 
be a source of circulating BDNF. In the rat, BDNF seems to be exclusively present in 
distal lobe cells that also contain thyroid-stimulating hormone (Conner et al., 1996). 
The rostral position and the low abundance of the BDNF-positive cells in the Xenopus 
laevis anterior lobe of the pituitary gland suggest that these cells may be corticotropes, 
but this possibility awaits further proof. 
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Abstract
We have raised the hypothesis that in the South African clawed toad Xenopus laevis urocortin 
1 (Ucn1), a member of the corticotropin-releasing factor (CRF) peptide family, functions not 
only within the brain as a neurotransmitter but also as a neurohormone, promoting the release 
of α-melanophore-stimulating hormone (α-MSH) from the neuroendocrine melanotrope cells 
in the intermediate lobe of the pituitary gland. This hypothesis has been investigated by (1) 
assessing the distribution of Ucn1 and CRF by light immunocytochemistry, (2) determining 
the subcellular presence of Ucn1 in the neural lobe of the pituitary gland by immuno-electron 
microscopy applying high-pressure freezing and cryosubstitution, and (3) testing the effect 
of Ucn1 on α-MSH release from toad melanotrope cells using in vitro superfusion. In the X. 
laevis brain, the main site of Ucn1-positive somata was found to be the Edinger-Westphal 
nucleus. Ucn1 immunoreactivity (ir) also occurs in the nucleus posteroventralis tegmenti, 
central grey, nucleus reticularis medius, nucleus motorius nervi facialis and nucleus motorius 
nervi vagi. Ucn1 occurs together with CRF in the nucleus motorius nervi trigemini, and in 
the magnocellular nucleus, which sends a Ucn1- and CRF-containing fibre tract to the median 
eminence. Strong Ucn1-ir and CRF-ir were found in the external zone of the median eminence. 
From the internal zone of the median eminence Ucn1-ir fibres, but few CRF-ir fibres, were 
found to project to the pituitary neural lobe, where they form numerous neurohemal axon 
terminals. Ultrastructurally, two types of terminal containing Ucn1-ir secretory granules 
were distinguished: type A contains large, moderately electron-dense, round secretory granules 
and type B is filled with smaller, strongly electron-dense, ellipsoid secretory granules. In vitro 
superfusion studies showed that Ucn1 stimulated the release of α-MSH from melanotrope 
cells in a dose-dependent manner. Our results support the hypothesis that in X. laevis, Ucn1 
released from neurohemal axon terminals in the pituitary neural lobe functions as a stimulatory 
neurohormone for α-MSH release from melanotrope cells in the pituitary intermediate lobe. 
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Introduction
Urocortin I (Ucn1) is a 40 amino acid peptide first isolated from rat brain by 
molecular cloning in 1995 (Vaughan et al., 1995). It is a member of the corticotropin-
releasing factor (CRF) peptide family and exhibits 45% amino acid sequence similarity 
to rat CRF, 63% sequence similarity to carp urotensin I and 35% sequence similarity to 
sauvagine (Vaughan et al., 1995). The main sites of Ucn1 production in the mammalian 
brain are the Edinger-Westphal nucleus, from which Ucn1 is transported to the spinal 
cord, the lateral septum (Bittencourt et al., 1999; Skelton et al., 2000) and the lateral 
superior olive where Ucn1 is proposed to target accessory optic, precerebellar and 
auditory structures and the spinal intermediate grey. In addition, moderate levels of 
Ucn1-immunoreactivity (ir) occur in the cerebellum, hippocampus, neocortex, olfactory 
system, basal ganglia, amygdala and the supraoptic, ventromedial and paraventricular 
nuclei of the hypothalamus (Kozicz et al., 1998; Bittencourt et al., 1999; Morin et al., 
1999). In amphibians, Ucn1-ir was reported in the brain of the frog Rana esculenta, where 
it mainly occurs in the Edinger-Westphal nucleus, anterior preoptic area, ventromedial 
thalamic nucleus, nucleus of the posterior tuberculum and the nucleus of the medial 
longitudinal fasciculus (Kozicz et al., 2002). 
Ucn1 may have various functions. It clearly has anorectic activity, inhibiting food 
intake via the ventromedial hypothalamic nucleus and the hypothalamic paraventricular 
nucleus (Ohata et al., 2000; Wang et al., 2001). A role for Ucn1 in stress adaptation is 
suggested by the fact that it may be released from the rat Edinger-Westphal nucleus 
under conditions of chronic stress (Kozicz, 2003) and is down-regulated in the Edinger-
Westphal nucleus in mice over-expressing CRF (Kozicz et al., 2004). While Ucn1 in the 
brain probably acts on central neurons in both synaptic and non-synaptic (“volume 
transmission”) ways, there is circumstantial evidence that Ucn1 can also control 
peripheral targets. In the rat, Ucn1 increases heart rate, probably via its action on CRF 
type 2 receptors (CRF2) (Parkes et al., 2001; Coste et al., 2002) and may induce a drop 
in blood pressure via mesenteric vasodilatation (Parkes et al., 2001). Moreover, the 
stimulatory action of Ucn1 on ACTH release from the distal lobe of the rat pituitary 
gland suggests that Ucn1 can act as a neurohormone (Asaba et al., 1998). However, the 
sites of synthesis and release of corticotrope-stimulating Ucn1 are unknown.
In the present study we analysed the distribution and possible neurohormonal 
actions of Ucn1 in the South-African clawed toad, Xenopus laevis. This species was 
chosen because it is a well-established model for studying the functioning and 
regulation of the intermediate lobe of the pituitary gland (Verburg-van Kemenade et 
al., 1987a,b; Jenks et al., 1993a,b, 2003; Roubos, 1997; Roubos et al., 2001, 2002, 2005; 
Tonosaki et al., 2001, 2004) but the roles of CRF and Ucn in these processes are unclear. 
The neurohormonal and neural control of the release of α-melanophore-stimulating 
hormone (α-MSH) from the melanotrope cells of the Xenopus intermediate pituitary 
lobe has been extensively studied. A rise in circulating α-MSH causes darkening of the 
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animal’s skin, a process known to occur in response to environmental challenges like 
placing the animal on a dark background or lowering the ambient water temperature 
(Roubos, 1997; Roubos et al., 2001, 2002, 2005; Tonosaki et al., 2001, 2004). Various 
inhibitory and stimulatory factors are proposed to control the release of α-MSH from 
the melanotrope cells, including CRF (Verburg-van Kemenade et al., 1987a; Jenks et al., 
1993b, 2003). Because both the X. laevis magnocellular nucleus and the neural lobe of the 
pituitary gland stained positively with an antiserum raised against mammalian CRF 
(Verburg-van Kemenade et al., 1987a), it has been proposed that CRF is released from 
neurohemal axon terminals in the neural lobe and diffuses towards the pars intermedia 
to activate the melanotropes (Jenks et al., 1993b). However, CRF-immunopositivity 
was also seen in the median eminence (Verburg-van Kemenade et al., 1987a), leaving 
open the possibility that it acts on the melanotropes via the classical median eminence-
pituitary portal system. 
The homology of xCRF with both rat and human CRF is 93% (Stenzel-Poore et 
al., 1992) and the homologies of xUcn1 with rat and human Ucn1 are 70% and 65%, 
respectively (Donaldson et al., 1996; Zhao et al., 1998). Recently, Dautzenberg and 
colleagues (Dautzenberg et al., 1997, 1998, 2001, 2002) isolated cDNAs for two X. laevis 
CRF receptors, xCRF1 and xCRF2, which share a high degree of sequence similarity with 
their mammalian counterparts. We recently demonstrated by RT-PCR the expression 
of both xCRF1 and xCRF2 mRNAs in the X. laevis neurointermediate lobe (Corstens, 
2006). The xCRF1 binds xCRF and X. laevis Ucn1 with similar affinities, whereas xCRF2 
binds X. laevis Ucn1 with higher affinity than xCRF (G.C. Boorse and R.J. Denver, 
unpublished results). Based on these results we have raised the hypothesis that in 
X. laevis both CRF and Ucn1 function as a neurohormone controlling the pituitary 
melanotrope cells.
We have tested this hypothesis by analysing the distribution of Ucn1-ir in 
comparison to that of CRF-ir, in the brain and pituitary gland of X. laevis. We have paid 
special attention to potential sites where these peptides could be released to act on the 
melanotrope cells, viz. the median eminence of the hypothalamus and, in particular, 
the neural lobe of the pituitary gland. Affinity purified antisera were used that had 
been generated against synthetic xCRF to detect xCRF-ir. To detect Ucn1-ir in X. laevis 
we used an antiserum to rat Ucn1, and verified the specificity of the immunoreaction 
by preabsorption with synthetic X. laevis peptides. We also determined the subcellular 
distribution of Ucn1 in the pituitary neural lobe by immuno-electron microscopy, 
applying our recently developed high-pressure freezing (HPF) and cryosubstitution 
method (Wang et al., 2004). Finally, the effect of Ucn1 on α-MSH release from X. laevis 
melanotrope cells was tested in an in vitro superfusion study.
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Methods
Animals
Forty adult (6 months) specimens of Xenopus laevis, with a body weight of 28-32 
g, were raised under standard laboratory conditions and fed weekly on ground beef 
heart and Trouvit trout pellets (Trouw, Putten, The Netherlands). They were kept 
under constant illumination at a water temperature of 22 ± 1 °C, and adapted to a grey 
background for 3 weeks. All experiments were carried out under the guidelines of the 
Dutch law concerning animal welfare.
Tissue preparation for light microscopic immunocytochemistry
Twenty-five toads were deeply anaesthetized by immersion in a solution of 
0.1% tricaine methane sulfonate (MS222; Novartis, Basel, Switzerland) in tap water 
transcardially perfused with ice-cold 0.6% sodium chloride, for 5 min, and perfused 
with 250 ml ice-cold Bouin’s fixative, for 15 min. After decapitation, brain and pituitary 
gland, either attached to it or separated, were dissected and postfixed in the same 
fixative, for 16 h at 4 °C, and washed in 70% ethanol, to eliminate excess of picric acid, 
for 24 h, and dehydrated in a graded ethanol series.
Free floating immunocytochemistry
Fifteen fixed brains without the pituitary glands were embedded in gelatine and 40 
µm serial coronal sections were cut with a Leica vibratome (Leica, Wetzlar, Germany). 
After four 15 min washes in sodium phosphate-buffered saline (PBS; pH 7.4), sections 
were treated with 0.3% hydrogen peroxide (H2O2) for 30 min to inactivate endogenous 
peroxidase. After two 15 min washes in PBS, sections were incubated in 0.5% Triton 
X-100 (Sigma, St. Louis, MO, USA) for 30 min, to enhance antibody penetration. After 
an additional four 15 min washes in PBS, sections were incubated in 2% normal goat 
serum (NGS) in PBS for 1 h. All steps were carried out at 20 oC, under continuous, 
gentle agitation. After a brief wash in PBS, sections were transferred to vials containing 
the primary antiserum. 
The anti-Ucn1 serum had been generated in rabbits against rat Ucn1 coupled by 
glutaraldehyde to human α-globulin, and the high specificity of the antiserum has 
been demonstrated (Turnbull and Rivier, 1997; Bittencourt et al., 1999). We previously 
raised in rabbit an antiserum against X. laevis CRF (xCRF; Boorse and Denver, 2004) 
conjugated to human α-globulin. The IgG fraction of the serum was isolated on a 
protein A column, and passed over an Affigel 10 affinity column to which xCRF had 
been coupled. Then, the IgGs were eluted from the column. The high specificity of the 
xCRF antiserum was shown before (Boorse and Denver, 2004; Yao et al., 2004). 
Sections of the brain and pituitary gland were incubated in primary antiserum 
(dilutions with 2% NGS in PBS: Ucn1, 1:30,000; xCRF, 1:15), for 16 h at 20 oC, followed 
by four 15 min washes in PBS. For detection of immunoreactivity, an ABC elite kit 
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(rabbit) (Vector Laboratories, Burlingame, CA, USA) was used. Immunostaining was 
visualized with 0.03% 3-3’-diaminobenzidine (DAB; Sigma) and 0.01% H2O2, in Tris-
HCl, for approximately 10 min. The reaction was controlled under a microscope and 
was stopped by several rinses in Tris-HCl buffer. Intensification of the staining was 
achieved with 0.5% nickel-ammonium sulphate in the DAB solution. Then sections 
were rinsed once in PBS, dehydrated in a graded series of ethanol, cleared in xylene, 
and mounted with Entellan (Merck, Darmstadt, Germany) on gelatine-coated glass 
slides.
Paraffin immunocytochemistry
Ten Bouin-fixed brains with the pituitary glands attached were dehydrated through 
a graded series of ethanol and embedded in paraffin. Coronal sections (7 µm) were 
mounted on poly-L-lysine-coated slides and allowed to air-dry, for 16 h at 45 °C, 
deparaffinated and rehydrated. The subsequent staining procedure was carried out 
at 20 °C. Endogenous peroxidase activity was quenched with 0.1% H2O2 in PBS, for 30 
min, by rinsing twice for 15 min. Then, to prevent non-specific binding, sections were 
rinsed for 1 h in PBS containing 0.5% Triton X-100 (PBST; Sigma) and a combination of 
2.5% NGS and 2.5% normal horse serum (Vector laboratories). Sections were then rinsed 
in avidin/biotin blocking solution (Vector Laboratories) for 15 min, and incubated in 
PBST with anti-Ucn1 (1:30,000) or anti-xCRF (1:15), for 16 h at  22 °C. Immunodetection 
was carried out with a Vectastain ABC elite kit (Vector Laboratories). After rinsing the 
sections in PBS and in Tris-HCl buffer for 30 min, the reaction product was visualized 
with 0.04% DAB (Sigma) and 0.015% H2O2 in Tris-HCl buffer. Intensification of the 
staining was achieved with 0.5% nickel-ammonium sulphate added to the DAB solution. 
The reaction was terminated by several rinses in Tris-HCl buffer. Finally, sections were 
dehydrated in a graded series of ethanol, cleared in xylene, and mounted in Entellan 
(Merck, Hohenbrunn, Germany).
High pressure freezing and cryosubstitution
Five toads were decapitated and their neurointermediate pituitary lobe dissected, 
rinsed in PBS, and mounted under 1-hexadecene (Merck) in the cavity of an aluminium 
planchette (ALU Ø 3 x 0.5 mm and an inner cavity of Ø 2 x 0.15 mm; Waldner, Uetliburg, 
Switzerland) for high pressure freezing (HPF). The planchette was covered with the 
flat side of another planchette coated with lecithin (3-sn-phosphatidyl choline; Fluka, 
Buchs, Switzerland) to ease opening of the planchette sandwich. The sandwich was 
placed into a Leica HPF apparatus (Leica Microsystem, Vienna, Austria) in which the 
tissue was rapidly cryofixed at 2,100 bar (Wang et al., 2004). Under liquid nitrogen, 
the planchette sandwiches were opened and the 1-hexadecene was removed with 
forceps and a dissection needle. Then the frozen lobes were put into Saf-T-Seal 
microtubes (Biozym, Landgraaf, The Netherlands) containing 0.5% uranyl acetate and 
0.2% glutaraldehyde in methanol, and kept at -90 °C in a CS Auto cryosubstitution 
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unit (Leica). Next, a substitution program was performed: after 50 h at -90 °C, the 
temperature was raised in steps of 4 °C/h and maintained at -40 °C for 6 h. Then samples 
were washed with precooled methanol and embedded at -40 °C into Lowicryl HM20 
resin (Electron Microscopy Science, Fort Washington, PA, USA). Polymerisation of the 
resin was performed under UV irradiation at -40 °C for 16 h and at 20 °C for another 
24 h (Wang et al., 2004).
Immuno-electron microscopy
For immunogold labelling, the procedure of Wang et al. (2004) was followed. 
Ultrathin pale-gold sections from the neurointermediate pituitary lobe were collected 
on 250-mesh, uncoated nickel grids and incubated in PBS, for 2 x 5 min. Non-specific 
protein binding sites were blocked by incubation in PBS-G (0.5% bovine serum albumin, 
fraction V, and 0.045% teleostean gelatine, both from Sigma, in PBS), for 2 x 15 min. 
Then, the sections were incubated with Ucn1-antiserum (1:10,000) or xCRF antiserum 
(1:20) in PBS-G, for 16 h. After washing in PBG for 6 x 5 min, sections were incubated 
with 10 nm gold-conjugated secondary goat-anti-rabbit serum (BB International, 
Cardiff, UK) in a dilution of 1:50, for 2 h. Then they were washed with PBG and PBS, 
each for 4 x 5 min, postfixed in 1% glutaraldehyde in PBS for 15 min, and contrasted 
with uranyl acetate and lead citrate. Sections were examined with a Jeol 1010 electron 
microscope (Jeol, Tokio, Japan). 
Immunocytochemistry controls
The specificities of the antisera were confirmed by preabsorption with synthetic 
peptides (50 µg/ml) for 16 h at 4 °C, before immunocytochemistry. The X. laevis Ucn1 
and Ucn3 peptides were synthesized by the protein structure facility at the University of 
Michigan based on the deduced amino acid sequences (Genbank accession #AY596827 
and #AY596826, respectively; G.C. Boorse and R.J. Denver, unpublished results). 
Both peptides were synthesized on an Applied Biosystems 433A peptide synthesizer 
using FMOC solid phase peptide chemistry and purified by reversed phase-HPLC to 
greater than 90% purity. Preabsorption of the anti-xCRF serum with xCRF abolished 
the immunoreaction whereas, preabsorption with Ucn1 or Ucn3 and the structurally 
related peptide sauvagine (Bachem, Bubendorf, Switzerland) had no effect (see also 
Yao et al., 2004). Preabsorption of the anti-Ucn1 serum with X. laevis Ucn1 abolished 
staining, while CRF (rat; see also Kozicz et al., 2002) or X. laevis Ucn3 and sauvagine 
(see also Kozicz et al., 2002) had no effect.
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Superfusion
Six animals were decapitated, their neurointermediate pituitary lobes dissected, 
and melanotrope cells isolated as described before (Scheenen et al., 1995). In short, 
lobes were incubated for 45 min in Ringer’s solution without CaCl2 to which 0.25% 
(w/v) trypsin (Gibco, Renfrewshore, UK) had been added. Cells were subsequently 
dispersed in Leibovitz’s L15 medium (Life Technologies, Paisley, UK) adjusted to X. 
laevis blood osmolality (XL15; L15 : ultrapure water = 2:1) and containing 10% foetal 
calf serum (Gibco), by gentle trituration of the lobes with a siliconised Pasteur’s pipette. 
After washing, cells were resuspended in lysine-free XL15 and in dialyzed foetal calf 
serum (FCS; Life Technologies). After centrifugation, cells were resuspended in lysine-
free XL15 containing 250 µCi 3H-labelled lysine (Amersham, Buckinghamshire, UK) 
and plated onto poly-L-lysine-coated 15 mm Ø glass cover slips. After the cells had 
been allowed to attach for 1 h, they were cultured for two days at 22 °C in humidified 
atmosphere in lysine-free XL15 containing 10% dialyzed FCS. For superfusion, cells 
were rinsed with X. laevis Ringer’s four times and placed in a 4-well plate (Nuclon, 
Roskilde, Denmark). This was followed by superfusing the cells with Ringer’s at a 
rate of 75 µl/min for 1.5 h, after which X. laevis Ucn1 was added in pulses of 10 min, 
in different concentrations. (For protocol, see Results.) Fractions were collected every 
2 min and 160 µl scintillation fluid (Optiphase Supermix, Wallac, Loughborough, UK) 
was added. The amount of radiolabelled peptides in each fraction was determined 
with a scintillation counter (Wallac) and data were collected with Microbeta software 
(Wallac). For each experiment the average of the first 20 fraction measurements was 
considered as the control release level and set as 100%. It was previously shown that 
about 30-50% of the radioactivity in the superfusate is unincorporated (3H)lysine 
(Scheenen et al., 1995).
Fig. 1. Top left: schematic dorsal view of the brain of X. laevis, with letters A-Q indicating the levels of 
transverse sections (A-Q) used in the study of CRF (on the left) and Ucn1 (on the right) distribution. 
Immunoreactive cell bodies are indicated by black dots and immunoreactive main axon tracts by lines. 
A, anterior thalamic nucleus; ac, anterior commissure; Acc, nucleus accumbens; Ad, anterodorsal 
tegmental nucleus; Apl, amygdala, pars lateralis; Apm, amygdala, pars medialis; Av, anteroventral 
tegmental nucleus; Cb, cerebellum; DB, diagonal band of Broca; dp, dorsal pallium; EW, Edinger-
Westphal nucleus; Hv, nucleus habenularis ventralis; igl, internal granule cells of the olfactory bulb; Lc, 
locus coeruleus; ls, lateral septum; lv, lateral ventricle; me, median eminence of the hypothalamus; Mgm, 
medial part of the magnocellular nucleus; Mgv, ventral part of the magnocellular nucleus; ml, mitral cell 
layer of the olfactory bulb; mot, medial olfactory tract; mp, medial pallium; ms, medial septum; NPv, 
nucleus of the paraventricular organ; nIX, nucleus motorius of the glossopharyngeus (glp) nerve; P, 
posterior thalamic nucleus; pc, posterior commissure; pd, pituitary gland, pars distalis; pe, post-olfactory 
eminence; pi, pituitary gland, pars intermedia; pn, pituitary gland, pars nervosa; Rm, nucleus reticularis 
medius; SC, suprachiasmatic nucleus; Str, striatum; tect, mesencephalic tectum; tegm, mesencephalic 
tegmentum; Tor, torus semicircularis; TP, posterior tubercle; VH, ventral hypothalamic nucleus; VM, 
ventromedial thalamic nucleus; Vm, nucleus motorius nervi trigemini; Xm, nucleus motorius nervi vagi 
(see abbreviations list).
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Results
Distribution of CRF and Ucn1 in the X. laevis brain and pituitary gland
Light microscopic immunocytochemistry was carried out on free-floating and on 
paraffin sections. All data presented are essentially the same for both types of technique. 
However, the free-floating technique yielded a more intense immunostaining and the 40 
µm thick sections permitted us to study the course of stained fibres over relatively long 
distances, whereas in the 7 µm paraffin sections, individual neuronal cell bodies and 
thin fibre tracts could be identified more accurately. The occurrence of immunoreactive 
cell bodies in a brain structure was assessed in serial sections and semiquantitatively 
expressed as follows: 1-4: ‘rare’ or ‘few’, 5-8: ‘some’, 8-20: ‘many’ or ‘numerous’. All 
neuronal elements described were strongly immunopositive, unless stated otherwise. 
The results are summarized in Table 1 and Fig. 1. 
CRF 
Telencephalon. A few round, small cell bodies (ca. 10 µm in diameter) occur in the internal 
granule cell layer of the olfactory bulb, surrounded by fibres. In the mitral cell layer, 
some cells are present together with rarely occurring fibres (Fig. 2a). Round, small 
cell bodies, exhibiting a rather weak staining, with moderately stained dendrites were 
observed in low numbers in the post-olfactory eminence (Fig. 2b). In the medial and 
dorsal pallium many varicose fibres are present. The lateral septum reveals rare, small, 
fusiform but clearly immunopositive cell bodies as well as heavily stained varicose 
fibres, while in the medial septum only varicose fibres appear. In the striatum a few 
cell bodies were encountered. They are small and have an oval shape. Their very long 
dendritic processes run in both ventral and dorsal directions. In the diagonal band 
of Broca many fibres occur. The nucleus accumbens contains numerous small, ovoid 
cell bodies with primary and secondary dendrites running ventrally, and also a few 
varicose fibres are present (Fig. 2c, inset). In the medial part of the amygdala sparsely 
occurring, round cell bodies were seen, whereas in the lateral part of the amygdala 
some cell bodies with an elongated shape and long dendrites occur (Fig. 2d). A network 
of varicose fibres is present throughout the amygdala and the anterior commissure. 
Diencephalon. In the neuropil of the anterior preoptic nucleus, many fibres, some with 
varicosities, are present. In the nucleus habenularis ventralis, numerous small, weakly 
stained cell bodies occur. The caudal part of the suprachiasmatic nucleus contains a 
Fig. 2. Transverse sections at levels A-J (see Fig. 1) of the brain and pituitary gland of X. laevis, showing 
CRF-immunoreactive cell bodies and fibres. (a) Mitral cell layer. (b) Post-olfactory eminence. (c) Nucleus 
accumbens, with varicose fibre (inset). (d) Amygdala pars lateralis. (e) Suprachiasmatic nucleus, 
with arrowhead indicating dendrite contacting the CSF. ep, ependymal cell layer. (f) Nucleus of the 
paraventricular organ, with dendrites contacting CSF (arrowheads). (g) Medial part of magnocellular 
nucleus. (h) Fibre tract running from the magnocellular nucleus to the median eminence. (i) Median 
eminence, with internal (i) and external (e) zone. (j) Neural lobe (N) and distal lobe (D) of the pituitary 
gland, with arrowheads indicating neurohemal axons. Bar a-f, i = 20 µm, g,h,j = 50 µm.
Chapter 4
56
few, round perikarya, with a diameter of ca. 13 µm. They have a thick, short den-
drite and the long process runs towards the ventricle, passing through the ependymal 
layer to contact the cerebrospinal fluid (CSF; Fig. 2e). In the ventromedial thalamic 
nucleus a few small, positive perikarya occur, occupying an area that extends into a 
medial direction towards the third ventricle. Their primary and secondary dendrites 
are moderately immunoreactive. In the anterior thalamic nucleus, a few small, weakly 
stained perikarya were encountered. A few small cell bodies are present in the ventral 
hypothalamic nucleus with many varicose fibres running in different directions. In the 
paraventricular organ some small perikarya are present, some of which extend a den-
drite to the CSF (Fig. 2f). Laterally and medially from this organ, many fibres run near 
the third ventricle. In the posterior tubercle a few, small perikarya were observed. In 
this area many fibres run near the ventricle and laterally to the posterior tubercle, some 
of them with varicosities. In both the ventral and medial part of the magnocellular 
nucleus some round cell bodies, with moderate diameters (ca. 13 µm) were found (Fig. 
2g). They send their axons in a tract toward the median eminence (Fig. 2h). The median 
eminence shows strong CRF-immunopositivity in both the internal and external zone. 
The external zone is studded with heavily stained axon terminals (Fig. 2i).
Pituitary gland. For the most part, the neural lobe of the pituitary gland is completely 
devoid of CRF-positive fibres. Only in a few paraffin sections some CRF-immunoreactive 
fibres are observed. They possess varicosities and occur mostly in the periphery of 
the lobe (Fig. 2j). In the intermediate and distal lobe of the pituitary gland no CRF-
positivity was seen.
Fig. 3. Transverse sections at levels K-Q of the brain of X. laevis, showing CRF-immunoreactive cell 
bodies and fibres. (a) Varicose fibres in Edinger-Westphal nucleus. (b) Tectum mesencephali, cell bodies. 
(c) Tectum mesencephali, fibres. (d) Anterior tegmental nucleus, with varicose fibre in inset. (e) Nucleus 
motorius nervi trigemini. (f) Locus coeruleus. Bar a,c = 10 µm, b,d-f = 20 µm.
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Mesencephalon. The Edinger-Westphal nucleus reveals some positive fibres, which 
possess varicosities (Fig. 3a). However, no cell bodies were found. Numerous 
pyriform cells and varicose fibres are present in the layers of the optic tectum (Fig. 
3b,c). Many varicose fibres occur in the posterior commissure and in the tegmentum. 
In the anteroventral tegmental nucleus some heavily stained cell bodies reveal a long 
dendrite running in the ventral direction (Fig. 3d). Many varicose fibres are present 
throughout the nucleus (Fig. 3d, inset). The torus semicircularis shows a few varicose 
fibres. The rare cell bodies in the posteroventral tegmental nucleus are small, and have 
a pyriform shape and a short, thick dendrite.
Rhombencephalon. Some small, heavily stained cell bodies surrounded by fibres are 
present in the nucleus motorius nervi trigemini (Fig. 3e). In the locus coeruleus some 
small perikarya were observed, with fibres running laterally (Fig. 3f). Also, the ventral 
part of the cerebellum shows some CRF-positive fibres.
Ucn1
Telencephalon. Some Ucn1-positive fibres were observed in the medial olfactory tract, 
the internal granule cell layer of the olfactory bulb, the dorsal pallium, the striatum, 
the nucleus accumbens and in the diagonal band of Broca. In the medial septum Ucn1-
positive fibres with small, beaded varicosities occur (Fig. 4a, inset). Furthermore, fibres 
showing some varicosities are present throughout the neuropil of the pars lateralis of 
the amygdala (Fig. 4b, inset) and the anterior commissure.
Diencephalon. In the neuropil of the anterior preoptic nucleus long fibres with many 
varicosities are present. A small number (1-3) of cell bodies and some scattered fibres 
were encountered lateral to the suprachiasmatic nucleus. Rarely, fibres occur in the 
anterior, central and posterior thalamic nucleus. In the posterior tubercle several fibres 
run ventral to the posterior commissure, towards the optic recess. Cell bodies also 
occur in the paired magnocellular nucleus of the hypothalamus in both the ventral (Fig. 
4c) and medial part (Fig. 4d) of the nucleus. Some neurons send processes toward the 
third ventricle, which may contact the CSF (Fig. 4c,d). In each nucleus, about 20 to 30 
perikarya are strongly immunopositive, as are their axons, which can be followed into 
a ventrolateral direction, running towards the median eminence of the hypothalamus 
(Fig. 4e). The median eminence shows two Ucn1-positive regions, an external zone with 
neurohemal axon terminals contacting the hypothalamo-hypophyseal portal system 
(Fig. 4f) and an internal zone through which numerous fibres pass to the pituitary 
neural lobe (Fig. 4g).
Pituitary gland. Throughout the neural lobe of the pituitary gland, numerous fibres are 
intensely Ucn1-immunopositive and reveal numerous, large varicosities (Fig. 4h, inset). 
No Ucn1-positivity was observed in the intermediate or distal lobe of the gland. 
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Mesencephalon. The Edinger-Westphal nucleus contains numerous Ucn1-positive 
neurons. They are moderately sized (ca. 13 µm in diameter) and mostly pyriform, 
showing primary, secondary and sometimes tertiary dendrites (Fig. 5a). Some neurons 
are fusiform, with primary and sometimes secondary dendrites (Fig. 5b). The Edinger-
Westphal nucleus also contains many Ucn1-positive fibres. Some fibres are also 
present in the tegmentum mesencephali, in the tectum mesencephali and in the torus 
semicircularis. In the caudal part of the mesencephalon, in the nucleus posteroventralis 
tegmenti, some small, moderately stained cell bodies were observed, very close to the 
border of the cerebral aqueduct. The neuropil of the nucleus contains many fibres, 
whereas a few fibres appear in the neuropil of the interpeduncular nucleus.
Rhombencephalon. Some cell bodies are located in the nucleus motorius nervi trigemini. 
They are large (ca. 15 µm in diameter), multipolar and rather weakly stained (Fig. 
5c). The nucleus motorius of the facial and glossopharyngeal nerves shows several 
weakly stained cell bodies while sparse fibres run in the surroundings of the nucleus. 
Some lightly stained cells occur in the central grey. Small cell bodies are present in low 
numbers lateral to the nucleus reticularis medius. Furthermore, many varicose fibres 
occur in the cochlear nucleus (Fig. 5d, inset). In the nucleus motorius nervi vagi some 
cell bodies were encountered, and laterally and medially to the solitary tract a few 
fibres were seen.
Immuno-electron microscopy of the X. laevis pituitary neural lobe
To identify neurohemal axon terminals containing Ucn1 and CRF, the neural lobe of 
the pituitary gland was investigated by immuno-electron microscopy. Neurointerme-
diate lobes were prepared by HPF and cryosubstitution (Wang et al., 2004).
Ucn1. At the ultrastructural level, the neural lobe shows numerous neurohemal axon 
terminals, situated near small blood vessels and capillaries (Fig. 6a). Two types of 
terminal were distinguished. The first type (A) contains large (mean diameter about 
145 nm), round and moderately electron-dense granules, while the second type (B) 
is characterized by smaller, highly electron-dense granules. In contrast to type A, 
these terminals reveal ellipsoid or pleomorph granules with a mean long diameter of 
ca. 140 nm and a mean short diameter of ca. 100 nm (Fig. 6b). Immunogold particles 
Fig. 4. Transverse sections from level A to level J of the brain and pituitary gland of X. laevis, presenting 
Ucn1-immunoreactive cell bodies and fibres. (a) Medial septum. Inset: varicose fibre. (b) Amygdala pars 
lateralis. Inset: varicose fibre. (c) Ventral part of the magnocellular nucleus with arrowhead indicating 
dendrite contacting the CSF. (d) Medial part of the magnocellular nucleus. (e) Fibre tract running from 
the magnocellular nucleus to the median eminence. (f) Median eminence, with internal (i) and external 
(e) zone. (g) Ucn1-positive fibres (arrowheads) running in the internal zone of the median eminence on 
their way to the neural lobe. (h) Neural lobe of the pituitary gland (N) with neurohemal axon terminals, 
shown in detail in inset. D, distal lobe. In a, b and c dorsal is not on top and orientation of dorsal (d)-
lateral (l) has been indicated. Bar a-e,g = 20 µm, f = 50 µm, h = 10 µm.
Chapter 4
60
indicating the presence of Ucn1 occur over secretory granules in both terminal types 
(Fig. 6c,d). No appreciable numbers of gold particles were seen outside the granules or 
in other neural lobe elements such as pituicytes, endothelium cells or fibroblasts, nor 
in melanotrope cells in the intermediate lobe (not shown). 
CRF. At the ultrastructural level, in the neural lobe neither A-type nor B-type terminals 
showed any appreciable amount of immunogold staining that would indicate the 
presence of CRF-immunoreactivity. Also, other elements of the neural lobe and the 
intermediate lobe were found to be immunonegative. Apparently, the CRF fibres seen 
at the light microscopic level in the neural lobe are too scarce to be identified by electron 
microscopy.
In vitro superfusion of X. laevis melanotrope cells 
A superfusion study was conducted to test if Ucn1 can stimulate α-MSH release 
from dissociated melanotrope cells cultured in vitro. Exposure to Ucn1 produced a clear 
dose-dependent stimulation of radiolabelled peptide release (Fig. 7). At a concentration 
of 10-10 M Ucn1 had no effect on the release of α-MSH. At a concentration of 10-9 M 
Ucn1 an increase of 15% in secretion took place, and at 10-8 M and at 10-7 M secretion 
was stimulated by more than 50%. 
Fig. 5. Transverse sections at levels K-Q of the brain of X. laevis, with Ucn1-immunoreactive cell bodies 
and fibres. (a) Edinger-Westphal nucleus. (b) detail of (a), showing intricate dendritic ramifications. (c) 
Nucleus motorius nervi trigemini. (d) Cochlear nucleus, with varicose fibre in inset. In c dorsal is not 
on top, and orientation of dorsal (d)-lateral (l) has been indicated. Bar a = 50 µm, b = 25 µm, c = 10 µm, 
d = 20 µm.
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Fig. 6. Electron micrographs of (a) neurohemal axon terminals (a) in the pituitary neural lobe near blood 
vessel contacting melanotrope cell (m) in intermediate lobe. e, erythrocyte, p, pituicyte; arrowhead 
indicates endothelial cell lining vessel, (b) type A and type B terminals filled with secretory granules, (c) 
detail of type A axon terminals with large, moderately electron-dense granules immunoreactive (gold 
particles) to Ucn1, (d) detail of type B axon terminals with many flat and pleomorph (arrows), mostly 
electron-dense granules immunoreactive (gold particles) to Ucn1. Bar a = 1 mm, b = 300 nm, c,d = 200 
nm.
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Discussion
CRF and Ucn1 compared
In previous studies performed in amphibians (Fasolo et al., 1984; Verhaert et al., 
1984; Olivereau et al., 1987; Gonzales and Lederis, 1988), including X. laevis (Verburg-
van Kemenade et al., 1987a), CRF-positive perikarya in the CNS did not appear to 
be numerous, and seemed largely restricted to the preoptic area including the 
magnocellular nucleus. In these studies CRF-positive axons were mainly seen in the 
external part of the median eminence and in some cases in the pituitary neural lobe 
(Tonon et al., 1985; Verburg-van Kemenade et al., 1987a). By contrast, the present 
study on X. laevis reveals large numbers of CRF-immunopositive neurons and fibres 
in various parts of the brain, i.e., in the telencephalon, diencephalon, mesencephalon 
and rhombencephalon. Our findings are in agreement with a recent report by Yao and 
colleagues (2004) in juvenile X. laevis. In the hypothalamo-hypophyseal system, CRF is 
present in the magnocellular nucleus and in the external zone of the median eminence. 
By contrast to earlier studies, we found that CRF-positive fibres were scarce in the 
neural lobe of the pituitary gland and could only be detected at the light microscopic 
level. The explanation for the difference between this distribution and that found in 
earlier studies may be our use of a highly specific, affinity-purified anti-Xenopus-CRF 
serum, while in the other studies an anti-mammalian CRF serum (unpurified) was 
applied. On the basis of the present data, we conclude that CRF is widespread in the 
X. laevis brain, and thus could play a role in behavioral and autonomic responses to 
Fig. 7. Effect of different concentrations of X. laevis Ucn1 (10-10 to 10-7 M) on the release of radiolabelled 
peptides (mainly α-MSH; see Scheenen et al., 1995) from dissociated melanotrope cells superfused in 
vitro. Vertical greyed bars indicate 10 min fractions during which Ucn1 was given. Secretion is expressed 
as a percentage of the control secretion level, which was set at 100% (n=4).
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stress (by analogy to CRF in mammals). Our data also support the view that CRF in 
X. laevis acts as a neurohormone, being released from the external zone of the median 
eminence to stimulate hormone secretion by the anterior pituitary. The paucity of CRF-
positive fibres in the neural lobe indicates that neurohormonal release from this part 
of the pituitary to control the melanotrope cells in the intermediate lobe is possible but 
likely to be rather unimportant, at least in a quantitative respect.
This study represents the first demonstration of Ucn1 in the brain and pituitary 
gland of X. laevis. The distribution is clearly distinct from that of CRF. Both peptides 
are present in the ventral and medial part of the magnocellular nucleus and in the 
nucleus motorius nervi trigemini, and various brain centres contain both Ucn1- and 
CRF-ir fibres (amygdala, medial septum, nucleus accumbens, neuropil of the anterior 
preoptic nucleus, posterior tubercle, Edinger-Westphal nucleus and tectum). However, 
Ucn1 also occurs in perikarya of the Edinger-Westphal nucleus, central grey, nucleus 
reticularis medius, nucleus motorius nervi facialis and nucleus motorius nervi vagi 
where CRF-ir was not observed. Similarly, Ucn1-ir, but not CRF-ir fibres run in the medial 
olfactory tract, central and anterior thalamic nucleus and nucleus posteroventralis 
tegmenti. Thus, the partial overlap in the distributions of Ucn1 and CRF indicates that 
these two members of the CRF family could have some related, but also other unique 
neurotransmitters/neuromodulator and hypophysiotropic functions.
In amphibians Ucn1-ir has been described by us before, viz. in the frog Rana 
esculenta (Kozicz et al., 2002). However, the distribution of Ucn1 in X. laevis shows 
clear differences with that in R. esculenta. In contrast to R. esculenta, in the X. laevis 
brain no Ucn1 is present in the anterior preoptic area, ventromedial thalamic nucleus 
and posterior tubercle. The largest differences were found in the neuroendocrine 
system. In X. laevis both the external and internal zone of the median eminence, and 
the pituitary neural lobe show many immunopositive fibres, whereas in R. esculenta 
only the external layer of the median eminence is immunopositive. These differences 
between the two amphibians might be explained by differences in the structure and/or 
the dynamics of their Ucn1 systems. Alternatively, the differences could be related to 
technical differences between the two studies, where R. esculenta, but not X. laevis, had 
been pre-treated with colchicine to block axonal Ucn1 transport leading to accumulation 
of the peptide within neuronal cell bodies (Kozicz et al., 2002).
In any case, the presence of strong dot-like Ucn1-immunostaining of the external 
zone of the median eminence in X. laevis suggests that Ucn1 occurs in neurohemal axon 
terminals of this neurohemal organ. Thus, Ucn1 could be released into the pituitary 
portal system to act as a neurohormone on the melanotrope cells in the intermediate 
lobe, and possibly also on the corticotrope cells in the pars distalis (Ohata et al., 2000).
Chapter 4
64
Ucn1 is released as a neurohormone from the pituitary neural lobe
Using light immunocytochemistry, we show the presence of Ucn1-ir in the 
hypothalamo-neurohypophyseal system (HNS) of X. laevis. The light microscope data 
strongly indicate that a subpopulation of neurons in the magnocellular nucleus produce 
and transport Ucn1 via axons toward the external zone of the median eminence, and 
via the internal zone of the eminence towards the neural lobe of the pituitary gland. 
The magnocellular nucleus of amphibians is considered to be homologous with the 
mammalian supraoptic and paraventricular nuclei (Tuinhof et al., 1994a). In rat, 
both nuclei contain Ucn1 (Kozicz et al., 1998; Morin et al., 1999) and Ucn1 was also 
demonstrated at the light microscope level in fibres in the rat posterior pituitary (Morin 
et al., 1999). The present study is the first to reveal the presence of Ucn1 in the HNS 
of a non-mammalian vertebrate, highlighting the neuroendocrine importance of this 
evolutionarily conserved peptide. 
To study the pituitary gland of X. laevis at the ultrastructural level, we applied the 
HPF technique, which yields excellent ultrastructural preservation of the X. laevis brain 
and pituitary gland, with maintenance of strong antigenicities for a variety of peptides 
and proteins (Wang et al., 2004). Secretory granules appear perfectly preserved, not 
only as to their delineation, showing clear and straight bounding membranes, but 
also with regard to the different electron-densities of their contents, enabling the 
distinction between type A and type B neurohemal axon terminals in the neural lobe 
of the pituitary gland. Thanks to this technique, we demonstrate at the ultrastructural 
level that Ucn1 occurs in the neural lobe within secretory granules in neurohemal axon 
terminals, indicating a neurohormonal role of Ucn1. Ucn1 is present in both type A and 
type B neurohemal axon terminals. This suggests that Ucn1 is produced by at least two 
different neuron populations in the magnocellular nucleus. Recently, we showed that 
secretory granules in the type A neurohemal terminals in the X. laevis neural pituitary 
lobe contain the amphibian diuretic neurohormone mesotocin (Wang et al., 2005a; 
Calle et al., 2006b/Chapter 3), which is known to be released from the neural lobe (Pang 
and Sawyer, 1978). This indicates that these terminals release mesotocin together with 
Ucn1, providing strong evidence that Ucn1 is released from the amphibian neural lobe 
as a neurohormone. 
Interestingly, type A but not type B terminals are immunopositive to mesotocin 
and to brain-derived neurotrophic factor (BDNF) (Wang et al., 2005a; Calle et al., 
2006b/Chapter 3), indicating that the two populations of Ucn1-producing neurons in 
the magnocellular nucleus innervating the neural lobe do not only differ as to their 
capacity to produce mesotocin but also to produce BDNF.
Table 1. Semiquantitative distribution of CRH- and Ucn1-immunoreactive cell bodies and fibres in the 
X. laevis brain and pituitary gland, as visualized by free-floating and paraffin immunocytochemistry of 
sections made at the levels A-Q as indicated in Fig. 1. The numbers of positive cell bodies are expressed 
as follows: 1 - 4: + ‘rare’ or ‘few’; 5 - 8: ++ ‘some’; 8 - 20: +++ ‘many’ or ‘numerous’ immunoreactive fibres 
are indicated with +.
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Brain region CRF Ucn1
Cells Fibres Cells Fibres
Telencephalon
Olfactory bulb, mitral cells (ml) ++ +
Olfactory bulb, internal granule cells (igl) + + +
Medial olfactory tract (mot) +
Post-olfactory eminence (pe) ++
Medial septum (ms) + +
Lateral septum (ls) + +
Medial pallium (mp) +
Dorsal pallium (dp) + +
Striatum (Str) + +
Accumbens (Acc) +++ + +
Diagonal band of Broca (DB) + +
Amygdala pars medialis (Apm) + +
Amygdala pars lateralis (Apl) ++ +
Anterior commissure (ac) +
Diencephalon
Nucleus habenularis ventralis (Hv) +++
Ventromedial thalamic nucleus (VM) +
Anterior thalamic nucleus (A) + +
Central thalamic nucleus (C) +
Posterior thalamic nucleus (P) +
Magnocellular nucleus, medial part (Mgm) ++ + ++ +
Magnocellular nucleus, ventral part (Mgv) ++ + +++ +
Suprachiasmatic nucleus (SC) +
Paraventricular organ (NPv) ++ +
Posterior tubercle (TP) + + +
Ventral hypothalamic nucleus (VH) + +
Median eminence zona interna + +
Median eminence zona externa + +
Pituitary pars nervosa (pn) + +
Mesencephalon
Tectum mesencephali (tect) +++ + +
Tegmentum mesencephali (tegm) + +
Edinger-Westphal nucleus (EW) + +++ +
Anteroventral tegmental nucleus (Av) ++ +
Anterodorsal tegmental nucleus (Ad) ++ +
Posterior commissure (pc) +
Nucleus posteroventralis tegmenti (Pv) + ++
Torus semicircularis (Tor) + +
Rhombencephalon
Locus coeruleus (Lc) ++ +
Central grey (cg) ++
Nucleus reticularis medius (Rm) +
Cochlear nucleus (LL) +
Nucleus motorius nervi trigemini (Vm) ++ + ++
Nucleus motorius of the facial and gp nerve (IX) ++ +
Nucleus motorius nervi vagi (Xm) ++
Cerebellum (Cb) +
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Ucn1 stimulates α-MSH release
The functional role of Ucn1 released from the X. laevis neural lobe is not known, but 
in view of the fact that the neural lobe is closely apposed to the intermediate lobe, it 
is likely that neurohormonally released Ucn1 will readily reach the melanotrope cells 
to stimulate their secretory activity. The fact that our in vitro superfusion study shows 
that Ucn1 is able to stimulate the release of α-MSH from X. laevis melanotrope cells in 
a dose-dependent fashion, supports this idea. This stimulation may be very effective, 
as even at a concentration as low as 10-8 M a clear stimulatory effect was noted. Because 
of the high affinity of Ucn1 for the CRF2 receptor (mammals: Vaughan et al., 1995; X. 
laevis: G.C. Boorse and R.J. Denver, unpublished results), the recent demonstration 
by RT-PCR of X. laevis CRF2 mRNA (Dautzenberg et al., 1997, 1998, 2001, 2002) in 
the neurointermediate lobe of the X. laevis pituitary (Corstens, 2006) is another strong 
indication that Ucn1 released from the neural lobe can stimulate α-MSH release by X. 
laevis melanotrope cells.
Ucn1 and other messengers in the neural lobe
In amphibians mesotocin has a diuretic action, most likely acting peripherally, on 
kidney, skin and bladder (Pang and Sawyer, 1978; Warburg, 1995). This raises the 
question as to the functional significance of the coexistence in type A terminals of 
Ucn1, controlling the nearby melanotrope cells, with mesotocin, acting on peripheral 
organs. Obviously, we cannot exclude the possibility that Ucn1 released from the 
neural lobe (also) has peripheral actions (Parkes et al., 2001; Huang et al., 2004), but it 
is noteworthy that not only Ucn1 but also mesotocin has a stimulatory action on the 
release of α-MSH from the X. laevis intermediate lobe (Calle et al., 2006b/Chapter 3). 
This effect is in contrast with the situation in the frog R. ridibunda, where mesotocin 
does not affect α-MSH release from the pituitary intermediate lobe (Tonon et al., 1986). 
Apparently, in X. laevis both Ucn1 and mesotocin can activate α-MSH secretion in a 
neurohormonal way.
In addition to CRF, Ucn1 and mesotocin, three other factors have been shown to be 
present in the neural pituitary lobe of X. laevis, viz. vasotocin, BDNF and TRH (Verburg-
van Kemenade et al., 1987a,b; Wang et al., 2005a; Calle et al., 2006b/Chapter 3). Each of 
these factors stimulate α-MSH release from X. laevis melanotrope cells in vitro (Verburg-
van Kemenade, 1987b; Kramer et al., 2002; L.C. Wang, B.G. Jenks, unpublished results). 
This strongly suggests that the neural lobe is an important site of neurohormonal 
control of the melanotrope cells, being responsible for the neurohormonal release of 
multiple stimulatory messengers. This highlights the functional significance of the 
close anatomical association between the neural and intermediate lobe in the pituitary 
gland.
As retrograde tracing of the neural lobe shows only labelling of the magnocellular 
nucleus (Tuinhof et al., 1994a), all messengers present in the neural lobe, viz. CRF, 
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Ucn1, mesotocin, vasotocin, BDNF and TRH, must be produced in the magnocellular 
nucleus. Detailed colocalization studies will have to further elucidate possible 
coexistence of these factors in various subpopulations of magnocellular neurons and 
their neurohemal axon terminal types.
In the frogs, R. ridibunda and Rana catesbeiana, mesotocin-containing axons in the 
pituitary neural lobe also contain TRH (Lamacz et al., 1989; Shioda et al., 1989), which 
is known to stimulate α-MSH release from melanotrope cells in R. ridibunda (Vaudry 
et al., 1977; Galas et al., 1998, 1999). Therefore, the important role of the neural lobe in 
the control of melanotrope cells may apply to amphibians in general.
Control of neurohormonal Ucn1 secretion
The question arises as to the nature of the stimuli that activate magnocellular neurons 
to release Ucn1 and mesotocin from the neural lobe axon terminals into the circulation. 
In mammals, Ucn1 may be an important component of the stress response mechanism 
(Vaughan et al., 1995; Kozicz, 2002; Kozicz et al., 2004). Hyperosmotic stress is known 
to activate c-fos expression in the X. laevis magnocellular nucleus (Ubink et al., 1997). 
Whether stressors like osmotic stress would activate Ucn1 mRNA expression in this 
nucleus and stimulate the release of Ucn1 (and of other messengers) from the neural 
pituitary lobe, awaits investigation, as is the possibility that Ucn1 production and 
release is under the control of the background adaptation condition.
Conclusions
Because of it distribution pattern, Ucn1 may have widespread local actions in the X. 
laevis brain. Its presence in the neuroendocrine system strongly indicates that it is also 
a neurohormone. We provide evidence that Ucn1 released from the neural lobe may 
control the secretory activity of the melanotrope cells in the adjacent intermediate lobe. 
In mammals, Ucn1 has, in addition to its central actions, various actions on peripheral 
organs like the heart and gut. Therefore, the possibility that Ucn1, released from the 
neural lobe into the systemic circulation, also acts on peripheral targets deserves 
investigation.
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Abstract
In Xenopus laevis, corticotropin-releasing factor (CRF) and urocortin 1 (Ucn1) are present 
in the brain and they both are potent stimulators of α-melanophore-stimulating hormone (α-
MSH) secretion by melanotrope cells in the pituitary gland. Since in mammals and Xenopus 
laevis both CRF and Ucn1 bind with high affinity to CRF receptor type 1 (CRF1), one of the 
purposes of this study was to identify the sites of action of CRF and Ucn1 in the Xenopus brain 
and pituitary gland. Moreover, we raised the hypothesis that the external light intensity is a 
physiological condition controlling CRF1 expression in the pituitary melanotrope cells. By in 
situ hybridization we have demonstrated the presence of CRF1 mRNA in the olfactory bulb, 
amygdala, nucleus accumbens, preoptic area, ventral habenular nuclei, ventromedial thalamic 
area, suprachiasmatic nucleus, ventral hypothalamic area, posterior tuberculum, tectum 
mesencephali and cerebellum. In the pituitary gland, CRF1 mRNA occurs in the intermediate 
and distal lobe. The optical density of the CRF1 mRNA hybridization signal in the intermediate 
lobe of the pituitary gland is 59.4% stronger in white-adapted animals than in black-adapted 
ones, supporting our hypothesis that the environmental light condition controls CRF1 mRNA 
expression in melanotrope cells of X. laevis, a mechanism likely responsible for CRF- and/or 
Ucn1-stimulated secretion of α-MSH.
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Introduction
In the mammalian central nervous system (CNS), corticotropin-releasing factor 
(CRF) (Vale et al., 1981) and other members of the CRF-family of peptides, such as 
the urocortins (Ucn) 1, 2 and 3 (Swanson et al., 1983; Vaughan et al., 1995; Kozicz 
et al., 1998; Bittencourt et al., 1999; Morin et al., 1999; Lewis et al., 2001; Reyes et al., 
2001) mediate various physiological, behavioral and immune responses to stressful 
challenges (e.g. Turnbull and Rivier, 1997; Skelton et al., 2000; Parkes et al., 2001; Coste 
et al., 2002; de Fanti et al., 2002; Tsigos et al., 2002; Huang et al., 2004; Kozicz et al., 
2004; Suda et al., 2004; Kórösi et al., 2005). The actions of CRF and Ucn are mediated by 
two G-protein-coupled receptors designated CRF-receptor 1 (CRF1) and CRF-receptor 
2 (CRF2) (Chen et al., 1993; Perrin et al., 1999), which have been localised in the brain 
by in situ hybridization and receptor autoradiography (Potter et al., 1994; de Souza, 
1995; Van Pett et al., 2000; Kórösi et al., 2006). CRF1 is most abundant in the pituitary 
intermediate and anterior lobe (de Souza, 1995; Van Pett et al., 2000), olfactory-related 
structures, amygdala, cerebral cortex, brainstem sensory relay nuclei and cerebellum, 
whereas CRF2 has a more restricted distribution, being present in the posterior lobe 
of the pituitary, in subcortical structures and, most prominently, in the lateral septal 
nucleus, hypothalamus and amygdala (Van Pett et al., 2000).
The present study is concerned with the sites of action of CRF and CRF-like peptides 
in the amphibian brain and pituitary gland. Molecular cloning studies in the South 
African clawed toad Xenopus laevis showed a CRF-like gene, which encodes for a protein 
with 93% homology with rat and human CRF (Stenzel-Poore et al., 1992), whereas 
Xenopus Ucn1 reveals about 70% homology with mammalian Ucn1 (Boorse et al., 2005). 
CRF is widely distributed in the X. laevis brain, with main CRF-immunoreactive (ir) 
sites in the nucleus accumbens, nucleus habenularis ventralis, magnocellular nucleus, 
paraventricular organ, tectum mesencephali, anterior tegmental nucleus, locus 
ceruleus and nucleus motorius nervi trigemini (Yao et al., 2004; Calle et al., 2005b/
Chapter 4). In contrast to CRF, Ucn1 shows a more limited distribution in the X. laevis 
brain, occurring in the magnocellular nucleus (Mg), Edinger-Westphal nucleus (EW), 
nucleus posteroventralis tegmenti, central grey and nucleus motorius nervi trigemini 
(Calle et al., 2005b/Chapter 4). In the pituitary gland, CRF-ir fibres are scarce, whereas 
many strongly stained Ucn1-ir fibres occur in the pars nervosa (Calle et al., 2005b/
Chapter 4).
The functions of CRF and Ucn1 in amphibians are less well investigated than 
in mammals, but CRF in the Mg, the amphibian homologue of the mammalian 
paraventricular and supraoptic nuclei, exerts its ‘traditional’ role as controller of 
the hypothalamo-hypophyseal-adrenal axis (Malagon et al., 1991; Ubink et al., 1997; 
Boorse and Denver, 2004; Yao et al., 2004), and both CRF and Ucn1 in the Mg may be 
involved in the control of feeding-related processes (Crespi et al., 2004; Boorse et al., 
2005; Calle et al., 2006a/Chapter 8). Most interesting are the roles of CRF and Ucn1 in 
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the regulation of the neuroendocrine melanotrope cells in the intermediate lobe of the 
amphibian pituitary gland, a regulation up to now unknown in mammals. Amphibian 
melanotropes release α-melanophore-stimulating hormone (α-MSH), a processing 
product of proopiomelanocortin (POMC), which is responsible for skin darkening 
during the process of background adaptation (e.g. Kramer et al., 2001; Kolk et al., 2002). 
In X. laevis CRF-like peptides, including Xenopus Ucn1, stimulate the production of 
POMC and the secretion of α-MSH (Verburg-van Kemenade et al., 1987a; Dotman 
et al., 1997; Calle et al., 2005b/Chapter 4). The mechanism(s) by which amphibian 
CRF and Ucn1 exert these actions on melanotrope cells are poorly understood as to 
receptor(s) and pathways involved. In X. laevis, two types of CRF receptor, CRF1 and 
CRF2, have been identified in both the brain and the pituitary gland, using RT-PCR. 
Both receptors share ca. 80% amino acid sequence homology with their mammalian 
counterparts, CRF1 binds with high affinity to both CRF and Ucn1, whereas CRF2 has 
a higher affinity for Ucn1 than for CRF (Dautzenberg et al., 1997, 1998, 2001, 2002; 
Boorse and Denver, 2006).
The present study focuses on CRF1, and aims to identify the possible sites by 
which CRF and Ucn1 act on this receptor in the brain and pituitary gland of Xenopus 
laevis. Moreover, in view of the dependence of melanotrope secretory activity in this 
animal on the external light condition, we hypothesised that this light condition is 
a physiological factor controlling the expression of melanotrope cell CRF1. We have 
assessed the presence of this receptor by in situ hybridization of CRF1 mRNA, and then 
we determined if this expression in the intermediate pituitary lobe depends on the 
state of the background light condition (black vs. white).
Materials and Methods
Animals
Ten young-adult specimens of Xenopus laevis, aged 6 months, with a body weight of 
28-32 g, were raised in our Nijmegen laboratory under constant illumination, at a water 
temperature of 22 ± 1 °C, and fed weekly on ground beef heart (Janssen, Nijmegen, 
The Netherlands) and Trouvit trout pellets (Trouvit, Trouw, Putten, The Netherlands). 
Before the experiments, animals had been adapted to either a black (n=5) or a white 
(n=5) background, for three weeks. Animal treatment was in agreement with the 
Declaration of Helsinki and the Dutch law concerning animal welfare, as tested by the 
ethical committee for animal experimentation of Radboud University Nijmegen. 
Tissue preparation for in situ hybridization
Toads were deeply anaesthetised by immersion in 0.1% tricaine methane sulfonate 
(MS222; Novartis, Basel, Switzerland) in tap water, and transcardially perfused with 
ice-cold 0.6% sodium chloride, for 5 min. Then they were perfused with 250 ml ice-
cold Bouin’s fixative, for 15 min. After decapitation, the brain and pituitary gland were 
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quickly dissected and postfixed in the same fixative, for 16 h at 4 °C, washed in 70% 
ethanol for 24 h, to eliminate excess of picric acid, dehydrated in a graded ethanol 
series, and embedded in paraffin. Sagittal serial sections (7 µm) were mounted on poly-
L-lysine-coated slides (Sigma Chemicals, St Louis, MO, USA) and allowed to air-dry, 
for 16 h at 45 °C, deparaffinised and rehydrated. Brain sections of black-adapted (BA) 
and white-adapted (WA) animals were processed in parallel for in situ hybridization 
for Xenopus CRF1 mRNA.
In situ hybridization
A Greenstar labelled probe was used (GeneDetect, Auckland, New Zealand) and 
a 3’-digoxigenin (DIG)-labelled antisense oligonucleotide probe was synthesised 
to hybridize with the Xenopus CRF1. The CRF1 probe was a synthetic antisense 
oligonucleotide corresponding to bases 264-311 (TCCTGGCATTGAGCGTAGTCTCC
TCTCCCAGCCCAGCTGCCGTTCAGG, 48 mer) of the cDNA sequence of Xenopus 
CRF1 (Dautzenberg et al., 1997) (Genbank accession no. Y14036). Starting from the same 
bases, a sense oligonucleotide probe (CCTGAACGGCAGCTGGGCTGGGAGAGGAG
ACTACGCTCAATGCCAGGA, 48 mer) was synthesised for specificity control tests 
with in situ hybridization. Computer analysis with the basic local alignment search tool 
(BLAST) (Altschul et al., 1997) did not reveal any homology or similarity of our probes 
with other X. laevis genes. After deparaffination, sections were rinsed in autoclaved 
0.1 M sodium phosphate-buffered saline (PBS; pH 7.4) for 10 min, and postfixed in 
4% paraformaldehyde in 0.1 M sodium phosphate buffer (PB; pH 7.4), for 5 min at 20 
°C. After rinsing the sections in PBS for 10 min, acetylation was performed with 0.25% 
acetic acid anhydride in 0.1 M tri-ethanolamine buffer (pH 8.0), for 10 min, followed 
by rinsing in 2 times concentrated (X2) standard saline citrate buffer (SSC; pH 7.0), for 
3 min. Sections were then treated with 0.1% pepsin (Sigma Chemicals) in 0.2 N HCl, 
at 37 °C for 15 min, followed by 2 x 5 min wash in PBS and subsequently incubated 
Fig. 1. Overview of in situ hybridisation of CRF1 mRNA in the brain of Xenopus laevis, at the level 
of the diencephalon (sagittal section), with various positive regions such as the preoptic area (Poa), 
suprachiasmatic nucleus (SC), ventromedial thalamic nucleus (VM) and ventral hypothalamic area (VH), 
with an antisense oligonucleotide probe (a), and lack of hybridisation signal with the complementary 
sense probe (b). Bar = 100 µm.
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in hybridization mixture containing 20% X20 SSC, 50% deionised formamide, 0.2 ml 
of 50X Denhardt’s solution for 20 ml of hybridization mixture, 10% dextran sulfate, 
0.25 mg/ml tRNA, 10% of 1 M DTT and 10% of autoclaved MQ, for 2 h at 37 °C. After 
rinsing in X2 SSC for 5 min, sections were incubated in hybridization mixture with 
the 3’-DIG-labelled antisense/sense oligonucleotide probe (ca. 100 ng/ml), for 16 h at 
37 °C, followed by a quick rinse in SSC containing 1 M DTT, at room temperature. 
Then, sections were stringently washed twice in X1 and X0.5 SSC containing 1 M DTT 
(Roche, Basel, Switzerland), for 15 min at 55 °C, and in SSC, for 10 min at 20 °C. DIG 
label was visualised by the alkaline phosphatase (AP) method with nitro-bluetetrazol
iumchloride/5-bromo-4-chloro-3-indolyl phosphate-toluidine salt (NBT/BCIP; Roche) 
as a substrate. In brief, after 3 x 5 min rinses in 0.1 M Tris-buffered saline (TBS; pH 7.5) 
sections were washed in TBS containing 1% of blocking agent (TBS-BA; Roche), for 30 
min, followed by incubation in sheep-anti-DIG-AP (1:200; Roche) in TBS-BA, for 4 h 
at 20 °C. Sections were then rinsed 3 x 5 min in TBS followed by a 5 min wash in TBS 
buffer containing 0.05 M MgCl2 (TBS-M; pH 9.5), and hybridization was visualised 
after 48h of incubation in TBS-M containing NBT/BCIP. The reaction was stopped by 
several rinses in tap water followed by rinses in distilled water. Sections were then 
mounted in Kaiser’s glycerol gelatine (Merck, Darmstadt, Germany) and examined 
using a Leica DMRBE microscope (Leica Microsystems, Heerbrugg, Switzerland).
Fig. 2. Schematic sagittal view of the brain of X. laevis. The locations of CRF1 mRNA-positive neurons as 
visualised by in situ are indicated by black dots. Acc, nucleus accumbens; Apl, amygdala, pars lateralis; 
Apm, amygdala, pars medialis; Cb, cerebellum; Hv, nucleus habenularis ventralis; igl, internal granule 
cells of the olfactory bulb; lpd, latero-dorsal pallium; lpv, latero-ventral pallium; pd, pituitary gland, pars 
distalis; pi, pituitary gland, pars intermedia; pn, pituitary gland, pars nervosa; Poa, preoptic area; SC, 
suprachiasmatic nucleus; tect, mesencephalic tectum; TP, posterior tubercle; VH, ventral hypothalamic 
nucleus; VM, ventromedial thalamic nucleus (see abbreviations list).
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Fig. 3. Sagittal sections of the brain and pituitary gland of X. laevis, showing CRF1 mRNA hybridization 
in (a) internal granule cell layer of the olfactory bulb, (b) nucleus accumbens, (c) medial part of the 
amygdala, (d) preoptic area of the hypothalamus (Poa), suprachiasmatic nucleus (SC), (e) ventromedial 
thalamic nucleus, (f) ventral hypothalamic area, (g) tectum mesencephali, and (h) cerebellum. Bar a,d = 
50 µm; b,c,e-h = 20 µm.
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Morphometry and statistical analysis
 Digital images of 5 WA and 5 BA toads were taken using the Leica DMRBE 
optical system with a Leica DC 500 digital camera (Leica Microsystems) and a x20 
objective lens, and analysed with Scion Image software (version 3.0b; NIH, Bethesda, 
MD, USA). In situ hybridization staining intensity was determined in three 7 µm 
sagittal sections per animal, in the middle of (a) the internal granule cell layer of the 
olfactory bulb, (b) the intermediate pituitary and (c) the distal pituitary lobe. Values 
were expressed as means of the optical density (OD) ± standard error of the mean 
(SEM). Means per adaptation state were analysed with analysis of variance (α=5%), 
using Statistica (StatSoft, Tulsa, OK, USA), after testing for homogeneity of variance 
(Bartlett’s test; Bliss, 1967) and normality (Shapiro and Wilk, 1965).
Fig. 4. CRF1 mRNA in the pituitary gland (sagittal section) of X. laevis. In the melanotrope cells in the 
pars intermedia (pi) hybridization is weak in a black-adapted animal (a, detail in c) but strong in a 
white-adapted one (b, detail in d). In the pars nervosa (pn) no signal is present (a). Only some cells of 
the pars distalis (pd) show a positive hybridization signal (e). Bar a,b = 50 µm, c = 30, d-f = 20 µm.
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Results
Distribution of CRF1 mRNA in the brain and pituitary gland
With the anti-sense mRNA probe, CRF1 mRNA hybridization signals were seen 
throughout the brain in the neuronal perikarya, with variable staining intensities, 
whereas the neuronal cell nucleus, axons, axon terminals and other elements in the 
brain like glial cells, and blood vessels are devoid of signal (Fig. 1a). The absence of any 
background staining and of staining with the sense probe (control) (Fig. 1b), indicates 
that the signal specifically reveals the presence of CRF1 mRNA. The occurrence of the 
CRF1 mRNA hybridization signal in a brain structure was further studied in serial 
sagittal sections (Fig. 2) and the different hybridization intensities, assessed by visual 
observation and semiquantitatively expressed as ‘low’, ‘moderate’ and ‘strong’, are 
summarised in Table 1. The detailed distribution of CRF1 mRNA is as follows.
Telencephalon. The most rostral perikarya expressing CRF1 mRNA are situated in the 
olfactory bulb (Fig. 2), where the internal granule cell layer surrounding the lateral 
ventricle shows a strong signal (Fig. 3a). In the latero-dorsal and latero-ventral pallium, 
cells are moderately stained, whereas in the mitral cell layer and post-olfactory 
eminence no signal was observed. In the nucleus accumbens a moderate expression 
signal is present (Fig. 3b), whereas in the medial and lateral part of the amygdala 
scattered cells were found with low expression levels of CRF1 mRNA (Fig. 3c).
Diencephalon. A rostral group of neurons showing moderate hybridization signals is 
situated in the anterior preoptic area of the hypothalamus (Figs. 2,3d). A low expression 
signal occurs in small cell group in the dorsal and ventral habenular nuclei. No signal 
was detected in the Mg. More caudally, moderate expression of CRF1 mRNA occurs in 
cells scattered in the suprachiasmatic nucleus (Fig. 3d) and in the parallel cell layers 
Fig. 5. Effect of background adaptation on the OD expressed as arbitrary units (a.u.) of CRF1 in situ 
hybridization signals in internal granule cell layer of the olfactory bulb (igl), distal (pd) and intermediate 
lobe (pi) of the pituitary gland. White bars indicate white-adapted and black bars black-adapted Xenopus. 
Values are expressed as mean ± standard error of the mean. Asterisk indicates significant difference 
between the two adaptation states (*P<0.05).
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Brain region CRF1 mRNA
CRF-ir
Yao et al., 2004
Calle et al., 2005
Ucn 1-ir
Calle et al., 2005
Cells Fibres Cells Fibres
Telencephalon
Olfactory bulb, internal granule cells (igl) +++ + + - +
Mitral cell layer (ml) - ++ + - -
Medial olfactory tract (mot) - - - - +
Post-olfactory eminence (pe) - ++ - - -
Medial septum (ms) - - + - +
Lateral septum (ls) - - ++ - -
Latero-dorsal/ventral pallium (lpd, lpv) ++ - + - -
Dorsal pallium (dp) - - + - +
Medial pallium (mp) - - + - -
Striatum (Str) - + - - +
Accumbens (Acc) ++ +++ + - +
Diagonal band of Broca (DB) - - + - +
Amygdala pars medialis (Apm) + + + - -
Amygdala pars lateralis (Apl) + ++ + - -
Anterior commissure (ac) - - + - -
Diencephalon
Preoptic area (Poa) ++ ++ + - -
Nucleus habenularis ventralis (Hv) ++ +++ - - -
Ventromedial thalamic nucleus (VM) ++ + - - -
Anterior thalamic nucleus (A) - + - - +
Central thalamic nucleus (C) - - - - +
Posterior thalamic nucleus (P) - - - - +
Magnocellular nucleus, medial part (Mgm) - ++ + ++ +
Magnocellular nucleus, ventral part (Mgv) - ++ + +++ +
Magnocellular nucleus, dorsal part (Mgd) - - - - -
Suprachiasmatic nucleus (SC) ++ + + - -
Paraventricular organ (NPv) - ++ + - -
Posterior tubercle (TP) + + + - +
Ventral hypothalamic nucleus (VH) +++ + + - -
Median eminence zona interna (zi) - - + - +
Median eminence zona externa (ze) - - + - +
Pituitary pars nervosa (pn) - - + - +
Pituitary pars intermedia (pi) s.d. - - - -
Pituitary pars distalis (pd) ++ - - - -
Table 1. Distribution of xCRF1 mRNA, CRF- and Urocortin 1-ir cells and fibres in the X. laevis brain 
and pituitary gland, as visualised by in situ hybridisation and immunocytochemistry, according to Yao 
et al. (2004) and Calle et al (2005). For the in situ hybridisation, ratings reflect the intensity of positively 
labelled cells as visually observed in 5 white- and 5 black-adapted animals, with (+) indicating a low, 
(++) moderate and (+++) strong intensity of the staining; for immunocytochemistry the number of 
positive cells is indicated as follows: 1-4 cell bodies (+), 5-8 cell bodies (++) and 8-20 cell bodies (+++). 
Immunoreactive fibres are indicated by (+), (-) indicates a complete lack of labelling; s.d. stimulus-
dependent staining.
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of the ventromedial thalamic nucleus (Fig. 3e). In the posterior tubercle some slightly 
stained cells are present, whereas in the infundibular area, strong CRF1 mRNA staining 
is shown by the ventral hypothalamic nucleus (Fig. 3f). 
Dorsal mesencephalon. Several pyriform cell layers of the optic tectum reveal hybridization 
signals with varying intensities, ranging from moderate in the internal layers to strong 
in the external layers 5 and 6 (Fig. 3g).
Rhombencephalon. Strong CRF1 mRNA expression was encountered in the cerebellum 
(Fig. 3h).
Pituitary gland. In the pars nervosa of the pituitary lobe no hybridization signal was 
observed (Figs. 2,4a), but strong staining is present in the melanotrope cells of the 
intermediate lobe (Fig. 4b,d). In the distal lobe, a moderate to strong CRF1 mRNA 
expression signal occurs in a rostral cluster of endocrine cells. In view of their position, 
it is suggested that these cells are corticotropes, but this idea awaits further proof. 
Differences between CRF1 mRNA expression as a result of different adaptation states 
are dealt with in the next paragraph.
Effect of background adaptation on the expression of CRF1 mRNA
In order to determine whether and to what extent the expression of CRF1 mRNA 
in pituitary melanotrope cells is physiologically regulated by the background light 
Brain region CRF1 mRNA
CRF-ir
Yao et al., 2004
Calle et al., 2005
Ucn 1-ir
Calle et al., 2005
Cells Fibres Cells Fibres
Mesencephalon
Tectum mesencephali (tect) ++ +++ + - +
Tegmentum mesencephali (tegm) - - + - +
Edinger-Westphal nucleus (EW-N) - - + +++ +
Anterior tegmental nucleus (Av, Ad) - ++ + - -
Posterior commissure (pc) - - + - -
Nucleus posteroventralis tegmenti (pv) - + - ++ -
Torus semicircularis (Tor) - - + - +
Rhombencephalon - - - - -
Cerebellum (Cb) +++ - + - -
Locus coeruleus (Lc) - ++ + - -
Central gray (cg) - - - ++ -
Nucleus reticularis medius (Rm) - - - + -
Cochlear nucleus (LL) - - - - +
Nucleus motorius nervi trigemini (Vm) - ++ + ++ -
Nucleus motorius of the facial and 
glossopharingeal nerve (IX) - - - ++ +
Nucleus motorius nervi vagi (Xm) - - - ++ -
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condition, we measured mRNA hybridization intensities in WA (n=5) and BA (n=5) 
X. laevis, and expressed them as optical density (OD) in arbitrary units. As controls 
we studied two other structures of which we had found (see above, Fig. 2, and Table 
1) that they are rich in CRF1 mRNA but which are not known to be involved in the 
process of background light adaptation: the internal granule cell layer of the olfactory 
bulb (igl) and the presumed corticotrope cells in the distal lobe. 
As can be readily seen at low magnification (Fig. 4a,b) the intermediate lobe of 
the pituitary gland in BA animals is much larger than in WA toads, which is due 
to hyperplasia of the melanotrope cells, which are the only endocrine cells in the 
intermediate lobe (de Rijk et al., 1990). On the other hand, the intensity of the CRF1 
mRNA hybridization signal in the intermediate lobe of WA animals is much higher than 
in BA animals (Fig. 4b,d). A special observation is that in WA animals, the intensity of 
the hybridization signal differs among individual melanotrope cells, being moderate 
in some cells, but strong or even very strong in others. In BA animals all cells are 
stained with the same, rather weak intensity (Fig. 4a,c). No effect of background light 
intensity on the expression of CRF1 in the brain was noted.
This stimulatory effect of white background adaptation on, specifically, the expression 
of CRF1 mRNA in the melanotrope cells, clearly appears from the morphometric study. 
In both the igl and in the distal lobe, the OD of the CRF1 mRNA hybridization signal 
does not differ between BA and WA animals (Fig. 5) but the melanotrope cells in the 
intermediate pituitary lobe of WA animals show a 59.4% higher OD than melanotropes 
of BA animals (P<0.05; Fig. 5). 
Discussion
Technical considerations
With in situ hybridization, using a DIG-labelled oligonucleotide probe, we here 
describe for the first time the detailed distribution of mRNA encoding CRF1 in the 
brain and in the pituitary gland of a non-mammalian vertebrate, the South African 
clawed toad X. laevis. The reasons for using an oligonucleotide probe instead of a 
ribonucleotide probe are: 1) the higher stability (resistance to RNAse degradation) 
when compared to a RNA probe, 2) the small molecular size of the oligonucleotide, 
which provides better tissue penetration, and 3) the fact that oligonucleotides do not 
self-hybridize. 
Comparison of CRF1 mRNA distribution in the brain of amphibians with mammals
The general existence of CRF1 in the brain of X. laevis was previously assumed 
on the basis of RT-PCR (Dautzenberg et al., 1997; Boorse and Denver, 2006), but no 
information was available regarding the brain structures expressing this receptor. This 
is the first report describing the presence of CRF1 mRNA, and hence, most probably, of 
CRF1, in the telencephalon, diencephalon and brainstem of X. laevis.
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The distribution of the CRF1 mRNA in the Xenopus brain, as detected by using a 
DIG-labelled oligonucleotide probe, appears to be substantially less extensive than 
that of CRF1 mRNA in the mammalian brain (Van Pett et al., 2000). For example, in 
the rat telencephalon, CRF1 mRNA occurs in the periglomerular layer, mitral layer 
and olfactory tubercle as well as in the hippocampus, diagonal band of Broca and 
bed nucleus of the stria terminalis (Van Pett et al., 2000), all regions that in X. laevis 
are devoid of CRF1 mRNA. In the rat diencephalon CRF1 mRNA is present in many 
thalamic areas such as the latero-dorsal and latero-posterior nucleus and the lateral 
geniculate nucleus, whereas in Xenopus only the ventromedial thalamic nucleus 
shows CRF1 mRNA expression. CRF1 mRNA has been observed furthermore in the 
rat brainstem, viz. in many sensory relay structures, whereas in the toad only the 
tectum mesencephali and the cerebellum reveal CRF1 mRNA hybridization. The wider 
distribution of this receptor mRNA in the rat suggests that its ligands CRF and Ucn1 
have acquired novel central functions during evolution. It might be argued that our 
DIG-labelling technique could be less sensitive than radioactive in situ hybridisation 
methods, which might be the cause of the different expression patterns of CRF1 mRNA 
between rat and toad. Although our preliminary results on CRF1 receptor studies in 
the mouse do not support this idea, as either method yields essentially the same results 
[Kőrösi, unpubl. data], only future quantitative comparisons between Xenopus and rat 
carried out with both methods, can definitely solve this issue.
On the other hand, the distributions of CRF1 mRNA in the brain of X. laevis and of 
mammals show some clear similarities. In X. laevis, going from rostral to caudal, strong 
CRF1 hybridization signals occur in the internal granule cell layer of the olfactory bulb, 
the ventral hypothalamic area, the tectum mesencephali and the cerebellum. The 
homologous nuclei in the rat brain, viz. the granule cell layer of the olfactory region, 
the arcuate nucleus, the superior colliculus and the granule layer of the cerebellum, 
respectively, also express CRF1 signals (Van Pett et al., 2000). Furthermore, neither in 
the Mg of X. laevis nor in its rat homologue, the PVN, any CRF1 mRNA signal has been 
observed (Van Pett et al., 2000). These similarities between CRF1 locations in Xenopus 
and rat indicate that the presence/absence and functions of this receptor type are 
strongly evolutionary conserved.
Relation between CRF1 mRNA and CRF/Ucn1 peptide distributions
The in situ hybridization signal for CRF1 mRNA is a strong indication for the local 
existence of CRF1 protein. Because in vitro studies showed that both Xenopus CRF 
and Ucn1 bind with high affinity to Xenopus CRF1 (Boorse and Denver, 2006) it is of 
functional interest to assess if the CRF1 mRNA expressions described in this study match 
with the descriptions of CRF- and Ucn1-ir fibres and perikarya (Yao et al., 2004; Calle et 
al., 2005b/Chapter 4). Table 1 lists our present description of CRF1 mRNA distribution 
in Xenopus, as well as literature data on the distribution of CRF and Ucn1 peptides in 
this animal (Yao et al., 2004; Calle et al., 2005b/Chapter 4). As the table shows, both 
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CRF- and Ucn1-ir elements occur in the olfactory bulb, nucleus accumbens, posterior 
tubercle and tectum mesencephali, suggesting that in these four areas both CRF and 
Ucn1 can act on CRF1. However, taking a more general view, in most brain structures 
CRF1 mRNA coexists with CRF-ir fibres (but not with Ucn1-ir fibres), supporting the 
notion that CRF is the endogenous ligand for CRF1, and that Ucn1 binds preferably to 
CRF2 (Dautzenberg et al., 1997; Boorse et al., 2005). In the nucleus habenularis ventralis, 
CRF1 mRNA expression occurs in CRF-ir perikarya. Here, ultrastructural studies may 
be helpful to determine if the same cells both release CRF and possess CRF1, which 
would point to an autocrine action of CRF.
These data together, support the idea that CRF and Ucn1 act on CRF1 receptors in 
the Xenopus brain. Whether the absence of CRF1 mRNA in CRF- and/or Ucn1-peptide 
containing brain structures points to actions of these ligands on CRF2, or on an action 
of these ligands in other areas of the brain that are reached by volume transmission 
or via axons, that cannot be revealed at the light microscope level, remains to be 
established. 
Physiological regulation of CRF1 mRNA expression in the amphibian intermediate pituitary 
lobe
We here demonstrate for the first time that CRF1 occurs in the intermediate lobe 
of the pituitary gland of a non-mammalian species. The presence of CRF1 in the 
intermediate lobe of X. laevis extends the previous general demonstration by RT-PCR 
of this receptor type in the total pituitary gland (Dautzenberg et al., 1997), as it shows 
that CRF1 is restricted to the melanotrope cells of the intermediate lobe. Recently, we 
showed the presence of CRF and Ucn1 peptides in the median eminence and in the 
pars nervosa of the pituitary lobe of Xenopus and revealed by in vitro superfusion 
studies that both peptides stimulate the release of α-MSH from melanotrope cells 
(Dautzenberg et al., 1997; Calle et al., 2005b/Chapter 4). We now show an upregulation 
of CRF1 mRNA in WA toads, as compared to BA animals. This receptor upregulation is 
specific for the melanotrope cells, as no effect of the background illumination state was 
visible in the igl or in the distal pituitary lobe. Our demonstration of CRF1 mRNA in 
the intermediate lobe fits in with the fact that the Mg, projecting to neurohemal areas 
in the median eminence and the pituitary pars nervosa, is controlling melanotrope cell 
secretory activity via the release of CRF and Ucn1, both peptides stimulating α-MSH 
release in vitro (Dautzenberg et al., 1997; Calle et al., 2005b/Chapter 4). Interestingly, in 
WA the strength of the CRF1 mRNA signal is not homogenous throughout the gland, 
suggesting that some cells are producing more receptors than others. This result 
supports the notion that the intermediate lobe of the pituitary gland is composed of a 
heterogeneous cell population as to size (de Rijk et al., 1990) and POMC production 
(Corstens et al., 2005).
Up to now, it is not known what factors control the release of CRF and Ucn1 release 
from the pituitary pars nervosa. In the present study we show that adaptation of 
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Xenopus to a white background upregulates the expression of CRF1 mRNA. This finding 
suggests that in these WA animals, melanotropes become highly sensitive to CRF and 
Ucn1 so that when placed on a black background, their high receptor density enables 
the cells to rapidly mobilise stored α-MSH to the secretory process. In this way, the 
animals can turn black quickly, permitting fast camouflage. Indeed, in line with these 
results, Verburg-van Kemenade et al. (1987a) reported that ovine CRF evokes stronger 
in vitro α-MSH release from neurointermediate lobes of WA than of BA toads. For X. 
laevis melanotropes a similar situation has been described with respect to thyrotropin-
releasing hormone-receptor type 3 mRNA, and for NPY Y1 receptor mRNA, which are 
both upregulated in WA animals (Jenks et al., 2002; Bidaud et al., 2004). Like CRF and 
Ucn1, TRH simulates α-MSH release, whereas NPY inhibits this release (Verburg-van 
Kemenade et al., 1987b; Scheenen et al., 1995). 
Further studies on the dynamics of the Mg and the in vivo conditions by which the 
activity of this nucleus is regulated, as well as on the possible presence and regulation 
of CRF2 receptors in the pituitary gland, may elucidate the plastic interactions 
between CRF and Ucn1 and their receptors that are crucial to the functioning of the 
neuroendocrine reflex mechanism by which melanotrope cells in amphibians control 
the process of skin colour adaptation to background illumination. We propose that this 
mechanism is an example of neuroendocrine plasticity crucial to adaptation processes 
in general and to adaptation to stressful environmental events in particular. 
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Abstract
The distribution of cocaine- and amphetamine-regulated transcript peptide (CART)-like 
immunoreactivity was studied only in the rat central nervous system (CNS). In mammals, 
CART peptides occur among others in brain areas that control feeding behavior. We mapped 
CART-immunoreactive structures in the CNS of the frog Rana esculenta and assumed that 
differences may exist in the CART-containing neuronal populations between the frog, which 
does not feed in winter, and the rat. In the forebrain, immunoreactive cells and fibers were found 
in the olfactory bulb, nucleus accumbens, amygdala, medial pallium, septum, striatum, the 
preoptic nuclei, ventromedial nucleus, central thalamic nucleus, and the hypothalamus. The optic 
pathway was free of immunoreactivity. The neurohypophysis showed intense immunostaining. 
In the mesencephalon, many cells were stained in the Edinger-Westphal nucleus, and a few in 
the optic tectum, where fibers were stained in all plexiform layers. In the retina, some cells in the 
inner nuclear layer contained CART. In the rhombencephalon, cells were stained in the raphe 
nuclei, central gray, nucleus of the solitary tract, and the vicinity of motor nuclei. Neurons of 
the motor cranial nerves were densely innervated by CART-positive fibers originating from 
the spinal cord. In the spinal cord, preganglionic cells were stained, and motoneurons were 
surrounded by immunoreactive varicose axon terminals. Major differences were found between 
the frog and the rat brains in the distribution of CART in the visual system, olfactory bulb, 
preoptic area, and the motor nuclei. Some of these differences may be related to feeding behavior 
of these animals. 
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Introduction
Cocaine- and amphetamine-regulated transcript (CART) mRNA was discovered in 
the rat striatum, after administration of cocaine or amphetamine (Douglass et al., 1995). 
The amino-acid sequence of the CART protein has been deduced, the active fragments 
were identified and characterized (Thim et al., 1998; Kuhar and Yoho, 1999). The rat 
proCART protein is composed of 129 amino acids. This long molecule is processed 
by neurons, and fragments may be released. Two of them had already been identified 
in extracts of the ovine hypothalamus, before the significance of these peptides was 
recognized (Spiess et al., 1981). CART peptides have been found in many brain areas, 
including those that participate in the control of feeding behavior (amygdala, nucleus 
accumbens, hypothalamus, nucleus of the solitary tract, intermediolateral cell column 
of the spinal cord; Koylu et al., 1997, 1998; Elmquist et al., 1999). In physiological 
experiments, the intracerebroventricular administration of the 55-102 fragment of 
CART inhibits food intake (Kristensen et al., 1998; Lambert et al., 1998; Adams et al., 
1999; Asakawa et al., 2001; Stanley et al., 2001) or causes anxiety (Chaki et al., 2003). 
Injection of CART into the ventral tegmental area increases the locomotor activity of 
rats (Kimmel et al., 2000). These findings raise the possibility that the decrease in food 
intake may be caused by motor disturbances.
The CART gene is highly conserved during phylogeny, and the complete sequence 
of mouse, rat, human, and goldfish CART genes is known (for review, see Kuhar 
et al., 2002). The carboxy-terminus of CART, which contains the biologically active 
sequences, is conserved in every species investigated. This finding may suggest that 
CART is expressed in homologous brain areas of various species; however, the 106-
129 CART fragment has only been studied in detail in the rat (Koylu et al., 1998). 
CART-immunoreactivity has also been demonstrated in brain areas involved in limbic 
functions, sensory processing, and autonomic regulation. A similar expression pattern 
of CART mRNA was found in the human brain (Hurd and Fagergen, 2000), and the 
distribution of CART-immunoreactivity was also studied in the human (Elias et al., 
2001) and monkey hypothalamus (Dall-Vechia et al., 2000). In the rat, projections of 
CART-immunoreactive neurons were described from the nucleus accumbens to the 
substantia nigra (Dall-Vechia et al., 2001) and from CART-containing hypothalamic 
cells to the intermediolateral cell column of the spinal cord (Elias et al., 1998).
In a recent study, CART precursor mRNAs were demonstrated in the olfactory bulb, 
telencephalon, hypothalamus, and the optic tectum in the goldfish brain (Volkoff and 
Peter, 2001). Volkoff and Peter also showed that CART controls feeding (2000, 2004) 
and locomation (2000) in goldfish. These results provide further evidence for the 
existence of CART in lower vertebrates as well as suggest an early evolutionary origin, 
and biological significance with repespect to feeding and locomotion for this peptide; 
however, the exact distribution of CART immunoreactivity in a lower vertebrate 
species has not yet been shown in a single study.
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The aims of the present account were to describe the distribution of CART in the 
central nervous system (CNS) of the frog Rana esculenta and to compare it with that 
found in the rat. We assumed that differences may exist in the CART containing neuronal 
structures between the frog, which does not feed in winter, and the continuously 
feeding rat. Furthermore, various lesions were made to study the projections of CART-
immunoreactive neurons and the source of immunostained fibers. The present study 
also fits into the series of investigations we have been conducting in the past 15 years to 
describe various systems exhibiting peptide-like immunoreactivities in the frog brain 
(see for references, Lázár, 2001).
Materials and Methods
Twenty-three green frogs (Rana esculenta) of either sex were used. The animals 
were collected from a fish pond at the end of October 2002 and were purchased from 
an authorized dealer. All animals were healthy and well-fed. In the laboratory, they 
were kept in a container that was continuously rinsed by tap water. The container was 
divided into a smaller compartment (0.25 m2) for operated and a larger one (0.75 m2) 
for intact animals. Half of the bottom area was covered by 3 cm deep of water, and the 
other half was an elevated dry area. Water temperature was 13-14 °C in winter and 
reached 17 °C in summer. Air temperature in the animal room varied between 20 and 
28 °C, depending on the season. Frogs were weekly fed beef heart and mealworms. 
Surgical procedures and killing of the animals for histology were performed under 
deep urethane anesthesia (2 mg/g body weight, i.p.).
One of the frogs was given 1 g/g body weight of colchicine into the lateral ventricle 
and killed 48 hours later. In two frogs, the mucous membrane of the roof of the oral 
cavity was opened in the midline. With the aid of a dental bore, a small piece of bone 
was removed below the optic chiasma, which was exposed by peeling away the 
meningeal membranes, and the left optic nerve was cut by means of iris spring scissors. 
The rostral telencephalon or the mesencephalic tegmentum were also exposed from 
below. In two animals, a transverse cut was made at one side of the brain, just behind 
the accessory olfactory bulb. In four animals, the brainstem was hemisected in front 
of the isthmic nucleus. In two animals, a superficial cut was made on the left side 
in the lateral part of the medulla at the caudal edge of the VIIIth cranial nerve. The 
operations were finished by reflecting the mucous membrane to the base of the skull 
and fixing it in place with tissue glue (Histoakryl blau, Braun, Melsungen, Germany). 
In two animals, the left optic tectum was exposed from above and this tectum was 
removed by suction. The goal of these lesions was to interrupt pathways that may 
contain CART-immunoreactive fibers or to destroy the possible source of fibers to the 
thalamus (in case of the optic tectum). All animals were in good condition during the 
experimental period. One colchicine-treated and eight intact animals were used for 
systematic mapping studies. Two frog brains were used for the absorption test of the 
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CART peptide and the Western blot analysis of the CART antiserum. The experiments 
were in accordance with the Hungarian laws on the protection of animals (Magyar 
Közlöny, no. 28/1998).
Tissue preparation
Frogs were perfused through the ascending aorta, first with 20-30 ml of 0.066 
M sodium-phosphate-buffered saline (PBS; pH 7.4) and then with 4% buffered 
paraformaldehyde in PBS (pH 7.4). One hour after completing the perfusion, brains 
and spinal cords were removed and immersed in 4% paraformaldehyde for 24-48 hours 
at 4 °C. Then the spinal cord was separated from the brain and the fixed tissues were 
embedded in polyethylene glycol 1000 (Sigma-Aldrich, Zwijndrecht, Netherlands). 
For sectioning in the coronal plane, the brains were cut into two pieces just behind the 
optic tectum. The specimens were cut serially at 20 m in coronal, sagittal, and horizontal 
planes on a sliding microtome (Leica Jung SM2000R). The sections were collected in 
five dishes in PBS. The first dish contained the 1st, 6th, 11th, etc., sections. This strategy 
of processing helped preserving serial order during mounting. A series of 27 schematic 
drawings that show transverse sections of the frog brain from the olfactory bulb to the 
second spinal segment also helped in the reconstruction of coronal sections. Two frog 
eyes, after removing the cornea and the lens, were also processed.
Primary antiserum
The primary antiserum was raised in mice against the 106-129 fragment of the CART 
peptide. The antiserum (C6-1 F4D4) was a generous gift from Dr. J. T. Clausen (Novo 
Nordisc A/S, Bagverd, Denmark).
Immunocytochemistry
After preincubation steps (0.1% Triton X-100 solution Sigma-Aldrich; 5% normal 
horse serum mouse: PK 6102, Vector Laboratories, Burlingame, CA, USA), the 
sections were incubated for 48-72 hours at 4 °C with the primary antiserum diluted to 
1:100,000. For visualization of immunoreactivity the ABC Elite Kit (mouse: PK 6102, 
Vector Laboratories) was used with 3,3-diaminobenzidine (DAB) as the chromagen. 
In sections from the brains of four unoperated animals, the DAB polymer was nickel-
intensified. The immunostaining was developed for 10 minutes at room temperature 
under microscopic control. The mounted sections were air-dryed and coverslipped by 
DePeX (Serva, Heidelberg, Germany).
Antiserum controls
Western blot analysis of the frog brain revealed a single band migrating at 
approximately 13 kDa, which corresponds to the molecular weight of the CART 
peptide (Fig. 1A). The specificity of the primary antiserum was further verified by a 
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series of increasing dilutions to the point where it just stained the sites of interest in 
the tissue. This staining was achieved at 1:300,000 dilution (Fig. 1B,D). At this dilution, 
adding 1 µg of native CART peptide (generous gift of Dr L. Thim, Novo Nordisc A/
S, Bagsverd, Denmark) to 1 ml of serum completely abolished immunostaining (Fig. 
1C,E). Omitting the primary antiserum or replacing it with the normal horse serum 
yielded a similar result. 
Morphometry
The diameters of the immunostained perikarya were measured by means of an 
ocular micrometer by using a 40x objective lens. Ten randomly selected cells were 
measured in each cell group identified. The diameter of the roughly round cells was 
measured across the widest part of the perikaryon. The smallest and the largest values 
of these measurements will be given, e.g., 10-11 µm disregarding the digits. In the 
case of pyriform and other elongated cells, the longitudinal axis was also measured, 
and the values will be given like the following: 10-12 x 20-25 µm. The aim of these 
measurements was only to show the range where CART-positive perikarya can be 
placed.
Fig. 1. Antiserum control preparations. A: Western blot analysis of cocaine- and amphetamine-regulated 
transcript (CART) immunoreactivity in the frog brain. The immunoblot (right side) shows CART-
immunoreactivity of the frog brain. Low molecular weight markers (kilodaltons) are indicated on the 
left side of the diagram. B: CART-immunoreactivity in the olfactory bulb using the primary antibody 
diluted to1:300,000. C: No immunostaining in an adjacent section to that shown in B after adding a 1 
mg/ml CART peptide, which completely blocked immunostaining. D: CART-immunoreactive neurons 
in the Edinger-Westphal nucleus using the primary antiserum at a dilution of 1:300,000. E: There are 
no stained cells in an adjacent section after adsorption of the primary antiserum with the native CART 
peptide. For abbreviations, see Chapter 11. Scale bars = 100 µm in C (applies to B,C), E (applies to D,E).
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Digital imaging
Digital images of the frog brain were taken by a Nikon Microphot FXA microscope 
equipped with a Spot RT Color digital camera (Diagnostic Instrument, Sterling Heights, 
MI, USA). By using the software supplied with this camera, images were taken at a 
resolution of 1,200 x 1,600 pixels, imported into Adobe Photoshop 7.0, and digitally 
processed (histogram levels, brightness, contrast, and sharpness were adjusted).
The nomenclature used to designate nuclei and pathways in the frog brain was 
mostly according to Lázár et al. (1991), whereas some structures in the telencephalon 
were named according to Marín et al. (1998).
Results
General considerations
The major part of the following descriptions is based on immunostained transverse 
sections. When either horizontal or sagittal sections are illustrated, their orientations 
are indicated in the figure captions. Most immunoreactive processes appeared as small 
(0.5-2 µm long) particles in transverse sections. When they were somewhat larger and 
irregular in shape, we used the term ‘particles’. When they were small and round, we 
referred to them as ‘grains’ or ‘dots’. In sagittal or horizontal sections, thin beaded 
fibers could sometimes be followed for a distance, especially in the brainstem and the 
spinal cord.
The effect of colchicine
We obtained similar pattern of cellular immunostaining in colchicine-treated and 
untreated frogs. In the optic tectum, however, neuronal staining was very weak in 
untreated animals, compared with the more intense perikaryal staining in the second 
layer of the tectum in the colchicine-treated frog. Because colchicine treatment did 
not reveal differences in CART-immunostaining in treated vs. non-treated animals, no 
further colchicine treatment was carried out to reduce the number of animals and their 
suffering.
Telencephalon
Olfactory bulb. The most intensely stained structure in the frog brain was the olfactory 
bulb (Figs. 2A,B,3A,C). Many cells of the internal granular layer were immunoreactive. 
Approximately one third of the immunoreactive perikarya were intensely stained, with 
one or two less intensely stained short, little branching dendrites. The other perikarya 
were faint, and no dendrites were seen. Very rarely a few, thin axons could be followed 
from the internal granular to the mitral cell layer. Among the cells, intensely stained, 
irregular particles were evenly distributed (Fig. 3B). Some of them were closely 
attached to immunostained cells. The mitral cell layer contained only immunoreactive 
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Fig. 2. A-G: Distribution of cocaine- and amphetamine-regulated transcript (CART)-immunoreactivity 
in schematic drawings of the frog brain. The right upper panel shows the transverse planes chosen for 
the illustrations: planes A-D are from the telencephalon, E and F from the diencephalon, and G shows 
the pretectal region and the infundibulum. The location of immunoreactive particles of nerve fibers 
and perikarya are shown in the left half of each drawings. Wavy lines represent CART-immunoreactive 
fibers, and dots indicate their terminals. Large dots with processes are neurons. Neuroanatomical 
parcellations are designated in the right half. For abbreviations, see list.
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dots, which were most numerous close to the pial surface. The olfactory nerve, the 
glomerular layer (Fig. 3A), and the glomeruli in the accessory olfactory bulb were free 
of immunostaining (Figs. 2B,3C). 
Pallium. In front of the caudal edge of the accessory olfactory bulb, no immunostained 
structures were seen in any parts of the pallium (Fig. 2B). At more caudal levels, 
stained cells appeared in the caudal two thirds of the medial pallium (Fig. 2C,D). The 
shape of these cells was best seen in parasagittal sections. The majority of the perikarya 
were multipolar, primarily stellate-shaped with a diameter of 12-16 µm. Some of them 
had an elongated perikaryon with measures of 8-10 x 20-25 µm, or pyriform with 
diameters of 10-11 µm in width and 14-16 µm in length (Fig. 3D). Most dendrites of 
these cells arborized in parasagittal planes. In the medial pallium, short segments of 
a few longitudinal varicose fibers were identified, which entered this area from the 
medial and lateral septum.
Subpallium. The nucleus accumbens as well as the lateral, medial, and central amygdala 
contained faintly stained, round cells with a diameter of 11-12 µm (Fig. 2C,D). More 
cells were stained in the striatum, primarily in its caudal half. Most of the striatal 
cells had small pyriform perikarya with a single dendrite oriented to the lateral or 
ventrolateral direction. Some fusiform and multipolar cells were also observed (Fig. 
2C,D). Among the cells, small immunopositive grains were distributed. They were 
more numerous in the lateral half of the striatum than medially, and laterally a diffuse, 
strong CART-immunostaining was also characteristic (Fig. 3E). Grains occurred also 
in all parts of the amygdala (Fig. 2C,D). In sagittal sections, a row of loosely arranged 
immunoreactive cells could be seen along the border of the medial pallium and the 
septum (Fig. 3A). In the ventral part of the rostral lateral septum, a triangular area was 
covered by intensely stained varicose fiber terminals. This finding was best observed 
in transverse sections. (Figs. 2D,3E). The termination field of septal fibers was located 
more dorsally in the caudal than in the rostral telencephalon, as seen in sagittal sections 
(Fig. 3A). In the medial septum, immunostained particles were loosely distributed 
(Fig. 3E). Scattered CART-positive grains also occurred in the brain area ventral to 
the septum, including the bed nucleus of the stria terminalis and the pallidum (Fig. 
2D). In transverse sections of two brains, the lateral forebrain bundle showed an 
intense, diffuse staining (Fig. 3F). In the other brains, grains dominated over a lighter 
background. A unilateral trans-section of the telencephalon just behind the accessory 
olfactory bulb did not influence immunostaining neither rostrally, nor caudally of the 
cut, after a 36 days survival time.
Diencephalon
Preoptic area. Several, round perikarya (9-10 µm in diameter) were faintly stained in the 
posterior preoptic nucleus. The cell group was continuous dorsally with immunostained 
cells in the magnocellular preoptic nucleus. These neurons were also round or slightly 
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pyriform with a diameter of 12-14 µm and occupied the whole length of the nucleus. 
Sometimes the origin of a single dendrite could be observed (Fig. 2E). A large number 
of immunoreactive grains and fine varicose fiber terminals occupied the whole preoptic 
area. Between the periventricular cell laminae, they formed rows and were diffusely 
Fig. 3. Distribution of cocaine- and amphetamine-regulated transcript (CART)-immunoreactive cells 
and fibers in the telencephalon. A: Immunostaining in the main olfactory bulb, the medial pallium, 
the subpallium, and the lateral septum. Arrows point to a row of immunostained cells located along 
the border of the medial pallium and the septum. Note very intense immunostaining in the olfactory 
bulb. Sagittal section. B: High-power photomicrograph from the internal granular layer of the olfactory 
bulb. Note the abundance of irregular immunopositive particles and a stained neuron (arrow). C: 
Immunoreactive perikarya in the internal granular layer of the olfactory bulb in a nickel-intensified 
horizontal section. Note the absence of staining in the olfactory glomeruli of the accessory olfactory bulb 
and the postolfactory eminence. D: Stained neurons in the medial pallium. Sagittal section. E: Section 
just in front of plane D in Figure 1. Note the termination of intensely stained fibers in the lateral septum. 
F: Transverse section at the rostral edge of the optic chiasm. For abbreviations, see Chapter 11. Scale bars 
= 250 µm in A,C,E,F; 25 µm for B; 50 µm for D.
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distributed in the lateral neuropil. Grain density was higher ventromedially than 
dorsolaterally (Fig. 3F).
Thalamus. Two immunoreactive cell groups could be identified in the thalamus. One 
in the ventromedial nucleus, where the cells were pyriform and projected a short 
dendrite to the ventrolateral direction (Figs. 2F,4A). The other group was located in 
the central thalamic nucleus in the pretectal area (Figs. 2G,4B) and consisted of small 
pyriform or round cells (Fig. 4Ba). Axons were not stained. A few well-stained cells 
were also observed in sagittal sections in the pretectal neuropil, just in front of layer 
7 of the optic tectum (Fig. 4D).  All thalamic nuclei were invaded by immunoreactive 
fibers and terminals, which appeared in the form of scattered grains or rows of grains 
between the periventricular cell laminae, suggesting that they are varicosities of axons. 
The density of grains was highest in the periventricular region, in the lateral thalamic 
neuropil, and in the caudal one third of the lateral thalamic nucleus and was lower 
in the rest of the thalamic nuclei (Fig. 2E,F). The neuropils of the lateral geniculate 
complex (Fig. 2E), the pretectal neuropil, and the optic tract (Fig. 2G) were free of 
immunoreactive structures and clearly demarcated from the lateral thalamic neuropil 
(Fig. 4E). In horizontal sections, the area of the tectothalamic tract was covered by 
immunoreactive particles back to the 7th layer of the optic tectum (Fig. 4A). In the 
medial and lateral forebrain bundle, short segments of varicose axons were observed.
Hypothalamus. In the rostral infundibulum, pyriform and fusiform neurons were 
intensely stained among the periventricular cells. In many cases, the single dendrite 
of the cells split into two branches close to its origin. At the periphery or lateral to 
the periventricular cells, the immunoreactive neurons were mainly fusiform with 
mediolaterally or dorsoventrally oriented dendrites (Fig. 2F). More caudally, in the 
dorsal hypothalamic nucleus, several small (8-10 µm in diameter), round cells were 
stained (Figs. 2G,4B). Occasionally, the origin of a single dendrite was also seen (Fig. 
4Bb). In the ventral hypothalamus, immunoreactive cells were less numerous and 
mainly occurred in the neuropil. Some of them had triangular perikarya and three stout 
dendrites that pointed ventrally and dorsally. Among the periventricular neurons, a 
few pyriform cells with laterally pointing dendrites were stained, and some of them 
seemed to be liquor-contacting neurons. Small, intensely stained perikarya occurred 
in the median eminence. Immunoreactive grains occupied the whole hypothalamus, 
most densely in the dorsal hypothalamic nucleus and the lateral half of the ventral 
hypothalamus (Fig. 4B).
Pituitary gland. The neural lobe of the pituitary gland was darkly stained, revealing large, 
irregular, immunoreactive particles that were loosely distributed. No immunostaining 
was observed in the adenohypophysis (Fig. 4C).
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Fig. 4. A: Cocaine- and amphetamine-regulated transcript (CART)-immunoreactive perikarya in the 
diencephalon and the torus semicircularis. The inset shows cells in the ventromedial nucleus of the 
thalamus. Horizontal section. B: CART-immunoreactive cells and fibers in the diencephalon at the level 
of plane G in Figure 1. Ba shows immunostained cells at high magnification in the central thalamic 
nucleus and Bb in the dorsal hypothalamic nucleus. C: Intense CART positivity in the neural lobe of 
the hypophysis. Sagittal section. Rostral is up. D: Immunostained neurons in the pretectal neuropil and 
the tectum. Sagittal section; 6, 7, tectal layers. E: CART-immunopositive fibers and their terminals in the 
diencephalon and mesencephalon. Sagittal section. F: Retina. CART-immunoreactive cells (arrows) and 
processes in the inner nuclear layer. Note absence of immunostaining in the other layers. G: Intensely 
CART-immunopositive cells in the ventral tegmentum. The middle third of the microphotograph 
corresponds to the Edinger-Westphal nucleus. Arrows point to caudally oriented dendrites. Sagittal 
section. Rostral is to the left. For abbreviations, see Chapter 11. Scale bars = 250 µm in A-D; 50 µm in 
inset A, Ba, (applies to Ba, Bb); 500 µm in E; 25 µm in F; 100 µm in G.
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Retina
In the inner nuclear layer of the retina, some cells showed CART-immunoreactivity. 
Approximately half of these cells had round perikarya with a diameter of 12-13 µm. 
The origin of two to three dendrites could be recognized. The cells were primarily 
located in the middle or inner one third of the layer and resembled amacrine cells (Fig. 
4F). A few multipolar cells were also seen. They had four to six short dendrites. Some 
ovoid and pear-shaped cells measured 8-9 x 12-13 µm. Occasionally, the perikaryon 
of a CART-positive cell was located in the outer or the inner plexiform layer, but the 
processes of these cells entered the inner nuclear layer.
The whole inner nuclear layer was densely filled with immunostained particles 
that surrounded unstained cells (Fig. 4F). Short segments of immunoreactive fiber-like 
structures could also be stained. Immunostaining could not be detected in any other 
layers of the retina.
Mesencephalon
Optic tectum. In the second layer of the tectum, many cells contained immunoreactive 
material in small clumps around the nucleus. Because the cytoplasm of the large 
pyriform cells occupying this layer is very narrow, the immunoreactive substance 
characteristically appeared in a triangular area at the origin of the main dendrite when 
only diaminobenzidine was the chromogen (Fig. 5A). In the colchicine-treated frog, 
nickel intensification of the sections resulted in more intense cellular staining, while 
the density of immunoreactive grains was reduced (Fig. 5B). In the rostral tectum, a 
few round cells were stained in layer 9 and 8 and at the lateral border of the pretectal 
neuropil. All plexiform layers of the tectum contained immunoreactive fiber elements 
(Figs. 5A,6A,B). Lamina A of layer 9 was almost free of immunostained grains in the 
rostral tectum, whereas in the caudal tectum, a narrow stripe appeared close to the 
pial surface that contained more grains. In lamina B, larger grains could be recognized. 
Lamina C could not be clearly distinguished. Grains in the outer half of this lamina 
merged with lamina B. In the inner half, the density of grains was low. The rest of layer 
8 and layer 9 contained fewer and smaller grains, whereas layer 7 was filled with coarse, 
immunoreactive particles. Grains were very sparse in layer 6, whereas in plexiform 
layers 3 and 5, they were more numerous (Fig. 5A,B). Occasionally, a varicose axon 
was also stained here (Fig. 5A). The medial and lateral divisions of the marginal optic 
tract were free of immunostaining. Trans-section of the optic nerve did not influence 
immunostaining in the corresponding tectum 36 days after the lesion. At 60 or 68 days 
after the unilateral removal of the optic tectum, the density of immunostained grains 
became strongly reduced ipsilateral to the lesion in the lateral thalamic neuropil, the 
termination site of the tectothalamic tract (Fig. 5Ca,b).
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Tegmentum mesencephali. The most intense cellular staining was found in the tegmentum. 
In the base of the tegmentum, cells formed a continuous column from the level of the 
posterior commissure to the level of the middle one third of the isthmic nucleus. The 
length of the column was 1,000 µm, the width was 200 µm rostrally, 300 µm in the 
middle, and 200 µm caudally (Figs. 4G,6A,B). The dorsoventral extent of the cell group 
was 350 µm rostrally and 100 µm at its caudal end. This area included the caudal part 
Fig. 5. Cocaine- and amphetamine-regulated transcript (CART)-immunoreactivity in the mesencephalon 
and rhombencephalon. A: Optic tectum. Note accumulation of immunoreactive particles in lamina B 
and C and a varicose fiber in layer 5 (arrow). A, B, C, tectal laminae. Numerals indicate tectal layers (also 
in B). B: Stained cells in layer 2 of the caudal optic tectum. Nickel intensification. Layer 2 was sectioned 
almost tangentionally in this plane; therefore, the cells appear in several rows. C: Immunostained 
fibers and their terminals in the lateral thalamic neuropil contralateral (a) and ipsilateral (b) to tectal 
ablation. Note reduced number of stained particles in b. D: Sagittal section of the mesencephalon and 
the rhombencephalon. Note intense fiber staining around the isthmic nucleus and the motor nuclei of 
cranial nerves. Da shows a well-stained fiber plexus in the isthmic nucleus. E: Immunostained cells 
dorsal to the interpeduncular nucleus (ip), and intense fiber staining in the ip. For abbreviations, see 
Chapter 11. Scale bars = 50 µm in A,B,Cb (applies to Ca,Cb); 250 µm in D; 100 µm in Da,E.
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of the nucleus of the medial longitudinal fasciculus, the Edinger-Westphal nucleus, 
and part of the anteroventral and posteroventral tegmental nuclei. The shape and the 
size of the cells, and the intensity of their staining were rather uniform. Almost all cells 
were pyriform measuring 9-10 x 14-15 µm. The main dendrite, which was sometimes 
stained to the first branching point, was mainly oriented ventrally or ventrolaterally 
in the rostral half of the cell column. In the caudal half, the dendrite of several cells 
pointed to the lateral direction. In sagittal sections, also caudally directed dendrites 
were seen (Fig. 4G). When the axon could be recognized, it originated opposite to 
the dendrite, and after a short course disappeared among immunoreactive grains. 
Some varicose axons left the nucleus rostrally or caudally. The laminar nucleus of 
the torus semicircularis also contained several faintly stained round or pyriform cells 
(Figs. 4A,6B). In coronal sections, a single dendrite pointed ventrally. Cells were not 
stained in the rest of the tegmental nuclei. Immunoreactive grains and short segments 
of fibers occurred throughout the tegmentum. Grains were most densely accumulated 
in the periventricular region, but above the cerebral aqueduct, the grains formed only 
a narrow stripe. The basal optic nucleus was free of immunostaining (Fig. 6A). In 
transverse sections of three brains, the interpeduncular nucleus, especially its ventral 
one-third, contained immunoreactive grains (Fig. 5E). In other brains this nucleus 
remained unstained. Immunoreactive particles accumulated around unstained cells 
in the anterodorsal tegmental nucleus close to the rostral aspect of the isthmic nucleus 
(Fig. 5D). In the isthmic region, several round cell bodies were faintly stained ventral 
and caudal to the isthmic nucleus in an area that was identified as the locus coeruleus 
by Marín et al. (1996). In the posterodorsal tegmental nucleus, immunoreactive 
particles accumulated medial to the isthmic nucleus (Fig. 7G). The two isthmic nuclei 
were interconnected by a bundle of immunostained fibers, which could be followed to 
the neuropil and the medial half of the medulla of the nucleus. It was the only part of 
the brain where the terminal branching of fibers could be recognized (Fig. 5Da). Tectal 
ablation did not affect the appearance of isthmic fibers.
Rhombencephalon
Cerebellum. No stained cells were found in the cerebellum. A loose network of intensely 
stained varicose fibers and their terminals occupied the granular layer. They were best 
seen in sagittal sections (Fig. 5D). Also in these sections, a dense plexus of varicose 
immunoreactive fibers occupied a narrow area between the isthmic nuclei, and the 
base of the cerebellum (Fig. 5D). In more lateral sections, the plexus continued in a 
fiber bundle that reached the lateral funiculus of the medulla.
Brainstem. Four groups of immunostained neurons could be distinguished in the 
brainstem. In the raphe nuclei (Fig. 6C,D), small round, fusiform and pyriform 
immunoreactive cells occurred. Most dendrites were oriented parallel to the bottom 
of the fourth ventricle (Fig. 7A). Some of them pointed to the ventral direction. The 
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diameter of round cells was 10-11 µm, whereas the dimensions of the other two cell 
types were 12-14 x 16-18 µm. Only the origin of the dendrites could be seen, and 
the emergence of the axon was rarely stained. The majority of cells in the brainstem 
belonged to this group.The second group was formed by immunoreactive neurons 
located close to the motor nuclei of the cranial nerves. Medial and caudal to the motor 
trigeminal nucleus, 1 to 6 stained cells were found in almost all sections. They had 
fusiform, pyriform, or elongated triangular perikarya measuring 9-11 x 12-15 µm. A 
few larger cells (12-15 x 25-35 µm) also occurred. The axon originated opposite to the 
emergence of the dendrite and could be followed only for a short distance. Similar cells 
as described above, less in number but in the same location, were also seen close to 
the facial motor nucleus (Fig. 7B). Between the caudal end of the motor facial nucleus 
Fig. 6. A-F: Distribution of cocaine- and amphetamine-regulated transcript (CART)-immunoreactivity 
in schematic drawings of the frog brain and spinal cord: planes A and B are from the mesencephalon, 
C-E from the rhombencephalon, and plane F shows the second spinal segment. The mode of labeling is 
the same as in Figure 1. For abbreviations, see list.
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and the rostral pole of the nucleus ambiguus, CART-positive cells were arranged in 
a row in sagittal and horizontal sections. Alongside the nucleus ambiguus and the 
hypoglossal nucleus, only very few immunostained cells were seen. Neurons belonging 
to the third group were found in the central gray (Fig. 6C,D). The fourth group was 
formed by immunoreactive cells in the nucleus of the solitary tract (Figs. 6D,7C). The 
neurons were pyriform with similar dimensions as those in the raphe nuclei. The main 
dendrite frequently was stained. In some cases, the origin of the axon could also be 
observed opposite to the emergence of the main dendrite. Fiber staining was sparse 
in the dorsolateral and ventromedial area of the whole brainstem. Between these two 
areas, large numbers of immunostained grains and short segments of varicose fibers 
could be observed (Fig. 6C,D). Immunoreactive fibers were also present in the solitary 
tract. The motor nuclei of the cranial nerves were densely innervated by very thin, 
varicose immunoreactive fibers (Figs. 5D,6C-E,7B,F). The varices around the motor 
cells were so dense that all motor nuclei clearly appeared in a CART-stained section, 
even at low magnification (Fig. 5D). At higher magnification, it was well visible that 
the immunoreactive beads surrounded the perikarya of motoneurons (Fig. 7D). A 
unilateral section in the basal tegmentum did not result in any detectable change of 
immunostaining in the rhombencephalon 14 or 21 days after the lesion. The dorsal 
extent of the cut reached the cerebral aqueduct. Contrary to that, 21 days after a 
unilateral superficial transverse section, just caudal to the entrance of the VIIIth cranial 
nerve, only few immunostained grains remained in the motor trigeminal nucleus on 
the side of the lesion (Fig. 7F). No change could be detected in this nucleus on the 
intact side and caudal to the lesion in the other motor nuclei on both sides. Rostrally 
to the trigeminal nuclei, only very few grains could be stained in the periaqueductal 
region on the side of the medullary lesion, in the caudal third of the mesencephalic 
tegmentum (Fig. 7G).
Spinal cord
CART-immunoreactive neurons, one to four cells per section on one side, occurred 
in the lateral field of the gray matter (Ebbesson, 1976) and at the base of the dorsal 
horn in thoracic and upper lumbar segments. The distribution was variable within 
the field. Sometimes three to four cells formed a cluster (Fig. 7E). In the majority of 
sections, however, they were loosely distributed in the periphery of the lateral field. 
They were mainly pyriform with a single dendrite, but in a few cases, two dendrites 
emerged from the perikayon. In the sacral region, some perikarya were stained in the 
lateral field. In the brachial region, similar cells were stained medial or dorsomedial to 
the lateral group of the motoneurons (Fig. 7H).
Immunoreactive grains, and a few beaded, thin fibers were distributed in the whole 
gray matter (Fig. 6F). In the brachial and lumbar enlargements, they accumulated in 
the inner half of the dorsal field, the central field, and among the lateral motoneurons 
(Figs. 6F,7H). Similar to the situation described for the trigeminal and facial motor 
Chapter 6
102
nuclei, motoneurons were closely surrounded by immunoreactive dots, suggesting 
multiple contacts. In the thoracic and sacral segments, the dots were evenly distributed 
in the gray matter. Along the whole spinal cord, immunoreactive particles densely 
populated the white matter just ventral to the entrance of the dorsal root, which was 
free of immunoreactivity. In the rest of the white matter, the particles were sparse (Fig. 
6F).
Fig. 7. Cocaine- and amphetamine-regulated transcript (CART)-immunoreactivity in the 
rhombencephalon and the spinal cord. A: Neurons in the rostral raphe nucleus. B: Motor facial nucleus. 
Note dense accumulation of immunoreactive grains among the motoneurons and cells medial to them. 
C: Neurons in the nucleus of the solitary tract. D: Immunoreactive fiber terminals around motoneurons 
(arrows) in the motor trigeminal nucleus. E: Stained cells in the lateral field of the spinal cord in a thoracic 
segment. The midline is to the right. F: Trans-section of the spinal lemniscus abolished immunostaining 
in the motor trigeminal nucleus ipsilateral to the lesion. The intact side is labeled by a longitudinal cut 
(asterisk) parallel with the midline. G: Absence of immunostaining medial to the isthmic nucleus as a 
result of the lesion in the same brain shown in F. H: CART-positive neurons medial and dorsomedial 
to the lateral group of motoneurons in the brachial spinal cord. For abbreviations, see Chapter 11. Scale 
bars = 50 µm in A-C,E,H; 25 µm in D; 250 µm in F,G.
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Discussion
Distribution of anuran CART
To our knowledge, the present account is the first on the occurrence of CART in 
a nonmammalian species. Most immunoreactive cells were found in the olfactory 
bulb, the medial pallium, the mesencephalic tegmentum, the hypothalamus, and the 
brainstem. Cells in the Edinger-Westphal nucleus were the most intensely stained, and 
the neurons in the medial pallium were the most variable in shape. Axons were seldom 
observed and could not be followed for a longer distance. Almost all parts of the frog 
brain contained immunoreactive grains, and longer fibers were rarely seen, except in 
the brainstem and the spinal cord. They were usually thin and densely varicose. A 
well-defined terminal plexus of thicker fibers with relatively few varices occurred only 
in the isthmic nucleus.
The origin of CART-positive fiber terminals
The origin of the immunoreactive dots and irregular particles in the olfactory bulb is 
probably intrinsic. The cells that project to the olfactory bulb are located in the diagonal 
band of Broca (Scalia et al., 1991) and the medial dorsal pallium (Westhoff and Roth, 2002). 
Marín et al. (1997) retrogradely labeled cells in the ipsilateral striatopallial transition 
area after injecting the tracer into the olfactory bulb but did not report labeled fibers 
in the olfactory bulb when the anterograde tracer was injected into the striatopallial 
transition area. Part of this area was later described as lateral amygdala (Marín et al., 
1998). Of these three areas, we could only stain cells in the lateral amygdala. They may 
project to the olfactory bulb, but we did not see any difference in the immunostaining 
within the two olfactory bulbs after an unilateral ventral cut behind the accessory 
olfactory bulb. Therefore, it is probable that the immunoreactive particles belong to 
cells within the olfactory bulb, and CART-positive neurons of the internal granular 
layer should be the source of immunoreactive fibers in this brain area.
CART-positive afferent fibers to the septum may originate from the preoptic area or 
the hypothalamus or from both. These brain areas project to the septum (Neary and 
Wilczynski, 1977; Kicliter, 1979; Sánchez-Camacho et al., 2003), and we found CART-
immunoreactive cells in both areas.
The source of CART-immunoreactive fibers in the lateral thalamic neuropil is  prob-
ably the optic tectum, because after removing the tectum, almost all immunoreactive 
fibers disappeared from here. The main target of the tectothalamic projection is the 
lateral thalamic neuropil (Lázár et al., 1983; Montgomery and Fite, 1991).
The majority of immunoreactive fiber terminals in the preoptic area and the 
hypothalamus most likely belong to the axons of CART cells in these parts of the brain. 
Some of them, however, may originate from telencephalic areas that project to the 
hypothalamus and contain CART-positive neurons. These are the nucleus accumbens, 
the striatopallidal transition area, the striatum, the lateral septum, and the medial 
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pallium (Marín et al., 1997).
The neural lobe of the pituitary gland may receive CART-containing fibers from 
the magnocellular preoptic nucleus that projects to the posterior pituitary in Bufo 
arenarium (Pasquier et al., 1980) and Xenopus laevis (Tuinhof et al., 1994a). This projection 
is homologous to the magnocellular hypothalamo-posterior pituitary pathway in 
mammals.
The origin of CART-immunoreactivity in the optic tectum is uncertain. Trans-section 
of one optic nerve did not have any effect on the immunopositive elements in the 
nineth layer of the contralateral tectum where retinal fibers terminate. CART-positive 
fibers could not be found in the optic chiasm, the optic tracts, the optic neuropils of the 
diencephalon, the pretectum, and the basal optic nucleus. Retinal ganglion cells were 
also unstained; therefore, the retinal origin of CART-immunoreactivity in the optic 
tectum can be excluded. Immunostaining in lamina B, and in layer 7, 5, and 3 may be 
related to the dendrites and axons of CART-positive neurons in layer 2.
The source of immunoreactive fibers in the tegmentum, the interpeduncular and the 
isthmic nucleus needs further studies. Fibers that form dense terminal plexus in the 
anterodorsal tegmental nucleus may arise from the striatum, and arrive here through 
the lateral forebrain bundle. Enkephalinergic fibers terminate in the same location, 
and they disappear after cutting the lateral forebrain bundle (Lázár et al., 1990). The 
absence of immunoreactivity in the interpeduncular nucleus and the lateral forebrain 
bundle in some brains, and the presence of it in others is rather puzzling. We could 
not find any relation between the season or the gender of the animals and the staining 
properties of these structures.
The CART-positive fiber bundle, which extends from the base of the cerebellum 
to the lateral funiculus, is in the same location as the spinal lemniscus (Nieuwenhuys 
and Opdam, 1976). Ebbesson (1976) showed degenerated fiber terminals in the motor 
nuclei of cranial nerves in his Figures 22-26 and medial to the isthmic nucleus (his 
Figure 28) after sectioning the anterolateral funiculus of the spinal cord in frogs.
Muñoz et al. (1997) described an ascending spinal pathway here. In their Figure 2, 
the cells of origin of this pathway were shown. Some retrogradely filled neurons were 
located in the intermediate zone, and in the vicinity of the lateral motoneurons where 
we also found some CART positive cells. The source of the dense terminal plexuses 
around the motoneurons of cranial nerves and the spinal motoneurons are probably 
these cells, because trans-section of the spinal lemniscus abolished immunostaining in 
the motor trigeminal nucleus ipsilateral to the lesion. Ascending CART-positive fibers 
also terminate in the periaqueductal region.
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Comparison of distribution of CART in the frog and the rat brain
The only study in which the distribution of a CART has been described in detail is 
by Koylu et al. (1998). They mapped the immunoreactivity of the 106-129 fragment of 
CART in the rat brain and spinal cord. Because we used an antiserum raised against 
the same fragment, we may readily compare our results with those obtained in the 
rat. Generally, more cells were stained in the frog than in the rat brain. In many areas, 
homologous structures showed similar staining patterns, but several differences were 
also apparent as will be discussed below.
Telencephalon. In the frog, dense fiber staining was characteristic in the main olfactory 
bulb, whereas in the rat a very low density of fiber staining has been reported (Koylu 
et al., 1998). There was an obvious difference in cellular staining between the two 
species. In the frog, only granule cells showed CART-immunoreactivity. In the rat, 
these cells were not stained, but mitral cells and neurons in the outer plexiform layer 
were immunoreactive. In the nucleus accumbens and the striatum, both fibers and 
cells were stained in the frog, while only fibers were stained in the rat. Staining in the 
septum and the amygdala was similar in the two species. In the rat hippocampus, fibers 
could be stained. In the homologous structure of the frog brain, the medial pallium, 
several cells showed CART-immunoreactivity and fiber staining was very sparse. In 
the preoptic area of the frog, dense cellular and fiber staining was characteristic. In the 
rat, weak immunoreactivity was found in the magnocellular nucleus.
Diencephalon. In the epithalamus and the dorsal thalamus, sparse fiber staining was 
found in both species. In the frog, CART-positive cells occurred in the ventromedial 
nucleus and the caudal end of the central thalamic nucleus. In the rat, cells were 
stained in four nuclei, including the lateral habenula. The hypothalamus contained 
many immunostained fibers and cells both in the frog and the rat (Koylu et al., 1997; 
Larsen et al., 2003). The neural lobe of the pituitary gland was intensely stained in both 
species, whereas in the distal lobe, immunoreactive cell groups were found only in the 
rat (Koylu et al., 1997).
Mesencephalon. Very strong neuronal staining was found in the Edinger-Westphal 
nucleus of both species. Cells were stained in the laminar nucleus of the torus 
semicircularis of the frog. Koylu et al. (1998) do not mention CART-immunoreactivity 
in the inferior colliculus, the homologous structure of the torus in the rat. In both 
species, the periaqueductal region contained immunoreactive fibers.
Retina and the visual pathway. In the frog retina, immunoreactive cells occurred only in 
the inner nuclear layer together with numerous immunopositive particles. In the rat, 
stained cell bodies were found in the ganglion cell layer, and immunoreactive processes 
were densely stained in the inner plexiform layer. All retinal recipient areas of the rat 
brain contained more or less CART-positive fibers, whereas in the frog, immunostained 
fibers occurred only in the optic tectum, but these fibers do not originate from the 
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retina. The location of this peptide in the visual system is clearly different in the two 
species investigated. It seems that the physiological role of CART is different between 
the strongly visually oriented frog and the laboratory rat with a relatively poorly 
developed visual system. At present, however, nothing is known about the functional 
significance of this peptide, neither in the frog nor the rat.
Brainstem. CART-immunoreactive cells were identified in the locus coeruleus, the 
central gray, and the nucleus of the solitary tract in both species, whereas neurons 
of some raphe nuclei were stained only in the frog. Koylu et al. (1998) also mention 
immunoreactivity in some raphe nuclei without defining the stained structures. 
There was an obvious difference in the fiber staining around motoneurons of cranial 
nerve nuclei. In the frog, dense networks of terminal fibers could be detected in all 
motor nuclei that are involved in feeding, i.e., the trigeminal, facial, ambiguus, and 
hypoglossal nuclei. In the rat, a moderate density of stained fibers was found in the 
nucleus ambiguus (Koylu et al., 1998).
Spinal cord. In both species, some neurons showed CART-immunoreactivity in the 
intermediolateral nucleus in the thoracolumbar segments. We found a few faintly 
stained cells also in the sacral part of the spinal cord in the frog, whereas in the rat, cells 
were not stained here (Dun et al., 2000). The CART-immunoreactive cell group found 
in the frog medial to the brachial motoneurons was not shown in the rat. Fiber staining 
was similar in the two species, with the exception of the ventral horn. In the frog, fiber 
staining around the spinal motoneurons was similar to that of the motor cranial nerve 
nuclei, whereas these fibers were not described in the rat.
Comparison with primates
In the nucleus accumbens of the squirrel monkey and the rhesus monkey, CART-
containing somata and varicose fiber plexuses were described (Smith et al., 1999). CART-
immunoreactive cells and fibers were also found in the hypothalamus and posterior 
pituitary in monkeys (Dall-Vechia et al., 2000) and the human hypothalamus (Elias et al., 
2001). As we have discussed above the occurrence of CART-positive neuronal elements 
was similar also in the frog and the rat. Expression of CART mRNA in human limbic- 
and sensory-related brain regions could be detected in similar locations (Hurd and 
Fagergren, 2000) than the CART-immunoreactivity in the rat brain (Koylu et al., 1998). 
Even this limited information strongly suggests that the CART system is preserved 
during evolution and may have similar functional roles in the different species.
Possible functional role of CART peptides in brain areas related to feeding behavior
The functional significance of CART peptides in mammals has been briefly described 
in the introduction section. For further details, see reviews by Kuhar and Dall-Vechia 
(1999) and Kuhar et al. (2000, 2002). Of the proposed functions of CART, a role in food 
intake has been studied most extensively. In a nonmammalian species (goldfish), the 
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effect of CART on feeding was similar to that in mammals, i.e., CART fragments inhibit 
food intake (Volkoff and Peter, 2000).
In mammals, feeding behavior is controlled by several peptides (Elmquist et al., 
1999), and many of them are present also in the frog brain. Some peptides are orexigenic 
(enhance food intake), others are anorexigenic (reducing or inhibiting food intake; see 
for details Hillebrand et al., 2002). All these peptides occur in the hypothalamus in 
mammals, and their distribution is very similar also in the frog or toad brain. Of the 
anorexigenic peptides corticotropin releasing hormone (Bhargava and Prasada Rao, 
1993), and thyrotropin releasing hormone immunoreactive cells and fibers (Miranda 
and Affanni, 2000) were localized in the magnocellular preoptic nucleus and the ventral 
hypothalamus. We found CART-immunoreactivity in the same places. Neurotensin 
(Bello et al., 1994), and melanophore stimulating hormone-like (Tuinhof et al., 1998) 
immunoreactivities were found in cells and fibers in the preoptic area and the ventral 
hypothalamus similarly to CART-immunoreactivity. Urocortin occurred in the anuran 
preoptic area and the magnocellular preoptic nucleus (Kozicz et al., 2002). The location 
of these immunoreactivites in the anuran brain is very similar to that in the rodent brain 
(Hillebrand et al., 2002); therefore, it may be supposed that these peptides, including 
CART, are involved in the regulation of food intake as inhibitory agents also in the 
frog. The location of orexogenic peptides in the anuran brain is also similar to that 
in the mammalian brain. Galanin-like (Lázár et al., 1991; Olivereau and Olivereau, 
1992), neuropeptide-Y-like (Danger et al., 1985; Lázár et al., 1993), and orexin-like 
(Galas et al., 2001) immunoreactive cells and fibers were located in the preoptic area, 
the magnocellular preoptic nucleus, and the ventral hypothalamus. Cells showing 
melanin concentrating hormone-like immunoreactivity in the frog brain were restricted 
to the posterior tubercle, periventricular organ, and the dorsal hypothalamic nucleus 
(Lázár et al., 2002). In the rat, they were located in a similar position in the dorsolateral 
hypothalamus (Risold et al., 1992). All these data show that the peptides involved in 
regulation of food intake in mammals, also exist in the amphibian brain in mainly 
homologous structures playing similar roles.
Comparing the location of the CART in the frog and the rat brain differences were 
found in the olfactory and the visual systems, some parts of the limbic system, in the 
motor nuclei of cranial nerves and the spinal cord. All these areas are related to the 
sensory and motor aspects of feeding behavior. In the frogs kept in the laboratory, 
we could not disclose any obvious differences in the CART staining pattern in the 
CNS of winter frogs or summer frogs. Seemingly, the small seasonal differences in the 
temperature of the water and the air did not cause noticeable changes.
Because the waters are frozen during winter, it was not possible to study whether 
hibernation has an effect on the CART system in frogs. Our assumption, however, 
that differences may exist between the rat and the frog CART neuronal systems was 
correct. Further studies are necessary to prove that these differences are related to 
feeding behavior or they are characteristic for the species.
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The identification of the CART receptor, and further studies on the physiological 
effects of the CART, may help understanding the functional significance of this peptide 
in amphibians and mammals.
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Abstract
The distribution of cocaine- and amphetamine-regulated transcript peptide (CART)-like 
immunoreactivity was studied in the central nervous system (CNS) of the South African clawed 
toad Xenopus laevis, and compared with the distributions of this peptide in the CNS of the 
green frog Rana esculenta and of the rat. In the Xenopus forebrain, only a few immunoreactive 
cells were found in the olfactory bulb, nucleus accumbens, amygdala, nucleus of Bellonci, 
suprachiasmatic nucleus, and ventromedial nucleus. More cells and fibers were stained in the 
medial pallium, septum, striatum, preoptic nuclei, central thalamic nucleus and hypothalamus. 
The neurohypophysis showed intense immunostaining. In the mesencephalon, many cells were 
stained in the Edinger-Westphal nucleus, and in the optic tectum, where immunoreactive fibers 
occurred in all plexiform layers. In the rhombencephalon, cells were stained in the raphe nuclei, 
central gray, nucleus of the solitary tract and in the vicinity of motor nuclei. Neurons of the 
motor cranial nerves were contacted by CART-positive fibers. In the spinal cord, cells were 
stained in the intermediate zone and motoneurons were surrounded by immunoreactive varicose 
axon terminals. Major differences were found between the Rana and the Xenopus brain, as to 
the distribution of CART in the olfactory bulb, visual system and the torus semicircularis. The 
distribution of CART in the rat had more common features, in some brain areas, with Xenopus 
than with Rana.
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Introduction
The cocaine- and amphetamine-regulated transcript peptide (CART) was discovered 
in the rat brain (Thim et al., 1998; Kuhar and Yoho, 1999). The proCART protein is 
composed of 129 amino acids. During neuronal processing of this long precursor 
molecule biologically active fragments may be formed and released (Kuhar and 
Yoho, 1999). CART (-related) peptides have been found in many brain areas, some of 
which participate in the control of feeding behavior (amygdala, nucleus accumbens, 
hypothalamus, nucleus of the solitary tract, intermediolateral cell column of the spinal 
cord) (Koylu et al., 1997, 1998; Elmquist et al., 1999). In rodents, intracerebroventricular 
administration of the 55-102 CART fragment inhibits food intake (Kristensen et al., 
1998; Lambert et al., 1998; Adams et al., 1999; Asakawa et al., 2001; Stanley et al., 2001) 
or causes anxiety (Chaki et al., 2003). Injection of CART into the ventral tegmental area 
increases the locomotor activity of rats (Kimmel et al., 2000). These findings raise the 
possibility that the decrease in food intake is caused by changed motor activity.
The sequences of mouse, rat, human and goldfish CART genes are known and 
indicate that the gene has been well-conserved during phylogeny (for review see Kuhar 
et al., 2002). Especially the carboxy-terminus of CART, which contains the biologically 
active part of the molecule, is highly conserved among all species investigated. The 
distribution of CART-immunoreactivity has been studied in the human (Elias et al., 
2001) and monkey hypothalamus (Dall-Vechia et al. 2000), and the data indicate that 
in primates not only the molecular structure but also the brain production sites of 
CART are similar. In non-mammalian vertebrates, CART precursor mRNAs were 
demonstrated in the olfactory bulb, telencephalon, hypothalamus and the optic tectum 
in the goldfish brain (Volkoff and Peter, 2001) where, like in mammals, CART seems to 
control feeding and locomotion (Volkoff and Peter, 2000, 2004).
Recently, we described the distribution of CART in the central nervous system 
(CNS) of the green frog Rana esculenta, and compared it with that in rat (Lázár et al., 
2004/Chapter 6), and found differences in the olfactory and the visual systems, some 
parts of the limbic system, in the motor nuclei of cranial nerves and the spinal cord. 
Since these areas have been implicated in the sensory and motor aspects of feeding 
behavior (Koylu et al., 1998), we assumed that these differences are related to the fact 
that the frog does not feed in winter whereas the rat is continuously feeding (Lázár 
et al., 2004/Chapter 6). However, we were not able to support this idea because no 
obvious differences in the CART staining pattern in the CNS between winter frogs and 
summer frogs were noticeable, probably due to the fact that differences disappeared 
under the experimental conditions in the lab (Lázár et al., 2004/Chapter 6).
In the present study we have tested the possibility of a relation between CART 
presence and feeding behavior by comparing the distribution of CART in rat with that 
in the South African toad Xenopus laevis. Since feeding behavior of Xenopus is more 
similar to that of the rat (i.e., absence of seasonal changes) than to that of Rana, we have 
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tested the hypothesis that the distribution of CART in the Xenopus brain is different 
from that in Rana but is similar to that in rat.
Materials and methods
Nine young, 6-month-old Xenopus laevis, with a body weight of 28-32 g, were 
used. The animals were raised under standard laboratory conditions, under constant 
illumination, at a water temperature of 22 ± 1 °C, on a grey background. Animals were 
fed weekly on ground beef heart (Janssen, Nijmegen, The Netherlands) and trout 
pellets (Trouvit, Trouw, Putten, The Netherlands). The experiments were in accordance 
with the Hungarian laws on the protection of animals (Magyar Közlöny, No. 28/1998) 
and the Dutch law concerning animal welfare, as tested by the Committee for Animal 
Experimentation of Radboud University Nijmegen. 
Tissue preparation
Toads were deeply anaesthetized by immersion in 0.1% tricaine methane sulfonate 
(MS222; Novartis, Basel, Switzerland) in tap water, and transcardially perfused with 
ice-cold 0.6% sodium chloride, for 5 min. Then they were perfused with 250 ml ice-
cold Bouin’s fixative, for 15 min. After decapitation, the brains and spinal cords were 
quickly dissected and postfixed in the same fixative, for 16 h at 4 °C and washed in 70% 
ethanol for 24 h, to eliminate excess of picric acid. Then brain and spinal cord (cervical, 
thoracic and lumbar segments) were separated and embedded in polyethylene glycol 
1000 (Sigma-Aldrich, Zwijndrecht, Netherland). Serial sections (20 µm) were cut 
in coronal (4 brains and spinal cords), sagittal (2 brains) and horizontal (3 brains) 
planes, on a sliding microtome (Leica Jung SM2000R). For each brain and spinal 
cord, sections were consecutively distributed in 5 series, and each series was stored 
in 0.1 M sodium-phosphate-buffered saline (pH 7.4; PBS). Three series were used 
for immunocytochemistry (positive reactions and controls), whereas the two others 
were stained with Nissl staining and hematoxyline-eosine, to support anatomical 
identification of brain areas. For this purpose also a series of 21 schematic drawings of 
coronal sections was made, from the olfactory bulb to the second spinal segment. 
Immunocytochemistry
Following pre-incubation steps in 0.1% Triton X-100 solution (Sigma-Aldrich) 
containing 5% normal horse serum (mouse: PK 6102, Vector Laboratories, Burlingame, 
CA, USA) the sections were incubated for 48-72 hours at 4 °C with a C6-1 F4D4 
mouse antiserum (1:100,000; generous gift from Dr. J.T. Clausen, Novo Nordisc A/S, 
Bagverd, Denmark) raised against the 106-129 fragment of CART. For visualization 
of immunoreactivity the ABC Elite Kit (mouse: PK 6102, Vector Laboratories) was 
used with 3,3’-diaminobenzidine (DAB) as the chromogen. The immunostaining was 
developed for 10 min at 20 °C, under microscopic control. In some cases the DAB 
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Fig. 1. Distribution of CART-immunoreactivity in schematic drawings of the brain of Xenopus laevis. 
The left upper panel shows the transverse planes chosen for the illustrations. Planes A to C are from 
the telencephalon, D and E from the diencephalon, F to I from the mesencephalon, J and K from 
the rhombencephalon and L shows the spinal cord. The location of immunoreactive particles of 
nerve fibers and perikarya are shown in the right hand side of each drawings. Small dots indicate 
CART-immunoreactive fibers and their terminals. Large dots with or without processes are neurons. 
Neuroanatomical parcellations are designated in the left half (for abbreviations, see list).
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polymer was nickel-intensified. Mounted sections were air-dried and coverslipped 
with DePeX (Serva, Heidelberg, Germany). The high specificity of the primary 
antiserum was verified by increasing its dilution till it just stained the sites of interest 
in the sections. At the dilution of 1:300,000, adding 1 µg of native CART (generous gift 
of Dr L. Thim, Novo Nordisc A/S, Bagsverd, Denmark) to 1 ml of serum completely 
abolished immunostaining. Omitting the primary antiserum or replacing it with 
normal horse serum also prevented immunostaining.
Digital imaging and morphometry
Digital images of the frog brain were taken by a Nikon Microphot FXA microscope 
equipped with a Spot RT Color digital camera (Diagnostic Instrument, Sterling Heights, 
MI, USA). Using the software supplied with this camera, images were taken at a size of 
1200x1600 pixels, imported into Adobe Photoshop 7.0, and digitally processed (adjusting 
histogram levels, brightness, contrast and sharpness). In order to characterize brain 
areas on the basis of size and shape of their immunoreactive neurons, the dimensions 
of immunostained perikarya were measured with the aid of the camera software. In 
each area, ten randomly taken perikarya were measured. In case of roughly round 
cells the diameter was measured, in case of clearly elongated cells, both the length and 
width were determined. The aim of these measurements was only to show the range 
of sizes of the CART-positive perikarya.
The nomenclature used to designate nuclei and pathways in the toad brain was 
generally according to Lázár et al. (1991), but some structures were named according 
to Milán and Puelles (2000).
Results
General considerations
In transverse sections, most immunoreactive neuronal processes appeared as 
small (diameter: 0.5-2 µm) particles, which will be referred to as ‘dots’. In sagittal or 
horizontal sections, some fibers could be followed for some distance, especially in the 
brainstem and the spinal cord. They often had a beaded appearance.
Telencephalon
Olfactory bulb. Some small cells of the internal granular layer had slightly immunoreac-
tive perikarya but no dendrites were seen. In between the cells, some immunoreactive 
dots and short segments of varicose fibres could be observed. The glomerular layer 
and the glomeruli in the accessory olfactory bulb were free of immunostaining (Figs. 
1A,2A). 
Pallium. In the medial pallium several neurons were immunostained. Their perikarya 
were round, pyriform or somewhat irregular, with a largest diameter of 8-10 µm and 
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the base of the dendrites was stained (Figs. 1B,C,2B).
Subpallium. The nucleus accumbens as well as the lateral and medial amygdala con-
tained some faintly stained, round cells with a diameter of 10-11 µm. More cells were 
stained in the striatum. These cells had small (10-12 x 13-15 µm) pyriform perikarya 
with a single dendrite oriented into lateral or ventrolateral direction. Some fusiform 
and multipolar cells were also observed (Figs. 1B,2C). In between them, immunoposi-
tive dots were sparsely distributed. They were more numerous in the lateral half of the 
striatum than medially. Such dots also occurred throughout the amygdala. In sagittal 
sections, a row of loosely arranged immunoreactive cells was found along the border 
of the medial pallium and the septum (Fig. 2B). Especially in transverse sections of the 
lateral septum, a triangular area was seen containing various immunoreactive varicose 
Fig. 2. Distribution of CART-immunoreactive cells and fibers in the telencephalon and the preoptic 
area. A: Immunostaining in the main olfactory bulb. Only few cells are stained in the internal granular 
layer (igl). Sagittal section. B: Immunoreactive perikarya in the medial pallium (mp), and the septum (s). 
Sagittal section. C: Immunoreactive neurons and fiber terminals in the striatum (Str). D: Three groups of 
immunoreactive neurons in the preoptic area (POa). Sagittal section. Rostral is to the right. E: Intensely 
stained neurons in the magnocellular preoptic nucleus (Mg). Note caudal extent of the nucleus over the 
optic chiasm (oc). Sagittal section. Rostral is to the right. Scale bar in A = 100 µm, B-E = 200 µm.
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fibers. In the medial septum, and in a large area ventral to the septum, including the 
bed nucleus of the stria terminalis and the pallidum, immunostained dots were loosely 
distributed (Fig. 1B).
Diencephalon
Preoptic area. In the preoptic area many cells were immunoreactive. They appeared in 
three vertically arranged columns, as is revealed in sagittal and horizontal sections 
(Fig. 2D). Just behind the lamina terminalis, an anterior column consists of small (6-8 
µm) round, faintly stained cells. In a middle group, round (8-11 µm) and pyriform 
Localization of CART peptide in the CNS of X. laevis
117
(9-12 x 13-15 µm) neurons were intensely stained. Only the origin of the dendrites 
could be seen. In coronal sections the dendrites pointed to lateral or ventrolateral 
direction. The most medial cells were close to the preoptic recess (Fig. 1C). The third 
group of cells was stained in the magnocellular preoptic nucleus (Fug. 2E). They were 
large, intensely stained pyriform cells (9-12 x 13-17 µm) with long dendrites that could 
be followed in coronal sections for up to 400-500 µm, near the pial surface (Fig. 3A). 
Large numbers of immunoreactive fine varicose, beaded fibers occupied the whole 
preoptic area. Between the periventricular cell laminae they formed rows and were 
diffusely distributed in the lateral neuropil. Ventromedially their density was higher 
than dorsolaterally (Fig. 1C).
Ventral thalamus. Three immunoreactive cell groups were present in the ventral thalamus. 
Most rostrally, faintly stained round perikarya (8-9 µm) were observed in the nucleus 
of Bellonci (Figs. 1D,3A). Some pyriform (9-10 x 11-12 µm) and triangular shaped (8-
9x10-11 µm) cells also occurred. A second group of CART-immunoreactive neurons 
was identified in the dorsal part of the ventrolateral nucleus and in the ventromedial 
nucleus, where the cells were pyriform and projected a short dendrite to ventrolateral 
direction (Figs. 1D,3A,E). The third group of intensely stained neurons was located in the 
central thalamic nucleus in the pretectal area (Fig. 1E) and consisted of pyriform (8-10 x 
11-13 µm) cells (Fig. 4A,D). Their axons were unstained. The posterior entopeduncular 
nucleus contained faintly stained small, round cells. No dendrites or axons could be 
identified (Fig. 3E). All thalamic nuclei were invaded by immunoreactive fibers and 
terminals, which appeared in the form of scattered dots or rows of dots between the 
periventricular cell laminae suggesting their varicose axonal nature. In the neuropils 
of the lateral geniculate complex and the pretectal neuropil, only few immunoreactive 
dots occurred and the optic tract was free of immunoreactive structures. In the medial 
and lateral forebrain bundle, short parts of varicose axons were observed. Thick, fiber-
like processes were stained in two brains in a location corresponding to the fasciculus 
retroflexus. The processes could be followed into the pretectal area (Fig. 4D).
Hypothalamus. In the rostral infundibulum, pyriform and fusiform neurons were 
intensely stained among the periventricular cells. At the periphery or lateral to the 
periventricular cells, the immunoreactive neurons were mainly fusiform with laterally 
Fig. 3. CART-immunoreactive perikarya in the diencephalon and the mesencephalon. A: Immunore-
activity in the rostral diencephalon. Note stained cells in the nucleus of Bellonci (arrows) and in the 
magnocellular preoptic nucleus (Mg, arrow). B: Immunoreactive cells and fibers in the infundibulum 
and the dorsal hypothalamic nucleus (dHy). C: Stained cells in the wall of the infundibulum. Note later-
ally oriented long dendrites. D: Immunoreactive cells in the hypothalamus and the Edinger-Westphal 
nucleus (EW), and intensely stained fiber terminals in the neural lobe of the pituitary gland (pn). Sagit-
tal section. Rostral is to the left. E: Immunostained infundibular neurons with long dendrites at the level 
of plane E in Fig. 1. Note stained perikarya in the ventromedial (VM) and the posterior entopeduncular 
nuclei (epp). F: Immunostained fibers in the pars nervosa (pn) of the pituitary gland and median emi-
nence of the hypothalamus. G: Detail of the median eminence, with small and less numerous stained 
dots in the internal zone (iz) and large stained dots and short varicose fibers in the external zone (ez). 
Scale bar in A and B = 200 µm, C and E = 100 µm, D = 300 µm, F = 150 µm, G = 15 µm.
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oriented dendrites (Figs. 1E,3B,C). More caudally, in the dorsal hypothalamic nucleus 
(superficial mammillary nucleus of Milán and Puelles, 2000), several small, round 
cells (8-10 µm) were stained together with pyriform and fusiform cells (7-8 x 11-13 
µm) (Fig. 3B,D). In the ventral hypothalamus, some cells had triangular perikarya 
and three pronounced dendrites that pointed ventrally and dorsally. In between the 
periventricular neurons, large pyriform cells (9-10 x 14-26 µm) with laterally pointing 
dendrites were stained. Some of them were liquor-contacting neurons with a 6-28 µm 
long ventricular process (Fig. 3C). Some vertically oriented fusiform cells, lateral to 
the periventricular cells (9-10 x 14-26 µm) were also stained (Fig. 3B). Both the external 
and internal zone of the median eminence showed immunopositive staining (Fig. 3F). 
The external zone of the median eminence was filled with large immunoreactive dots 
and short segments of varicose fibers (Fig. 3F). In the inner zone, the dots were smaller 
and less numerous (Fig. 3F). Immunoreactive dots occupied the whole hypothalamus, 
most densely in the dorsal hypothalamic nucleus and the lateral half of the ventral 
hypothalamus. 
Hypophysis. The neural lobe of the hypophysis was darkly stained, revealing large, 
irregular immunoreactive dots, which were loosely distributed and most likely are 
neurohemal axon terminals (Figs. 1F,3D). A few faintly stained cells also occurred in 
the adenohypophysis.
Mesencephalon
Optic tectum. The outer layers of the tectum contained several immunoreactive cells, 
while in the inner (periventricular) layers only few cells occurred. The most superficial 
part of the tectum, which may correspond to lamina A of Rana (Potter, 1969), was free 
of immunostaining. The rest of layer 9 was diffusely stained and revealed several 
immunoreactive cells (Figs. 1F-H,4B,C). Most neurons were round (7-8 µm) but small 
pyriform (6-8 x 8-11 µm) and fusiform cells (7-8 x11-13 µm) were also stained. Only the 
origin of dendrites could be identified. Very few cells were stained in layer 8 and some 
large pyriform cells in the lateral half of layer 6. In layer 7, some varicose axons were 
stained, while in the periventricular plexiform layers and in between the neurons of 
layer 6 immunoreactive grains and short segments of varicose axons were present.
Tegmentum mesencephali. At the base of the tegmentum, immunoreactive cells 
formed a continuous column from the level of the posterior commissure to the 
level of the isthmic nucleus. This area included the caudal part of the nucleus of the 
longitudinal fasciculus, the Edinger-Westphal nucleus and parts of the anteroventral 
and posteroventral tegmental nuclei (Figs. 1G,3D). Almost all cells were pyriform, 
measuring 8-11 x 11-12 µm. In the rostral half of the cell column, their main dendrite, 
which was sometimes stained till the first branching point, was mainly oriented 
ventrally or ventrolaterally. In the caudal half, dendrites of several of these neurons 
pointed laterally. Some perikarya were fusiform (7-8 x 11-13 µm). The magnocellular 
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nucleus of the torus semicircularis showed many immunoreactive neurons (Figs. 
1G,4C). At the level of the caudal margin of the tectum this group was continuous with 
stained cells forming a transverse plate at the rostral aspect of the principal nucleus. 
This nucleus also contained a few stained cells in its rostral part. Immunoreactive dots 
and short parts of fibers occurred throughout the tegmentum. Immunoreactive dots 
were most densely arranged in the anteroventral, anterodorsal, posteroventral and 
posterodorsal tegmental nuclei (Fig. 1G). In the basal optic nucleus some very thin 
Fig. 4. CART-immunoreactivity in the mesencephalon and rhombencephalon. A: Pretectal region. Note 
heavy staining of neurons in the central thalamic nucleus (C). B: Optic tectum. Note stained cells in layer 
9 and intense fiber staining in the periventricular layers (pvl). C: Immunostained fibers and cells in the 
optic tectum (tect) and the magnocellular nucleus of the torus semicircularis (mt). D: Sagittal section 
of the mesencephalon and the rhombencephalon. Note intense fiber staining in the tectum, dorsal 
tegmentum, fasciculus retroflexus (arrow), and heavily stained neurons in the central thalamic nucleus 
(C). Rostral is to the left. E: Intense fiber staining in the isthmic region. Note that the isthmic- and the 
interpeduncular nuclei are free of immunostaining. F: Stained cells and fibers in the superior raphe 
nucleus (r). Scale bar in A = 300 µm, B and F = 100 µm, C and E = 200 µm, D = 500 µm.
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varicose fibers were stained. In the periventricular region scattered dots were seen. 
The interpeduncular nucleus was free of immunostaining, but around the nucleus a 
remarkable accumulation of immunopositive dots was present (Figs. 1H,4E). Close 
to the rostral aspect of the isthmic nucleus, intense immunostaining was observed in 
the white substance. In the isthmic region, in the posterodorsal tegmental nucleus, 
immunoreactive particles accumulated medially to the isthmic nucleus (Figs. 1I,4E). 
A dense network of intensely stained varicose fibers occurred ventral to the nucleus. 
A thick, immunoreactive axon bundle could be followed to the rhombencephalon. 
Another bundle arched over the caudal end of the cerebral aqueduct (Fig. 4E).
Rhombencephalon
Cerebellum. No stained cells were found in the cerebellum (Fig. 4D), and only a very 
loose network of fine varicose fibers and their terminals occurred in the granular 
layer.
Brainstem. Five groups of immunostained neurons could be distinguished in the 
brainstem. In the first group, small round (10-11 µm) and pyriform (8-10 x 11-13 µm) 
immunoreactive cells were encountered (Fig. 4F). Only the origin of the dendrites 
could be seen, and the emergence of the axon was rarely stained. The second group 
revealed some faintly stained triangular and multipolar neurons in the dorsal column 
nuclei (Figs. 1K,5C). The third group was formed by immunoreactive neurons located 
close to the motor nuclei of the branchial nerves (Figs. 1K,5B). They had fusiform 
(12-13 x 18-20 µm), pyriform or elongated (11-12 x 13-16 µm) triangular perikarya. 
Between the caudal end of the motor facial nucleus and the rostral pole of the nucleus 
ambiguous, CART-positive cells were arranged in a row. Neurons belonging to the 
fourth group were found in the central gray (Fig. 1J,K). The fifth group was formed by 
immunoreactive cells in the nucleus of the solitary tract (Figs. 1K,5A). The neurons were 
pyriform with similar dimensions as those in the raphe nuclei. The main dendrite was 
frequently stained. In some cases, the axon hillock could be observed. Fiber staining 
was sparse in the dorsolateral and ventromedial area of the brainstem. Between these 
two areas, large numbers of immunostained dots and short profiles of varicose fibers 
were seen (Figs. 1J,K,5B). Immunoreactive fibers were also present in the solitary tract 
(Fig. 5A). In sagittal sections long, thin beaded axons were stained close to the bottom 
of the fourth ventricle. The motor nuclei of the cranial nerves were densely contacted 
by very thin, varicose immunoreactive fibers (Figs.1J,K,5B) that originated from a fiber 
tract running near the dorsolateral surface of the brainstem.
Spinal cord
One to eight CART-immunoreactive neurons occurred in the lateral field (Ebbesson, 
1976) of the gray matter, in a coronal section of the spinal cord at the base of the dorsal 
horn in thoracic and upper lumbar segments, and medial to the motoneurons. They 
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were mainly pyriform (9-11 x 13-18 µm) with a single dendrite, but also some fusiform 
(10-12 x 18-22 µm), triangular (11-13 x 12-17 µm) and multipolar (10-13 x 16-16 µm) 
perikarya were encountered. Only short parts of dendrites appeared to be stained 
(Figs. 1L,5D). Immunoreactive dots, and a few beaded, thin fibers were distributed 
throughout the gray matter (Figs. 1L,5E). In the brachial and lumbar enlargements, 
they accumulated in the inner half of the dorsal field, the central field and among 
the lateral motoneurons (Figs. 1L,5E). In the thoracic segments, the dots were evenly 
distributed in the gray matter. Along the whole spinal cord, immunoreactive particles 
densely populated the white matter just ventral to the entrance of the dorsal root, 
which was free of immunoreactivity. In the rest of the white matter, the particles were 
sparse.
Fig. 5. CART-immunoreactivity in the rhombencephalon and the spinal cord. A: Neurons in the nucleus 
of the solitary tract (nst, arrow). B: Intense staining of fiber terminals in the ambiguous nucleus (IX-Xm, 
arrow). Note stained cells dorsomedially. C: Neurons in the gracile nucleus (Ng). D: Fiber terminals and 
neurons in the intermediate zone of the spinal cord. Horizontal section. E: Stained cells (arrows) medial 
and dorsal to the lateral motoneurons in the spinal cord in a lumbar segment. Note fiber staining in the 
dorsal horn (dh), and among unstained motoneurons (vh). The midline is to the left. Scale bar in A and 
C = 150 µm, B = 200 µm, D = 100 µm, E = 300 µm.
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Discussion
Distribution of anuran CART in the CNS
In Xenopus laevis most CART-immunoreactive cells were found in the medial pallium, 
preoptic area, the mesencephalon and the hypothalamus. Cells in the magnocellular 
preoptic nucleus, periventricular zone of the hypothalamus and the Edinger-Westphal 
nucleus were the most intensely stained. Axons were seldom observed and could not 
be followed for a long distance. Almost all parts of brain contained immunoreactive 
dots, considered as cross-sectioned nerve fibers, while longitudinally sectioned fibers 
were seen mainly in the brainstem and the spinal cord. They were usually thin and 
possessed many varicosities. Fiber staining was most intense in the optic tectum and 
the isthmic region. 
Comparison of distribution of CART in Rana and Xenopus
Generally, the distribution of CART-immunoreactivity in the CNS of the two 
amphibian species was similar, but several differences were also apparent. In Rana 
(Lázár et al., 2004/Chapter 6) very intense immunoreaction was found in the olfactory 
bulb, where in Xenopus only a few cells and fiber terminals were stained. In Rana, 
cells were not stained in the anterior preoptic area, and less cells were stained in the 
posterior preoptic nucleus than in Xenopus. In Rana, the nucleus of Bellonci and the 
posterior entopeduncular nucleus did not contain CART-positive neurons. In Xenopus, 
however, these nuclei revealed several faintly stained small cells. 
The neural lobe of the hypophysis was intensely stained in both species. In Xenopus, 
the distal lobe of the adenohypophysis also contained a few, faintly stained cells. In 
Rana, some neurons were immunoreactive in the pretectal neuropil, while the Xenopus 
pretectum was free of stained cells. In the optic tectum and the torus semicircularis, 
immunoreactive neurons occurred in both species, but their distribution was different. 
In Rana, less cells were stained in the tectum than in Xenopus and they were located 
mainly in layer 2 and some in layer 9. In Xenopus, layer 9 contained most of the CART-
positive cells, but some occurred also in layer 8 and the uppermost cell row in the lateral 
half of layer 6. In the tectum, fiber staining was more intense in Xenopus than in Rana. 
In the torus semicircularis, stained cells were located in the laminar nucleus in Rana. In 
Xenopus, most CART-positive cells occurred in the magnocellular nucleus and some in 
the principal nucleus. We did not find immunoreactive fiber terminals in the isthmic 
nucleus in Xenopus, while in Rana, widely arborizing axon terminals were stained. In 
Rana, cells in the dorsal column nuclei were CART-negative, while in Xenopus some 
faintly stained cells could be observed. In the Rana spinal cord, intensely stained axon 
terminals formed dense networks around motoneurons. In Xenopus, loose plexuses of 
immunoreactive varicose fibers could be observed in the brachial segments.
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Comparison of distribution of CART in the Xenopus and the rat brain
The only paper in which the distribution of CART has been described in detail was 
published by Koylu et al. (1998). They mapped the immunoreactivity of the 106-129 
fragment of CART in the rat brain and spinal cord. Since we used an antiserum raised 
against the same fragment, we may readily compare our results with those obtained 
in the rat. Generally, more cells were stained in the Xenopus than in the rat brain. In 
many areas, homologous structures showed a similar staining pattern, but several 
differences were also apparent.
In the olfactory bulb, immunostaining was weak in both species. In Xenopus, some 
granule cells showed CART-immunoreactivity. In the rat, these cells were not stained, 
but mitral cells and neurons in the outer plexiform layer were immunoreactive. In 
the rat hippocampus various fibers were stained. In the homologous structure of the 
frog brain, the medial pallium, several cells showed CART-immunoreactivity but 
fiber staining was very sparse. In the preoptic area of the toad, dense cellular and 
fiber staining was apparent. In the rat, weak immunoreactivity was found in the 
magnocellular nucleus, while it was intense in Xenopus.
In both species, cells were stained in four other nuclei of the diencephalon, but their 
possible homology is uncertain. The hypothalamus contained many immunostained 
fibers and cells both in Xenopus and rat (Koylu et al., 1997; Larsen et al., 2003). In 
both species, the neural lobe of the pituitary gland was intensely stained, and in the 
distal lobe immunoreactive cells of unidentified nature were found (Koylu et al., 1997). 
Positive cells were encountered in the magnocellular nucleus of the torus semicircularis 
of the toad, but Koylu et al. (1998) do not mention CART-immunoreactivity in the 
inferior colliculus, the homologous structure of the torus, in the rat. In both species, the 
periaqueductal region contained immunoreactive fibers.
CART-immunoreactive cells were identified in the central gray of the brainstem, 
and the nucleus of the solitary tract in the rat, while neurons of some raphe nuclei were 
stained only in the toad, and cells in the locus ceruleus only in the rat. There was an 
obvious difference in the fiber staining around motoneurons of cranial nerve nuclei. 
In Xenopus, networks of terminal fibers could be detected in all motor nuclei that are 
involved in feeding i.e., the trigeminal, facial and the ambiguous nuclei. In the rat, 
a moderate density of stained fibers occurs in the nucleus ambiguous (Koylu et al., 
1998).
In the spinal cord, in both species some neurons showed CART-immunoreactivity 
in the intermediolateral nucleus in the thoracolumbar segments. Fiber staining was 
similar in the two species with the exception of the ventral horn. In the rat, fibers were 
not described around motoneurons.
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Peptides in brain areas related to feeding behavior
The functional significance of CART in mammals has been briefly described in the 
Introduction. For further details see also reviews by Kuhar and Dall-Vechia (1999) and 
Kuhar et al. (2000, 2002). Of the proposed functions of CART, a role in food intake 
has been studied most extensively. In a non-mammalian species (goldfish), the effect 
of CART on feeding was similar to that in mammals, i.e., CART fragments inhibited 
food intake (Volkoff and Peter, 2000). It may be supposed that CART is involved in 
the regulation of food intake as inhibitory agents also in amphibians. We have found 
significant differences in CART-immunoreactive structures between the two amphibian 
species in the olfactory and the visual system. Both systems participate in food intake. 
In this function, the visual system is probably more important for the largely terrestrial 
and highly visually oriented Rana, than for the mainly aquatic Xenopus in which the 
olfactory system may dominate. Since the physiological effect of CART at the neuronal 
level is not known, further studies are needed to elucidate if the above mentioned 
differences in the distribution of this peptide between the toad Xenopus and the frog 
Rana are related to differences in feeding behavior.
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Abstract
In mammals complex interactions between various brain structures and neuropeptides such as 
corticotropin-releasing factor (CRF) and urocortin 1 (Ucn1) underliy the control of feeding by 
the brain. Recently, in the amphibian Xenopus laevis, CRF- and Ucn1-immunoreactivities were 
shown in the hypothalamic magnocellular nucleus (Mg) and evidence was obtained for their 
involvement in food intake. To gain a better understanding of the brain structures controlling 
feeding in X. laevis, the effects of sixteen weeks starvation on neurons immunoreactive (ir) to 
Fos and neuropeptides in various brain structures were quantified. In the Mg, compared to 
controls, starved animals showed fewer neurons immunopositive for Fos (-55.9%), Ucn1 (-
44.0%), cocaine and amphetamine-regulated transcript (CART) (-94.3%) and metenkephalin 
(ENK) (-65.0%), whereas CRF-ir neurons were 2.1 times more numerous. These differences 
were mainly apparent in the ventral part of the Mg, followed by the medial and dorsal part of 
the nucleus. In the neural lobe of the pituitary gland a 22.5% lower optical density of CART-ir 
was observed. In the four other brain structures investigated, starvation had different effects. 
The dorsomedial part of the suprachiasmatic nucleus showed 5.9 times more NPY-ir cells and 
in the ventromedial thalamic area a lower number of NPY-ir cells (-33.6%) was found, whereas 
the Edinger-Westphal nucleus contained less CART-ir cells (-42.2%); no effect of starvation 
was seen in the ventral hypothalamic nucleus. Our results support the hypothesis that in X. 
laevis, the Mg plays a pivotal role in feeding-related processes and, moreover, that starvation 
also has neuropeptide- and brain structure-specific effects in other parts of the brain and in 
the pituitary gland, suggesting particular roles of these structures and their neuropeptides in 
physiological adaptation to starvation. 
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Introduction
Corticotropin-releasing factor (CRF) is a 41 amino acid neuropeptide that in 
mammals controls a wide range of physiological responses to physical and emotional 
stressors (e.g. Vale et al., 1981; Tsigos and Chrousos, 2002) including neuroendocrine 
and behavioral responses, inflammatory responses to immunological agents, and 
modulation of gastrointestinal (Baigent and Lowry, 2000) and cardiovascular activity 
(Parkes et al., 2001). Urocortin 1 (Ucn1) is a 40 amino acid peptide structurally related 
to CRF. It was discovered in 1995 (Vaughan et al., 1995) and although its physiological 
significance is less extensively documented than that of CRF, it seems also to be 
involved in various autonomic and behavioral stress adaptation processes (e.g. Skelton 
et al., 2000; Kozicz et al., 2004; Kórösi et al., 2005). Recently, roles of CRF and Ucn1 in 
the regulation of feeding have been suggested because their central administration 
diminishes food intake (e.g. Spina et al., 1996; Jones et al., 1998; Heinrichs and Richard, 
1999; Momose et al., 1999) and counteracts neuropeptide Y (NPY)-induced feeding 
(Wang et al., 2001). 
The profound and widespread physiological actions of CRF and Ucn1 become 
even more apparent from research on amphibians and, especially, on the aquatic 
toad Xenopus laevis. CRF and Ucn1 are present in the amphibian homologue of the 
supraoptic and paraventricular nucleus in mammals, the magnocellular nucleus (Mg; 
Verburg-van Kemenade et al., 1987a; Ubink et al., 1997; Calle et al., 2005a/Chapter 4). 
The Mg is activated by acute hyperosmotic challenge (Ubink et al., 1997), suggesting 
the involvement of CRF and Ucn1 in the amphibian stress response. Furthermore, both 
CRF and Ucn1 stimulate the release from the intermediate lobe of the pituitary gland of 
α-melanophore-stimulating hormone, a hormone involved in skin colour adaptation 
to changed background illumination (Roubos, 1997; Jenks et al., 2002; Roubos et al., 
2005). Moreover, central administration of CRF and Ucn1 suppresses food intake by 
X. laevis in a dose-dependent way (Crespi et al., 2004; Boorse et al., 2005) and the brain 
content of X. laevis CRF mRNA varies with the level of the animal’s nutritional state, 
strongly decreasing upon food deprivation (Crespi et al., 2004). However, the brain 
structures that control feeding-related processes in X. laevis have not been identified, 
which was the reason to start the present investigation. 
Recently, detailed studies were made of the distribution of CRF and Ucn1 in the 
central nervous system of X. laevis. It appeared that both peptides are widespread, 
indicating that they exert a large variety of actions, but they also show some overlap, 
mainly in the Mg (Yao et al., 2004; Calle et al., 2005a/Chapter 4). Because of this 
coexistence of both feeding-related neuropeptides, we hypothesize that CRF and Ucn1 
in the Mg are involved in the regulation of feeding. Using a long-term (sixteen weeks) 
starvation paradigm we have assessed the degree of activation of the Mg by studying 
Fos expression, and the dynamics of CRF and Ucn1 using immunocytochemistry. 
To determine if the starvation stimulus would have a feeding-specific rather than 
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a general stressor effect, and would specifically act on the Mg, a number of other 
neuropeptides and brain structures were studied as well. These peptides comprised 
factors known to be involved in some way in feeding control in mammals, namely 
cocaine and amphetamine-regulated transcript (CART; Douglass et al., 1995; Kuhar 
and Dall-Vechia, 1999; Vrang et al., 1999), NPY (Stanley and Leibowitz, 1985) and 
metenkephalin (ENK; Gosnell and Lipton, 1986). In addition to the Mg, we studied 
the suprachiasmatic nucleus (SC), a main centre of NPY expression in the X. laevis 
brain (Tuinhof et al., 1994b), the ventral hypothalamic area (VH), which is homologous 
with the mammalian arcuate nucleus, a main hypothalamic centre involved in the 
regulation of food intake (Johansen et al., 2000), the Edinger-Westphal nucleus (EW), 
which is the main site of Ucn1 expression in both amphibians and mammals (Kozicz et 
al., 1998; Bittencourt et al., 1999; Skelton et al., 2000; Calle et al., 2005a/Chapter 4) and 
is involved in the stress response in mammals (Kozicz et al., 2004; Kórösi et al., 2005), 
and the ventromedial thalamic nucleus (VM), which served as a negative control as it 
is not known to play a role in the control of feeding (ten Donkelaar, 1998).
Materials and methods
Animals
Twenty young adult aged 6 months specimens of Xenopus laevis, with a body 
weight of 32-35 g, were raised under standard laboratory conditions, under constant 
illumination, at a water temperature of 22 ± 1 °C, on a grey background, for 16 weeks. 
Ten control animals were fed weekly on ground beef heart (Janssen, Nijmegen, The 
Netherlands) and trout pellets (Trouvit, Trouw, Putten, The Netherlands). The other 10 
animals did not receive any food. A first group (n=5) was used for the Fos study and a 
second group (n=5) was used to study effects of starvation on the immunoreactivities 
against various neuropeptides. Brain sections of control and starved animals were 
processed in parallel for immunocytochemistry, for each peptide studied. Studies were 
carried out in accord with the Declaration of Helsinki and the Dutch law concerning 
animal welfare, as tested by the Committee for Animal Experimentation of Radboud 
University Nijmegen.
Immunocytochemistry
Toads were deeply anaesthetized by immersion in 0.1% tricaine methane sulfonate 
(MS222; Novartis, Basel, Switzerland) in tap water, and transcardially perfused with 
ice-cold 0.6% sodium chloride, for 5 min. Then they were perfused with 250 ml ice-
cold Bouin’s fixative, for 15 min. After decapitation, the brain and pituitary gland were 
quickly dissected and postfixed in the same fixative, for 16 h at 4 °C, washed in 70% 
ethanol for 24 h, to eliminate excess of picric acid, dehydrated in a graded ethanol 
series, and embedded in paraffin. Coronal serial sections (7 µm) were mounted on 
poly-L-lysine-coated slides (Sigma, St Louis, MO, USA) and allowed to air-dry, for 
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16 h at 45 °C, deparaffinized, rehydrated and treated for immunocytochemistry, as 
described before (Calle et al., 2005a/Chapter 4). As to the Fos staining, the antigen 
retrieval method of Shi et al. (1993) was used. After deparaffinization, sections were 
pre-heated in a microwave oven at 90 °C in 0.3% tri-sodium citrate buffer (pH. 6.0), for 
10 min. After a 10 min wash in cold water, immunostaining was performed. In brief, 
endogenous peroxidase activity was quenched with 0.1% H2O2 in sodium phosphate-
buffered saline (PBS), for 30 min, after which sections were rinsed twice in PBS, for 
15 min. Then they were incubated for 1 h in PBS containing 0.5% Triton X-100 (PBST; 
Sigma), 2.5% normal goat serum (NGS; Vector Laboratories, Burlingame, CA, USA) 
and 2.5% normal horse serum (NHS, Vector Laboratories), treated with avidin/biotin 
blocking solution (Vector Laboratories), for 15 min, and incubated with the respective 
primary antisera, diluted in PBST, for 16 h at 20 oC. 
The rabbit anti-c-Fos serum (dilution: 1:100) was from Santa Cruz Biotechnology 
(sc-253, Santa Cruz, CA, USA) and shown to specifically recognize Xenopus Fos protein 
(Ubink et al., 1997). The highly specific rabbit anti-Xenopus CRF (xCRF; dilution: 1:15) 
(Boorse and Denver, 2004; Yao et al., 2004; Calle et al., 2005b/Chapter 4), rabbit anti-rat 
Ucn1 (1:30,000) (Bittencourt et al., 1999; Kozicz et al., 2002), rabbit anti-bovine ENK 
(1:1,000) (Calle et al., 2005/Chapter 2) and rabbit anti-Xenopus NPY (xNPY; 1:8,000) 
(Tuinhof et al., 1994; Ubink et al., 1997) sera had been used in our laboratories before. 
The C6-1 F4D4 CART-antiserum (1:100,000) had been raised in mice against the 109-
126 fragment of rat CART peptide (Koylu et al., 1997; Lázár et al., 2004/Chapter 6).
Immunodetection was carried out with a Vectastain ABC elite kit (Vector 
Laboratories). After rinsing the sections in PBS and in Tris-HCl buffer for 30 min, the 
reaction product was visualized with 0.04% 3-3’-diaminobenzidine (DAB; Sigma) 
and 0.015% H2O2 in Tris-HCl buffer containing 0.5% nickel-ammonium sulphate. The 
reaction was terminated by several rinses in Tris-HCl buffer. Finally, sections were 
dehydrated in a graded series of ethanol, cleared in xylene, and mounted in Entellan 
(Merck, Hohenbrunn, Germany).
For all of the sera no immunostaining was seen after preabsorbtion with the 
respective synthetic peptides (50 µg/ml) for 16 h at 4 °C. Synthetic ENK peptide was 
from Bachem (Weil am Rhein, Germany). Omitting primary antisera also abolished 
immunostaining. 
Quantification 
For each animal, immunopositive neurons were counted in every tenth section of 
serial sections of each brain structure, consecutive sections being stained with the 
respective antisera. Only cell body profiles with a clearly visible nucleus were counted. 
Per antiserum, counts of the left and the right part of a paired brain structure were 
summated over all sections of that structure, per animal. For quantifying the density 
of CART-, Ucn1- and ENK-immunoreactivities in the pituitary neural lobe and CRF in 
the median eminence, images were taken of every tenth section of the lobe or median 
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eminence, with a 20x objective lens and a Leica DC 500 digital camera mounted on 
a Leica DMRBE microscope (Leica Microsystems, Heerbrugg, Switzerland). Using 
Scion Image software (version 3.0b; NIH, Bethesda, MD, USA), specific signal density 
(SSD) was determined relative to neutral background density present in the unstained 
intermediate lobe of the pituitary gland (for the neural lobe) or the lateral hypothalamic 
area (for the median eminence). The diameters of ENK-positive cells in the three sub-
areas of the Mg were measured using a 40x objective lens and an eyepiece micrometer, 
over all sections of a sub-area, and averaged per animal.
To check per peptide and per nucleus for a statistically significant effect of starvation 
on the numbers of immunoreactive cell bodies and on the size of perikarya, data 
averaged per animal, were tested for homogeneity of variance (Bartlett’s test, see Bliss 
1967) and normality (Shapiro and Wilk, 1965), and entered into analysis of variance 
(α=5%), using Statistica (StatSoft, Tulsa, OK, USA).
Results
General observations
The body weight of control and starved X. laevis were measured at the start and at 
the end of the starvation period. During this period, the mean weight of control animals 
(46.7 ± 2.4) had increased by 26.1% (P<0.005), whereas for starved animals (29.0 ± 0.5) 
a clear decrease by 10.9% (P<0.005) was observed, demonstrating a profound effect of 
starvation on body growth.
Effect of starvation on Fos expression
In control X. laevis, Fos expression was observed in many structures throughout the 
brain (Fig. 1). In the telencephalon scattered Fos-positive neurons occur in the medial 
and lateral pallium. The diencephalon shows a high number of such neurons in the SC 
(Fig. 1a) and moderate numbers in the VM, the VH and the Mg. In the mesencephalon 
a moderate number of Fos-positive neurons are present in the torus semicircularis and 
in the Edinger-Westphal nucleus. In the cerebellum a high number of strongly stained 
Fos-positive neurons are found (Fig. 1b).
The Mg of control animals contains about thirty Fos-positive cells. In the Mg of 
starved animals, however, the number of these cells is markedly lower (-55.9%; P<0.05) 
(Fig. 1c,d). Since three sub-areas in the Mg have been distinguished, viz. the ventral 
(MgV), the medial (MgM) and the dorsal (MgD) area (Ubink et al., 1997), it is relevant 
to study these areas with respect to their response to the starvation stimulus. Compared 
to the controls, in starved animals the number of Fos-immunoreactive (ir) neurons is 
much lower in both the MgV and the MgM (-69.4% and -52.1%, respectively; P<0.05) 
while no effect of starvation was seen in the MgD. 
No effect of starvation is statistically demonstrable in any other brain structure 
quantified (SC, VM, VH and Edinger-Westphal nucleus; Table 1). 
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Effect of starvation on neuropeptides
In the brain of control X. laevis CRF-, Ucn1-, ENK-, NPY- and CART-ir neurons 
and fibers can be clearly observed, and their distributions are in accord with previous 
descriptions (CRF and Ucn1: Calle et al., 2005a/Chapter 4; ENK: Merchenthaler et al., 
1987; NPY: Tuinhof et al., 1994a; CART: Lázár G./Chapter 6, Calle M. et al./Chapter 
7). 
In the Mg, starved animals (n=5) show 2.1 times more CRF-ir neurons than controls 
(P<0.005; Fig. 2a,b) whereas the numbers of CART-ir neurons (-94.3%; P<0.001; Fig. 
2c,d), ENK-ir neurons (-65.0%; P<0.05; Fig. 2e,f) and Ucn1-ir neurons (-44.0%; P<0.05; 
Fig. 2g,h) are much lower than in controls. In both control and starved animals only 
ENK-ir neurons occur in each of the three sub-areas, whereas CRF-, Ucn1- and CART-
ir neurons are only present in the MgV and MgM (Fig. 2). Compared to controls, in 
starved animals the peptide antisera reveal the most extensive effects in the MgV, 
where the number of CRF-ir neurons is 1.6 times higher (P<0.05) and the numbers of 
Ucn1-ir (-44.0%; P<0.05), CART-ir (-86.1%; P<0.05) and ENK-ir neurons (-72.6%; P<0.05) 
are much lower. In the MgM, starved animals show four times more CRF-ir neurons 
(P<0.05) and a much lower number of ENK-ir neurons (-58.2%; P<0.05) than controls. 
Fig. 1. Neurons in coronal sections of the brain of X. laevis, immunoreactive to Fos, in (a) the 
suprachiasmatic nucleus, (b) the cerebellum and (c) the ventral part of the Mg (MgV) of a representative 
control animal, and (d) in the MgV of a representative starved animal. In c and d, dorsal is not on top 
and orientation of dorsal (d)-lateral (l) has been indicated. Scale bar a,b = 50 µm, c,d = 20 µm. 
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Fig. 2. Coronal sections at different levels of the Mg, in a representative control (left) and starved (right) 
animal, immunopositive for (a,b) CRF (in MgV), (c,d) CART (in MgM), (e,f) ENK (in MgM) and (g,h) 
Ucn1 (in MgV). Scale bars = 20 µm.
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Moreover, in the starved animals CART-ir neurons are absent from this part of the Mg 
whereas they are numerous in controls (18.6±7.6; P<0.01). In the MgD, starvation only 
results in a clearly lower number of ENK-ir neurons (-67.0%; P<0.05).
Neurons in the Mg send axons to the pituitary gland where they form neurohemal 
axon terminals in the neural lobe. The lobe clearly stains with antisera against Ucn1, 
ENK and CART and this staining was measured and expressed as SSD. Starved 
animals reveal a lower SSD (-22.5%; P<0.05) of CART-ir (Fig. 3a,b) whereas no effect 
was found for Ucn1- and ENK-ir. Since CRF-ir fibres are very scarce in the neural lobe 
(cf. Roubos et al., 2005), their staining could not be reliably assessed. In contrast, the 
median eminence contains many CRF-containing fibres, enabling measurement of the 
SSD of CRF-ir in this brain structure. However, no difference was observed between 
control and starved animals (Table 1).
The other brain structures quantified show less extensive reactions to the starvation 
stimulus than the Mg. NPY-ir neurons occur in three sub-areas of the SC, viz. in the 
dorsomedial, the ventrolateral and the caudal area. The dorsomedial area shows 5.9 
times more NPY-positive neurons in starved than in control animals (P<0.05; Fig. 
3c,d); the other two areas do not reveal a difference between the experimental groups. 
Furthermore, starved animals reveal a lower number of NPY-positive neurons in the 
VM (-33.6%; P<0.05; Fig. 3e,f), whereas CART-positive neurons are less numerous in 
the Edinger-Westphal nucleus (-42.2; P<0.05; Fig. 3g,h; Table 1). In the VH no effect of 
starvation on any of the neuropeptide-containing neurons was observed.
Cell size and stainability
In general, the shape and size of neurons in the brain of X. laevis is rather variable, 
round, ovoid and pleomorph perikarya of different sizes being intermingled within a 
given brain structure. Moreover, variability was seen in the degree of immunoreactivity 
among such neurons. Pilot studies have shown before that, because of this variability, 
no accurate measurements can be made to show a possible effect of starvation on 
shape, size and intensity of immunostaining of individual perikarya. Nevertheless, 
in one case quantitative assessment of cell size could be carried out reliably, as the 
difference between controls and starved animals turned out to be very considerable: in 
the three subareas of the Mg of starved animals ENK-ir neurons appeared to be clearly 
smaller than their counterparts in control animals (MgV: -17.0%, P<0.05; MgM: -22.4%, 
P<0.001; MgD: -26.0%, P<0.001). Also, these neurons were clearly less intensily stained 
(Fig. 4).
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Fig. 3. Coronal sections of a representative control (left) and starved (right) animal at the level of (a,b) the 
neural lobe of the pituitary gland, showing CART-ir fibers, (c,d) dorsomedial part of the suprachiasmatic 
nucleus with NPY-ir neurons, (e,f) ventromedial thalamic area with NPY-ir cells, and (g,h) Edinger-
Westphal nucleus with CART-ir neurons. Scale bar = 20 µm. 
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Discussion
Methodological considerations
In this study we have followed a combined physiological (starvation paradigm) 
and quantitative immunocytochemical (neuropeptide and Fos presence) approach to 
test the hypothesis that CRF and Ucn1 peptides in the Mg of the brain of X. laevis 
are involved in the control of feeding-related processes. Starvation is a common tool 
to investigate the role of brain peptides in such processes as it drastically affects the 
dynamics of feeding and gastrointestinal activity (e.g. Chaillou et al., 2000; Bertile et al., 
2003), but it may have the disadvantage of evoking strong side-effects when it inhibits 
general metabolism and activates the hypothalamic-pituitary-adrenal stress axis, 
especially after a prolonged period of food deprivation (Hervant et al., 2001; Hervant 
and Renault, 2002). However, since Crespi et al. (2004) showed that in X. laevis plasma, 
corticosterone levels are not increased after one month of food deprivation and since 
X. laevis is well capable to survive long periods of drastically reduced food supply, 
up to 18 months (Merkle and Hanke, 1988), such side-effects may not be expected in 
our study, making our starvation stimulus of 16 weeks a specific factor acting on the 
feeding control system rather than being a factor activating the stress axis. Moreover, 
the effects of starvation on the presence of various neurochemical messengers and Fos 
are distinct and specific for a given messenger and brain structure, which would not 
have been expected when the starvation stimulus would have led to general inhibition 
of neuronal secretory activity. Moreover, some of the effects observed, like changes 
in NPY-ir in the SC and CART-ir in the EW have never been shown to be related to 
chronic stress effects (CART in the EW only changes during acute stress in mammals; 
Fig. 4. Effect of starvation on mean diameter of neuronal perikarya profiles immunoreactive to ENK 
in the Mg subareas, MgV, MgM and MgD, in control animals (white bars) and starved animals (black 
bars). Values are expressed as mean ± standard error of the mean (S.E.M.). Asterisks indicate significant 
difference between control and starved animals (*P<0.05, **P<0.001).
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Brain structure Fos CRF Ucn1 CART ENK NPY
Mg MgV Control 7.2 ± 1.6* 8.2 ± 1.6* 28.6 ± 4.4* 13.0 ± 3.2* 25.6 ± 5.2** a
Starved 2.2 ± 0.8 13.8 ± 1.8 16.0 ± 2.3 1.8 ± 0.8 7.0 ± 1.6 a
MgM Control 14.2 ± 2.7* 2.2 ± 0.3** 17.8 ± 1.1 18.6 ± 7.6** 43.6 ± 7.2** a
Starved 6.8 ± 1.7 8.8 ± 1.7 22.2 ± 2.2 a 18.2 ± 6.4 a
MgD Control 7.2 ± 1.7 a a a 50.4 ± 2.8** a
Starved 3.6 ± 1.1 a a a 16.6 ± 5.4 a
Mg total Control 28.6 ± 5.5* 10.4 ± 1.8* 46.4 ± 4.4 31.6 ± 7.0** 119.6 ± 10.6* a
Starved 12.6 ± 3.4 22.6 ± 1.8 38.2 ± 2.5 1.8 ± 0.8 41.8 ± 10.7 a
SC SCDM Control 18.4 ± 5.3 17.0 ± 1.7 a 78.8 ± 3.4 22.0 ± 3.6 2.8 ± 1.3*
Starved 25.2 ± 10.5 17.0 ± 3.3 a 65.2 ± 8.3 22.2 ± 2.4 16.6 ± 4.4
SCVL Control 13.0 ± 5.1 a a a a 4.8 ± 2.1
Starved 22.8 ± 8.4 a a a a 2.8 ± 1.2
SCC Control 5.0 ± 1.3 3.2 ± 0.7 a a 4.2 ± 2.0 1.6 ± 0.9
Starved 7.2 ± 2.4 3.8 ± 1.2 a a 8.8 ± 3.4 6.2 ± 1.8
SC total Control 36.4 ± 10.3 20.2 ± 2.1 a 78.8 ± 3.4 26.2 ± 4.7 9.2 ± 3.0*
Starved 55.2 ± 20.9 20.8 ± 4.4 65.2 ± 8.3 31.0 ± 5.5 25.6 ± 5.8
VM Control 25.4 ± 11.3 7.4 ± 1.8 a 165.0 ± 21.3 a 94.4 ± 9.3*
Starved 14.8 ± 6.0 6.2 ± 0.7 a 150.2 ± 24.5 a 62.6 ± 6.4
VH Control 14.6 ± 4.8 17.4 ± 1.6 a 79.6 ± 11.1 59.0 ± 7.3 23.2 ± 2.9
Starved 12.8 ± 4.8 21.0 ± 2.1 a 67.4 ± 7.4 66.5 ± 11.2 24.1 ± 3.5
EW Control 12.8 ± 5.2 a 29.2 ± 1.2 47.8 ± 5.0* a a
Starved 9.6 ± 3.9 a 34.7 ± 5.2 27.6 ± 3.6 a a
NL Control a nm 1.1 ± 0.2 82.0 ± 6.3* 48.6 ± 4.2 a
Starved a nm 1.7 ± 0.8 63.5 ± 1.2 55.8 ± 9.0 a
Me Control nm 51.1 ± 1.6 nm nm nm nm
Starved nm 49.0 ± 5.1 nm nm nm nm
Table 1. Quantification of the numbers of cell body profiles immunoreactive to Fos, CRF, Ucn1, CART, 
ENK and NPY, in different brain structures of control and starved X. laevis, viz. magnocellular nucleus 
(Mg) and ventral (MgV), medial (MgM) and dorsal (MgD) subareas, suprachiasmatic nucleus (SC) and 
dorsomedial (SCDM), ventrolateral (SCVL) and caudal (SCC) subareas, ventromedial thalamic area (VM), 
ventral hypothalamic area (VH) and Edinger-Westphal nucleus (EW). Intensity of immunostaining of 
fibres positive to Ucn1, CART and ENK in the neural lobe (NL) of the pituitary gland and in the median 
eminence (Me) is measured as specific signal density (SSD). Values are expressed as mean per group ± 
standard error of the mean (S.E.M.). Asterisks indicate statistically significant difference between control 
and starved group (* = P<0.05 and ** = P<0.01). n = 5 animals per group. a, absent; nm, not measured.
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Kozicz, 2003). Therefore, the effects on brain structures observed in the present study 
seem to be related to starvation-induced changes in neuronal control mechanisms of 
feeding-related events, rather than to stress- and/or metabolism-related processes. 
Quantitative immunocytochemistry and in situ hybridization comprise the best 
techniques to obtain information about the secretory activity of individual neurons and 
their specific messengers, in intact brain tissue. Our approach to count the number of 
immunopositive cell profiles yields an impression about the amount of neuropeptide 
present in the brain structure. Obviously, this amount of stored messenger is not a 
direct measure for the cell’s secretory activity, as according to the ‘bath tube’ principle, 
this amount depends on the balance between production and turnover and, in case 
of the messengers, also of the rate of axonal transport (e.g. Siegel, 1999). However, 
changes in the amount of stored stainable material indicate that this balance is changed 
and, therefore, such changes are good indicators that the brain structure in question is 
responding to the stimulus, in our case to starvation. Moreover, staining of a neuron 
with the Fos method is well-accepted to be a reliable indicator of neuronal activity, so 
that the Fos method in combination with immunoreactions to the various messengers 
provides a meaningful picture of the structures responding to the stimulus. In X. laevis 
the expression of Fos was demonstrated previously as being prolonged and apparently 
related to events like stimulated neuronal plasticity and chronic stimulation of secretory 
activity (Ubink et al., 1997). 
Starvation and the magnocellular nucleus 
Of the five brain structures investigated in detail, the Mg shows the strongest 
difference between starved and control animals as to the various immunocytochemical 
parameters. On the basis of the assumptions made above with regard to the significance 
of the parameters for neuronal activity, we conclude that especially the MgV and the 
MgM are extensively responding to the starvation stimulus by showing changed 
dynamics in storage, and hence, production and/or secretion of CRF, Ucn1, CART and 
ENK. The significance of the differential responses of the three subareas of the Mg 
awaits their detailed functional elucidation. In any case, these responses are specific 
for the Mg because no other structure shows a decrease in Fos expression in response 
to starvation. 
Since the Mg is a well-known centre of CRF production, it is tempting to relate 
the decreased Fos activity to a decreased activity of CRF-producing neurons. Such a 
decrease would be in accordance with and extend the observation by Crespi et al. (2004) 
that long-term starvation of X. laevis leads to a decrease in CRF mRNA in the preoptic/
optic tectum/mid-posterior hypothalamus, as this region contains the Mg. However, 
to date it is not possible to relate the decreased amount of Fos in the Mg to CRF or to 
any other of the messengers investigated. This will only be possible by colocalization 
studies at the cellular level, which are difficult to perform because antisera available 
for immunodouble stainings are mainly raised in the same animal (rabbit) and for 
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most peptide mRNAs of interest, specific (Xenopus) in situ probes are not available.
Meanwhile, our data show markedly changed immunoreactivities of the Mg to the 
various antisera, which strongly indicates that CRF, CART and/or ENK in the Mg, 
and particularly in the MgV and the MgM, play a role in feeding in X. laevis. A main 
role of the Mg in amphibians in feeding-related events fits with the notion that the 
Mg homologue in mammals, the PVN, may control feeding as well (Krahn et al., 1988; 
Wang et al., 2001). Our results furthermore indicate for the first time a role in feeding-
related processes in amphibians of CART and ENK, peptides shown before to be 
involved in this process in mammals (Kristensen et al., 1998; Glass et al., 1999; Henry 
et al., 2001). As we found a low intensity of CART-staining in the pituitary neural lobe 
after starvation, it may be that CART is released into the general circulation to act on 
peripheral targets, as is the case in mammals (Vicentic et al., 2004, 2005). On the other 
hand, the possibility cannot be ruled out that CART, like many other peptides present 
in the neural lobe (Roubos et al., 2005; Wang et al., 2005a), has a stimulatory effect on the 
pituitary intermediate lobe, as it has in mammals (Baranowska et al., 2004; Kuriyama et 
al., 2004), regulating (in addition to feeding) the activity of the melanotrope cells. As to 
ENK, our observation of a decreased stainability and decreased cell size underlines the 
notion that these cells change, and probably reduce, their activity during starvation. 
The possibility that ENK plays a role in starvation-induced adaptive processes in 
amphibians deserves further attention. 
Although statistically an effect of starvation on the number of Ucn1-ir neurons 
in the total Mg could not be demonstrated, such an effect became visible when the 
subareas of the nucleus were considered, revealing a much lower number of Ucn1-
positive neurons in the MgV. This result supports our hypothesis that Ucn1 in the 
Mg, and more particularly in the MgV, is involved in the control of food intake in X. 
laevis. This conclusion extends the finding that central Ucn1 administration in X. laevis 
suppresses food intake in a dose-dependent manner (Boorse et al., 2005) and is in line 
with the situation in mammals, where food deprivation induces a down-regulation of 
Ucn1-ir neurons in the PVN (Hara et al., 1997). 
Starvation and other brain centres
Besides having an effect on the Mg, starvation also affects three other brain structures, 
albeit in different ways. Crespi et al. (2004) have shown that food deprivation leads to 
changes in the amount of NPY mRNA in the Xenopus brain. In the present study we 
find two centres that respond to starvation with changed dynamics of NPY as to the 
number of neurons containing NPY: the SC (more neurons immunoreactive to NPY) 
and the VM (fewer neurons immunoreactive to NPY), suggesting changed amounts of 
NPY stored in these nuclei. Neither nucleus has been shown before to be involved in 
the regulation of processes related to feeding, neither in mammals nor in amphibians. 
Therefore, more evidence is needed to conclude that these nuclei would play such a role. 
In case of the SC this role would be in addition to the control by NPY of melanotrope 
 Starvation and neuropeptide immunoreactivities in the CNS of X. laevis
139
cell activity in the pituitary pars intermedia. NPY neurons in the dorsomedial part of 
this nucleus are supposed to inhibit the so-called SMINs (suprachiasmatic melanotrope 
cell-inhibitory neurons) in the ventrolateral part, which, also by releasing NPY, inhibit 
the melanotrope cells. Further research is needed to see if the neurons reacting to the 
starvation stimulus are identical with these dorsomedial inhibitory neurons (Tuinhof 
et al., 1994b; Scheenen et al., 1995; Kramer et al., 2001). Similarly, it would be of interest 
to determine if the neurons in the thalamus that inhibit tectal pathways controlling 
prey-catching behavior (Carr, 2005) are identical to the NPY-neurons presently studied 
in the VM. 
No differences between starved and control animals were found in the VH. The 
VH is considered to be the homologue of the arcuate nucleus in mammals (Tuinhof et 
al., 1998) where it is supposed to play an important role in the control of food intake 
(Schwartz et al., 2000). The present study does not support such a role of the VH in X. 
laevis but does not exclude it either as our paradigm probably covers only a minor part 
of all activities of this extensive nucleus.
Finally, we have found a lower number of CART-ir cells in the Edinger-Westphal 
nucleus of starved animals. This oculomotor nucleus has recently gained much 
attention as it is the main site of Ucn1, the member of the CRF peptide family that 
may play important roles in various types of stress adaptation in rodents (Kozicz et 
al., 2004; Kórösi et al., 2005). The present study represents the first report of an effect 
of starvation on this nucleus. The fact that in this nucleus no effect on Ucn1-containing 
neurons is seen, is in line with the assumption reached above that 16 weeks of starvation 
is not a stressor for X. laevis. Meanwhile, the possible role of Ucn1 in the EW-N of 
amphibians in stress adaptation needs to be established (cf. in mammals: Kozicz et 
al., 2004; Kórösi et al., 2005). The change in CART neurons, may indicate a role of this 
peptide in feeding, but more research on the role of this peptide to substantiate this 
suggestion and to test a possible relationship between CART and Ucn1 activities in 
this nucleus is needed. 
Conclusions
We conclude that starvation has profound effects on the neurochemical contents 
of the three subareas of the Mg, especially the MgV and MgM, of X. laevis, indicating 
a role of CRF and Ucn1 and possibly of CART and ENK in the regulation of feeding 
activity. Moreover, we have found indications that in amphibians CART, ENK and 
NPY may be involved in the regulation of feeding-related processes, acting in distinct 
brain centres.
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In order to survive the various challenges life puts on them, organisms maintain 
their internal homeostasis by regulating and co-ordinating a large number of essential 
physiological processes. These regulations are mainly the result of the collaboration 
between two important systems: the central nervous system and the endocrine system. 
The neuroendocrine regulation of background adaptation in the two anuran species, 
X. laevis and Rana esculenta, provides a good example of such a collaboration. In the 
research described in this thesis, various new aspects of this regulation have been 
investigated, with particular attention to the ways of communication by neurons and 
endocrine cells involved in this process. Moreover, attention has been paid to the 
regulation of stress adaptation and feeding-related processes in these two amphibians. 
In the next paragraphs, the results of these investigations will be discussed, with 
emphasis on the way(s) these different physiological processes are regulated in a 
co-ordinated fashion by integration of information at the level of neuronal centres, 
neurochemical messengers and receptors.
Communication via the cerebrospinal fluid
Recent observations confirm the importance of ‘non-synaptic’ or ‘volume 
transmission’ in several functions of nervous tissue (Agnati et al., 1995, 2000, 2005; 
Hoistad et al., 2005). Already in the 1970’s and 1980’s it was suggested that the 
cerebrospinal fluid (CSF) serves as an alternative communication channel for hormones 
and neurotransmitters (Black, 1982; Agnati et al., 1986). This way of communication 
would allow neurochemical messengers to travel over long distances to act on receptors 
located far from their sites of release (Black, 1982). Since communication via the CSF 
is a relatively slow process, it may particularly control delayed-onset processes like 
emotion and stress adaptation. 
It has been suggested that neuropeptides can reach the CSF in different ways: 1) 
they could be transported from the circulation via the chorioid plexus to the CSF, 2) 
‘blind’ nerve terminals could secrete them into the CSF, and 3) they might be released 
into the extracellular fluid (ECF) of the interneuronal space in the CNS and diffuse 
from there into the CSF (Schmitt, 1984; Vigh et al., 2004; Johanson et al., 2005). In this 
thesis, data have been obtained that support these assumptions. 
In Chapter 2 we have described the presence of various types of CSF-contacting 
neurons in the Xenopus brain, which are immunopositive to antisera raised to the 
opioid peptides β-endorphin, met-enkephalin and endomorphin and to the stress-
related neuropeptides CRF and Ucn1. These neurons occur in several structures of the 
X. laevis brain, suggesting a wide distribution of release sites. More precisely, liquor-
contacting neurons producing β-endorphin occur in the suprachiasmatic nucleus, the 
paraventricular nucleus and in the ventral hypothalamic area whereas met-enkephalin 
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seems to be released into the CSF from the suprachiasmatic nucleus and the posterior 
tuberculum, and endomorphin from the suprachiasmatic nucleus. As to the stress-
related peptides, CRF is present in liquor-contacting neurons in the suprachiasmatic 
nucleus and the paraventricular nucleus, and Ucn1 in the magnocellular nucleus. 
Obviously, the suprachiasmatic nucleus contains the largest variety of peptides that 
may be released into the CSF. This is in line with the observation in mammals describing 
CRF, enkephalin, endorphin and vasopressin in the suprachiasmatic nucleus (Morin et 
al., 2006). Moreover, Schwartz and Reppert (1985) presented evidence for the relevance 
of the suprachiasmatic nucleus in the release of neuropeptides in the CSF, since the 
secretion of vasopressin into the CSF is abolished by lesioning suprachiasmatic efferent 
axons. 
In accordance with the presence of this variety of liquor-contacting structures in 
Xenopus and other vertebrates, several neuropeptides such as CRF, β-endorphin and 
met-enkephalin have been detected in human and animal CSF (Post et al., 1982; Nemeroff 
et al., 1984; Barna et al., 1990). Interestingly, their CSF levels have been correlated with 
particular emotional states and mental disorders (Post et al., 1982). For instance, high 
levels of CRF occur in the CSF of depressed human patients (Nemeroff et al., 1984) and 
are increased by fear-inducing stimuli in the CSF of macaque monkeys (Kalin et al., 
2000). Furthermore, high CSF levels of β-endorphin and met-enkephalin are present in 
patients with chronic pain and in addicted persons after electroacupunture (Post et al., 
1982). Ucn1 and endomorphin have not yet been detected in the CSF, but they occur 
in human plasma (Watanabe et al., 1999; Somogyvari-Vigh et al., 2004), are produced 
in the CNS (Kozicz et al., 1998; Pierce and Wessendorf, 2000) and can cross the blood-
brain barrier via a saturable transport system (Kastin and Akerstrom, 2002; Kastin et 
al., 2002; Pan et al., 2004; Somogyvari-Vigh et al., 2004) indicating their possible release 
from the brain into the circulation and, possibly, into the CSF. Preliminary studies in 
our laboratory to detect CRF, Ucn1, β-endorphin and met-enkephalin in the X. laevis 
CSF by mass-spectrometry have been unsuccessful (M. Calle and K.W. Li, unpublished 
data). Possibly, peptides released into the CSF are too rapidly metabolized or degraded 
to be detected (Sweep et al., 1990).
Chapter 5 presents support for a remote, possibly non-synaptic, action of Ucn1 
in our Xenopus laevis model, where the distribution of CRF1 receptor mRNA in the 
brain and pituitary gland has been described. It is shown that CRF1 receptor mRNA 
expression is higher in the intermediate pituitary lobe of Xenopus adapted to a white 
background than in black-adapted animals. This result has been confirmed by Q-
PCR (G. Corstens, M. Calle et al., unpublished data). The presence of this receptor 
on the melanotrope cells in the intermediate pituitary lobe explains the stimulatory 
action on α-MSH release by melanotrope cells exerted by both CRF and Ucn1, and 
further supports our assumption that these peptides can act as neurohormones 
(Chapter 4). In X. laevis both CRF and Ucn1 bind to both CRF1 and CRF2, the binding 
affinities of CRF and Ucn1 to CRF1 being quite similar, whereas Ucn1 binds CRF2 with 
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much higher affinity than CRF1 (Dautzenberg et al., 1997; Boorse and Denver, 2006). 
Pharmacological studies performed in our laboratory revealed that astressin, a CRF1 
and CRF2 antagonist, blocks the stimulatory action of Ucn1 whereas Ucn3, a specific 
agonist of CRF2, does not stimulate the release of α-MSH from melanotrope cells. This 
indicates that CRF1 is the functional CRF receptor type involved in the Ucn1-induced 
release of α-MSH from the melanotrope cells (Corstens, 2006). Interestingly however, 
by RT-PCR, both receptors have been identified in the Xenopus neurointermediate lobe, 
and antisauvagine, a specific CRF2 antagonist, inhibits Ucn1-induced α-MSH release 
from melanotrope cells (Corstens, 2006). This data suggest that also CRF2 is involved 
in the control of release of α-MSH from the melanotropes, but the physiological role of 
this receptor type has to be established. 
Further evidence that CRF-related peptides may act in volume transmission, comes 
from the observation that CRF- and Ucn1-immunoreactive axon terminals have been 
identified in Xenopus brain structures where CRF1 receptor mRNA is undetectable 
(Chapters 4 and 5). This situation suggests a mismatch between ligand and receptor. 
Such a ligand-receptor mismatch is a classical indication for volume transmission of 
the ligand. However, the mismatch might also be irrelevant, as these ligands could act 
on a local, other types of CRF-like receptor. For instance, in catfish, molecular cloning 
studies identified a third catfish CRF receptor type, ctCRF3, that has different structural 
and functional properties and tissue expression patterns than CRF1 and CRF2 (Arai et 
al., 2001). Moreover, in the mouse CNS a soluble alternative splice variant of CRF2 
has been discovered. This soluble CRF2 (Chen et al., 2005) has a high affinity for both 
CRF and Ucn1 and has been proposed to modulate the activity of these two important 
ligands by competing with the full length membrane receptor for available ligand or 
by presenting the ligand or prolonging its action (Chen et al., 2005). This soluble splice 
variant is present in CRF1-expression areas, suggesting that these receptor types can 
collaborate. However, the existence of a third receptor type binding to CRF-related 
peptides in X. laevis is unclear. 
As to the diffusion of neuropeptides in the ECF, recent studies by Hoistad et al. 
(2005) further support this way of neurochemical communication as they shown that β-
endorphin injected into the striatum diffuses through the ESF over long distances to reach 
the CSF. Furthermore, recently, a new family of mitochondrial proteins was discovered, 
called UCPs (uncoupling-proteins), which produce a substantial amount of energy 
and therefore cause convective fluid movements. They may enhance the migration of 
neurotransmitters in the CNS (Horvath et al., 1999). UCP2-immunoreactivity has been 
observed in regions where a mismatch between ligand and receptor occurs, such as in 
the dopaminergic innervation area of the nucleus accumbens (Fuxe et al., 2005; Rivera 
et al., 2006). It would be interesting to study the distribution of the UCPs in the X. laevis 
brain and to relate this distribution to the areas where a mismatch exists between CRF/
Ucn1 and CRF1 and CRF2 receptors.
The function of neuropeptides in the CSF is enigmatic. Possibly, the CSF serves to 
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transport the peptides to other brain areas to let them act on neurons that have the 
appropriate receptors. Specialized structures bordering the ventricular spaces called 
circumventricular organs (Johnson and Gross, 1993) having large perivascular spaces 
and lacking tight junctions between endothelial cells, are good candidates for the sites 
of access of these neuropeptides from the CSF to the brain. Already in the early 1970’s, 
processes from subependymal neurons were observed to contact the CSF in the third 
ventricle and in the central canal of the spinal cord, and the peculiar location and 
morphology of these neuronal elements suggested that they would act as receptive 
structures mediating transfer of neurochemical information from the CSF to nearby 
brain areas (for review, see Vigh et al., 2004). Moreover, since intracerebroventricular 
administration of neuropeptides increases neuronal activity in periventricular brain 
structures such as the arcuate nucleus, Amat et al. (1999) have suggested that CSF 
peptides pass between the ependymal cells lining the ventricle to enter the intercellular 
space surrounding neuronal somata and processes of the arcuate neurons. In addition, 
Vigh-Teichmann and Vigh (1974) reported that dendrites of neurons of the arcuate 
and periventricular nuclei of mammalian species are in direct contact with the CSF. 
In this thesis research (Chapter 4), we provide further evidence for this idea, showing 
that Ucn1-immunoreactivity is not present in the ventral hypothalamic area, the 
homologue structure of the arcuate nucleus in mammals, whereas in this area a high 
amount of CRF1 receptor mRNA has been detected (Chapter 5). These results suggest 
the presence of a ligand-receptor mismatch and provide further evidence for volume 
transmission of Ucn1. 
Neurohormonal communication
The second way of neurochemical information processing that is involved in the 
regulation of physiological processes is that by the release of peptide neurohormones 
from the brain into the general circulation. This process of ‘neurosecretion’, discovered 
by Ernst Scharrer (1928) as one of the important concepts in physiology, establishing 
the discipline of Neuroendocrinology and promoted by him and his wife Berta Scharrer 
(for an ‘In Remembrance’ see Irmgard and Ziegler, 2004), has been investigated here 
into detail in the X. laevis brain with respect to BDNF (Chapter 3) and to Ucn1 (Chapters 
2, 4 and 5). 
Both Ucn1 and BDNF have been found in the hypothalamus-neurohypophyseal 
system (HNS), namely in neurons of the Mg. These neurons form axon terminals in the 
external zone of the median eminence and in the neural lobe of the pituitary gland, where 
at the ultrastructural level secretory granules immunoreactive to Ucn1 and BDNF appear 
in neurosecretory axon terminals, abutting capillaries (‘neurohemal axon terminals’). 
We show in the neural lobe, that in these terminals BDNF and mesotocin coexist in the 
same secretory granules. Moreover, we demonstrate that not only BDNF (Kramer et 
al., 2002) but also Ucn1 and mesotocin stimulate α-MSH release from the melanotrope 
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cells of the neurointermediate lobe. The presence of Ucn1, BDNF and mesotocin in 
secretory granules in these neurohemal terminals, strongly suggests their release into 
the neurointermediate plexus, via the process of exocytosis (Roubos and van der Wal-
Divendal, 1980). In this way, the peptides, acting as neurohormones, would reach the 
melanotrope cells of the intermediate lobe. Alternatively or in addition, Ucn1, BDNF 
and mesotocin could be released into the extracellular fluid between the neurohemal 
axon terminals, and then reach by diffusion the nearby located intermediate lobe 
(Chronwall et al., 1998). Studies in rodents have revealed that not all melanotrope cells 
in the intermediate pituitary gland are innervated and that there is cell heterogeneity 
as to receptors and proopiomelanocortin peptide production (Chronwall et al., 1998). 
They support the possibility that also in mammals the control of melanotropes occurs 
also via ‘non-synaptic’ communication, but ultrastructural and immunocytochemical 
evidence as presented here for X. laevis, is lacking. More generally, the idea that Ucn1 
can act as a neurohormone is in line with recent data on sheep where Ucn1 in the blood 
was shown to be released from the brain (Charles et al., 2006). 
As to the possible action of BDNF as a neurohormone, both the high affinity 
neurotrophin receptor TrkB and the low affinity neurotrophin receptor p75 occur in 
Xenopus melanotrope cells (Kidane et al., 2005). This finding supports the view that 
BDNF acts as a neurohormone to stimulate the release of α-MSH from the melanotropes. 
In Chapter 3 we show that BDNF is produced in the brain, and particularly in the Mg, 
which is known to be an important neurosecretory centre in vertebrates. Plasma BDNF 
levels reflect BDNF levels in the mammalian brain, which has been explained by the 
fact that BDNF is released within the brain and then crosses the blood-brain-barrier 
to enter the blood stream (Pan et al., 1998). However, our data indicating that BDNF 
is released as a neurohormone from neurohemal axon terminals into the circulation, 
provide an alternative explanation for the occurrence of BDNF in the blood: release as 
a neurohormone. In rats, systemic co-injection of BDNF improves the rate and extent of 
sciatic functional recovery after nerve damage (Cheng et al., 1998), supporting the idea 
that circulating BDNF can have a physiological, neurotrophic effect. If in mammals 
BDNF can also act as a neurohormone in the pituitary gland, as in Xenopus, remains to 
be investigated.
Integrative physiology
Several neuropeptides treated in this thesis appear to participate in the regulation 
of more than one physiological process, indicating a high level of integration between 
different such processes in the X. laevis brain. In the following paragraphs the various 
physiological processes in which the different neurochemical messengers examined in 
this thesis play a role will be considered.
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Met-enkephalin. Opioid peptides such as β-endorphin and met-enkephalin (ENK) were 
described previously in the X. laevis brain and pituitary gland (Merchenthaler et al., 
1987; Tuinhof et al., 1998). In this research, special attention has been given to the 
opioid peptide ENK, which is a product of the proenkephalin gene (Martens and Her-
bert, 1984). In amphibians, opioid peptides have been implicated in the regulation of 
several physiological processes such as hibernation (Stevens and Pezalla, 1989), an-
algesia (Stevens et al., 1987), stress adaptation (Mosconi et al., 1994) and background 
adaptation (Tuinhof et al., 1998). In Chapter 8, involvement of ENK in the regulation of 
feeding-related processes in X. laevis has been proposed, because the number of ENK-
immunoreactive neurons in the Mg is decreased after long-term starvation. There are 
indications for a role of opioid peptides in the regulation of food intake in mammals 
(Gosnell and Lipton, 1986), but such a role in amphibians had never been indicated 
before. 
CRF and Ucn1. Both CRF and Ucn1 may exert a variety of physiological actions in X. 
laevis. The stimulatory role of CRF on the secretion of α-MSH by amphibian melanotrope 
cells is well known (Verburg-van Kemenade et al., 1987a), and the higher expression 
of CRF1 receptor mRNA observed in the intermediate lobe of white-adapted animals 
compared to black-adapted animals (Chapter 5) is strengthening this role. Furthermore, 
CRF in X. laevis, like in mammals, has been supposed to be involved in the stress 
response (Boorse and Denver, 2004; Yao et al., 2004). A third role of CRF in X. laevis is 
proposed in Chapter 8, where CRF from the Mg seems to play a role in the regulation 
of feeding-related processes. Together with CRF, Ucn1 has been described in Chapter 
4 to be present in the X. laevis HNS, and evidence has been presented that this CRF-
related peptide is involved in the process of background adaptation, stimulating in 
vitro the release of α-MSH from melanotrope cells. Since Ucn1 probably stimulates α-
MSH release by acting on CRF1 (Chapter 5) and CRF1 mRNA expression is inhibited by 
placing Xenopus on a white background (Chapter 5), the possible involvement of Ucn1 
in background adaptation could be further tested by determining its expression in the 
Fig. 1. In situ hybridization for Xenopus laevis Ucn1 mRNA in (a) Mg and (b) EW in a representative 
black-adapted animal. Bar = 25 µm.
a b
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Mg in animals placed at different light intensities of their background. Preliminary data 
from in situ hybridization studies, have shown that in both black-adapted and white-
adapted animals Ucn1 mRNA is present in the Mg and the EW (Fig. 1). In rodents, Ucn1 
in the EW has recently been presented as another control centre of stress adaptation, in 
addition to the HNS (Kozicz et al., 2004). A possible role of Ucn1 in the regulation of 
stress adaptation in X. laevis deserves investigation. Also in Chapter 8, a role of Ucn1 in 
the regulation of feeding-related processes in X. laevis has been proposed, because the 
number of Ucn1-containing neurons in the Mg decreases upon long-term starvation. 
Such an involvement of Ucn1 in the regulation of food intake seems to have been 
conserved throughout evolution, as in both amphibians and mammals the peptide has 
an anorexigenic effect, inhibiting food intake (Heinrichs and Richard, 1999; Boorse et 
al., 2005). 
Brain-derived neurotrophic factor. Apart from its classical role to promote survival, 
growth and differentiation of neurons, and its involvement in the modulation of 
neurotransmission and synaptic plasticity (Chao, 2003), in X. laevis, BDNF has been 
implicated in the regulation of background adaptation (Kramer et al., 2002). In Chapter 
3, this growth factor has been described in the Mg, and in secretory granules together 
with mesotocin in Mg neurohemal axon terminals in the pituitary neural lobe. This 
finding suggests that BDNF is released as a neurohormone, together with mesotocin. 
The question arises as to the nature of the stimuli that activate Mg neurons to release 
BDNF and mesotocin (and other neuropeptides) from these axon terminals into the 
circulation. Using in situ hybridization, it was found previously that BDNF mRNA, 
present in the parvocellular portion of the rat paraventricular nucleus, becomes 
upregulated in response to an immobilisation stressor (Smith et al., 1995). This finding 
suggests that BDNF is a component of the stress response mechanism. More recently, it 
was found that osmotic stress increases BDNF mRNA expression in the rat supraoptic 
and paraventricular nuclei, indicating that BDNF has an autocrine or paracrine action 
in these hypothalamic nuclei to regulate vasopressin secretion (Aliaga et al., 2002). Salt 
loading stress activates c-fos expression in the X. laevis Mg (Ubink et al., 1997). Whether 
an immobilisation stressor and osmotic load activate BDNF mRNA expression in this 
nucleus, similar to the situation in mammals, and stimulate neurohormonal BDNF 
and mesotocin release from the X. laevis neural pituitary lobe, deserves attention.
Mesotocin. In the amphibian brain the two peptides mesotocin and vasotocin, members 
of a large family of nonapeptides, have been related to the regulation of osmotic and 
electrolyte balance, vasotocin having an antidiuretic function and mesotocin acting as a 
diuretic agent (Pang and Sawyer, 1978; Warburg, 1995). These two peptides are present 
in the Mg and are released as classical neurohormones into the general circulation 
to act on their distant targets (e.g. kidney and skin). In Chapter 3 mesotocin, besides 
its classical role in hydromineral regulation, is shown to be involved in the process 
of background adaptation because it stimulates melanotrope cells to release α-MSH. 
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In a recent study in the frog Rana esculenta, the mRNA of the mesotocin receptor has 
been detected in the intermediate lobe of the pituitary gland (Acharjee et al., 2004), 
supporting the notion that mesotocin stimulates melanotrope cell activity. 
Cocaine and amphetamine-regulated transcript. The physiological role of CART in 
amphibians has not yet been established. In mammals and fish a role of CART in the 
regulation of food intake as an anorexigenic factor has been proposed (Kristensen et 
al., 1998; Volkoff and Peter, 2000). Moreover, in rodents, CART may be a regulator of 
the stress response (Kozicz et al., 2003). In Chapters 6 and 7 the detailed distribution 
of CART in the brain of two anuran species, the frog Rana esculenta and the toad X. 
laevis, has been presented. Between these species clear differences have been observed 
in the peptide distribution in the olfactory and visual system, which participate in 
feeding-related processes. The visual system is probably more important for the largely 
terrestrial and highly visually oriented Rana than for the mainly aquatic Xenopus, 
in which the olfactory system may dominate. Many similarities in the distribution 
of CART in the Rana brain and, especially, in the X. laevis brain have been observed 
with the mammalian brain (rat), indicating the conservation of the function of this 
peptide during evolution. Moreover, in Chapter 8 the involvement of CART in the 
regulation of feeding-related processes in X. laevis has been supported by showing 
that in starved animals the number of CART-immunoreactive neurons in the Mg and 
EW and the optical density of fibres-immunoreactive to CART in the neural lobe of the 
pituitary gland substantially differs from those in fed Xenopus. The changed number 
of neurons containing CART in the HNS in starved toads suggests a neuroendocrine 
function of this peptide. In rodents, such a neuroendocrine function for CART was 
proposed because CART mRNA coexists in the paraventricular nucleus with the 
neurohormones vasopressin and CRF (Larsen et al., 2003). Moreover, centrally and 
intravenously administered CART affects pituitary growth hormone, prolactin and 
adrenocorticotropin (ACTH) release (Baranowska et al., 2004). On the basis of this data 
one might expect that in X. laevis, CART would also have a neuroendocrine function, 
for instance controlling the release of α-MSH from the pituitary melanotrope cells. 
This possibility needs to be tested, the more so as until now all peptides that have 
been shown to be present in the Xenopus neural lobe appear to have a stimulatory 
action on α-MSH release (Roubos et al., 2005). In this thesis research we show that 
both CART and Ucn1, known to inhibit food intake in rodents (Kristensen et al., 1998; 
Heinrichs and Richard, 1999), are present in the EW of X. laevis. In the rat EW, CART 
and Ucn1 coexist within the same neurons (Kozicz et al., 2003) and these neurons are 
activated by acute stressors (Kozicz et al., 2003). It will be interesting to determine if 
such a role also holds for CART and Ucn1 in the EW of X. laevis. Furthermore, the 
changed number of CART-containing neurons in the EW of starved Xenopus suggests 
the involvement of this brain structure in the regulation of feeding-related processes in 
X. laevis. In line with this finding, recently in rodents (mice), EW lesions reduced basal 
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and deprivation-induced food consumption (Weitemier and Ryabinin, 2005).
Neuropeptide Y. In X. laevis, NPY is one of the main hypothalamic peptides inhibiting 
α-MSH release from the melanotrope cells (de Rijk et al., 1992; Tuinhof et al., 1993b), 
playing an important role in the regulation of background adaptation. In mammals NPY 
is involved in the regulation of feeding, as intracerebroventricular injections of NPY or 
into the hypothalamus potently stimulate food intake (Stanley and Leibowitz, 1985) and 
NPY gene expression and secretion in the hypothalamus are increased during fasting 
periods (White and Kershaw, 1989). Recently, intracerebroventricular administration 
of NPY also increased food intake in X. laevis (Crespi et al., 2004), similarly to the 
situation in mammals (Stanley and Leibowitz 1985). Therefore, NPY may also play a 
role in the regulation of feeding-related processes in this amphibian. In accord with 
these findings, in Chapter 8, NPY-immunoreactive neurons in the suprachiasmatic and 
ventromedial thalamic nucleus have been demonstrated to change in number upon 
long-term starvation. In mammals one of the main brain structures involved in the 
regulation of food intake is the arcuate nucleus, where NPY-containing neurons are 
present (Schwartz et al., 2000). In X. laevis the ventral hypothalamic area, the structure 
homologous with the arcuate nucleus, also contains NPY-immunoreactive neurons 
but does not seem to be involved in the regulation of feeding-related processes. 
Apparently, the function of NPY as a key regulatory peptide in the control of food 
intake has been well-preserved in evolution, but the brain structures involved in this 
regulatory pathway seem to be species-specific. 
Possible site of integration of all these signals
Above we have shown and discussed that various neural factors stimulate α-
MSH release from Xenopus melanotrope cells. All of these neurochemical messengers 
are present in the Mg, as has been shown for mesotocin, CRF and TRH in the past 
(Vandesande and Dierickx, 1976; Olivereau et al., 1987; Verburg-van Kemenade et al., 
1987a,b; Gonzáles and Smeets, 1992) and for BDNF and mesotocin (Chapter 3), CRF 
and Ucn1 (Chapter 4), CART (Chapter 6 and 7) and ENK (Chapter 8). With the Fos 
technique, the Mg appears to be activated by several acute stressors such as shaking 
(Yao et al., 2004) and hyperosmotic stimuli (Ubink et al., 1997). As to the response to 
shaking stress, CRF-positive cells in the Mg seem to be involved (Yao et al., 2004). 
Moreover, during lowering ambient temperature from 20 to 5 °C (Tonosaki et al., 
2004) TRH cells in the Mg are activated. TRH is most likely released from the pituitary 
neural lobe to stimulate α-MSH release as well (Tonosaki et al., 2004). In Chapter 8, 
the Mg in starved X. laevis appears to have less Fos-positive (active neurons) cells than 
in fed animals, whereas no differences are seen in other brain structures investigated. 
Moreover, CRF, Ucn1, CART and ENK in the Mg change their dynamics after three 
months of starvation, providing further evidence that the Mg in X. laevis produces 
these particular neuropeptides to control feeding-related processes. 
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In conclusion, the Mg is involved in the control of background adaptation, 
hydromineral regulation and stress adaptation, by the multiple action of a large 
variety of neuropeptides. Therefore, we propose that the Mg plays a central role in the 
co-ordination of these different physiological processes. In mammals the homologue 
structure of the Mg in amphibians is considered to be the paraventricular nucleus 
(Ubink et al., 1997). In this brain structure vasopressin, oxytocin, CRF, Ucn1, BDNF, 
CART and ENK have been described (Lightman, 1988; Morin et al., 1999; Chao, 2003; 
Larsen et al., 2003) and all these peptides, as shown in this thesis research for X. laevis, 
regulate different physiological processes such as food intake (Schwartz et al., 2000), 
stress adaptation (Vale et al., 1981; Skelton et al., 2000), and hydromineral homeostasis 
(for refs see Aliaga et al., 2002). However, the neuronal locations and interactions 
of these peptides, and their release sites are poorly known with the exception of 
vasopressin and oxytocin. Colocalization studies in X. laevis are necessary to unravel 
the cellular presence and interneuronal connections of the neurons producing these 
various peptides, and will be a first step in the understanding of how the integration 
of various inputs in this important brain structure is accomplished. A next step will be 
to identify the precise distribution of these peptides at the level of the neural pituitary 
lobe, their dynamics of release and the location and actions of their respective receptors 
in their target cells. 
Final considerations
Taken together, the findings presented in this thesis on the amphibian brain and 
neuroendocrine system, and especially with respect to the South African clawed toad 
Xenopus laevis lead to a novel view on the integrative capabilities of an important 
neuroendocrine brain centre, the Mg of the hypothalamus and its neurohemal organ, 
the neural lobe of the pituitary gland. Moreover, deeper insight has been obtained 
in the various modes of communication between neurons and their target cells. 
The descriptions of the distribution and possible functional significance of novel 
neuropeptides in the amphibian CNS may facilitate a better insight into the integrative 
role of these neuropeptides in the regulation of different physiological processes in 
general and of the co-ordinated control of pituitary melanotrope cells in particular.
References

References
155
Abbott NJ. Evidence for bulk flow of brain interstitial fluid: significance for physiology 
and pathology. Neurochem Int 2004; 45: 545-552.
Acharjee S, Do-Rego JL, Oh DY, Moon JS, Ahn RS, Lee K, Bai DG, Vaudry H, Kwon HB, 
Seong JY. Molecular cloning, pharmacological characterization, and histochemi-
cal distribution of frog vasotocin and mesotocin receptors. J Mol Endocrinol 2004; 
33: 293-313.
Adams LD, Gong W, Dall-Vechia SE, Hunter RG, Kuhar MJ. CART: from gene to func-
tion. Brain Res 1999; 848: 137-140.
Agnati LF, Fuxe K, Zoli M, Ozini I, Toffano G, Ferraguti F. A correlation analysis of 
the regional distribution of central enkephalin and beta-endorphin immunoreac-
tive terminals and of opiate receptors in adult and old male rats. Evidence for the 
existence of two main types of communication in the central nervous system: the 
volume transmission and the wiring transmission. Acta Physiol Scand 1986; 128: 
201-207.
Agnati LF, Zoli M, Stromberg I, Fuxe K. Intercellular communication in the brain: wir-
ing versus volume transmission. Neuroscience 1995; 69: 711-726.
Agnati LF, Fuxe K. Volume transmission as a key feature of information handling in 
the central nervous system possibly new interpretative value of the Turing’s B-
type machine. Prog Brain Res 2000; 125: 3-19.
Agnati LF, Genedani S, Lenzi PL, Leo G, Mora F, Ferre S, Fuxe K. Energy gradients for 
the homeostatic control of brain ECF composition and for VT signal migration: 
introduction of the tide hypothesis. J Neural Transm 2005; 112: 45-63.
Aliaga E, Arancibia S, Givalois L, Tapia-Arancibia L. Osmotic stress increases brain-de-
rived neurotrophic factor messenger RNA expression in the hypothalamic supra-
optic nucleus with differential regulation of its transcripts. Relation to arginine-
vasopressin content. Neuroscience 2002; 112: 841-850.
Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped 
BLAST and PSI-BLAST: a new generation of protein database search programs. 
Nucleic Acid Res 1997; 25: 3389-3402.
Amat P, Pastor FE, Blazquez JL, Pelaez B, Sanchez A, Alvarez-Morujo AJ, Toranzo D, 
Amat-Peral G. Lateral evaginations from the third ventricle into the rat medio-
basal hypothalamus: an amplification of the ventricular route. Neuroscience 1999; 
88: 673-677.
Arai M, Assil IQ, Abou-Samra AB. Characterization of three corticotropin-releasing 
factor receptors in catfish: a novel third receptor is predominantly expressed in 
pituitary and urophysis. Endocrinology 2001; 142: 446-454.
Asaba K, Makino S, Hashimoto K. Effect of urocortin on ACTH secretion from rat an-
terior pituitary in vitro and in vivo: comparison with corticotropin-releasing hor-
mone. Brain Res 1998; 806: 95-103.
Asakawa A, Inui A, Yuzuriha H, Nagata T, Kaga T, Ueno N, Fujino MA, Kasuga M. Co-
caine-amphetamine-regulated transcript influences energy metabolism, anxiety 
and gastric emptying in mice. Horm Metab Res 2001; 33: 554-558.
Baigent SM, Lowry PJ. mRNA expression profiles for corticotrophin-releasing factor 
(CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tis-
sues. J Mol Endocrinol 2000; 25: 43-52.
References
156
Baranowska B, Wolinka-Witort E, Martynska L, Chmielonwska M, Baranowska-Bik A. 
Effects of cocaine-amphetamine regulated transcript (CART) on hormone release. 
Regul Pept 2004; 15: 55-59.
Bargmann W, Knoop A. On the morphological relationships of the neurosecretory di-
encephalon system to the intermediate lobes of the hypophysis (light- and elec-
tron microscopic studies). Z Zellforsch Mikrosk Anat 1960; 52: 256-277.
Barna I, Sweep CGJ, Veldhuis HD, Wiegant VM, de Wied D. Effects of pituitary beta-
endorphin secretagogues on the concentration of beta-endorphin in rat cerebro-
spinal fluid: evidence for a role of vasopressin in the regulation of brain beta-en-
dorphin release. Neuroendocrinology 1990; 51: 104-110.
Beaudet A, Descarries L. The monoamine innervation of rat cerebral cortex: synaptic 
and nonsynaptic axon terminals. Neuroscience 1978; 3: 851-860.
Bello AR, Milan J, Anglade I, Martin A, Negrin I, Diaz C, Conlon JM, Tramu G, Kaho G. 
Comparative distribution of neurotensin-like immunoreactivity in the brain of a 
teleost (Carassius auratus), an amphibian (Hyla meridionalis), and a reptile (Gallotia 
galloti). J Comp Neurol 1994; 348: 511-530.
Berghs CAFM, Tanaka S, van Strien FJC, Kurabuchi S, Roubos EW. The secretory gran-
ule and pro-opiomelanocortin processing in Xenopus melanotrope cells during 
background adaptation. J Histochem Cytochem 1997; 45: 1673-1682. 
Bertile F, Oudart H, Criscuolo F, Maho YL, Raclot T. Hypothalamic gene expression 
in long-term fasted rats: relationship with body fat. Biochem Biophys Res Commun 
2003; 303: 1106-1113.
Bhargava S, Prasada Rao PD. Distribution of corticotropin-releasing factor immunore-
active neurons in the brain of the tiger frog, Rana tigrina. Neurosci Lett 1993; 154: 
27-30.
Bidaud I, Galas L, Bulant M, Jenks BG, Ouwens DTWM, Jégou S, Ladram A, Roubos 
EW, Tonon MC, Nicolas P, Vaudry H. Distribution of the mRNAs encoding the 
thyrotropin-releasing hormone (TRH) precursor and three TRH receptors in the 
brain and pituitary of Xenopus laevis: effect of background colour adaptation on 
TRH and TRH receptor gene expression. J Comp Neurol 2004; 477: 11-28.
Bittencourt JC, Vaughan J, Arias C, Rissman RA, Vale WW, Sawchenko PE. Urocortin 
expression in rat brain: evidence against a pervasive relationship of urocortin-
containing projections with targets bearing type 2 CRF receptors. J Comp Neurol 
1999; 415: 285-312.
Black PM. Neuropeptides in cerebrospinal fluid. Neurosurgery 1982; 11: 550-555.
Bliss CJ. Statistics in biology. McGraw-Hill, Inc., 1967, New York, Vol. 1.
Boorse GC, Denver RJ. Expression and hypophysiotropic actions of corticotropin-re-
leasing factor in Xenopus laevis. Gen Comp Endocrinol 2004; 137: 272-282.
Boorse GC, Crespi EJ, Dautzenberg FM, Denver RJ. Urocortins of the South African 
clawed frog, Xenopus laevis: conservation of structure and function in tetrapod 
evolution. Endocrinology 2005; 146: 4851-4860.
Boorse GC, Denver RJ. Widespread tissue distribution and diverse functions of cor-
ticotropin-releasing factor and related peptides. Gen Comp Endocrinol 2006; 146: 
9-18
References
157
Buma P, Roubos EW. Ultrastructural demonstration of nonsynaptic release sites in the 
central nervous system of the snail Lymnaea stagnalis, the insect Periplaneta ameri-
cana, and the rat. Neuroscience 1986; 17: 867-879.
Buma P, Nieuwenhuys R. Ultrastructural characterization of exocytotic release sites in 
different layers of the median eminence of the rat. Cell Tissue Res 1988; 252: 107-
114.
Calle M, Claassen IEWM, Veening JG, Kozicz T, Roubos EW, Barendregt HP. Opioid 
Peptides, CRF, and urocortin in cerebrospinal fluid-contacting neurons in Xenopus 
laevis. In: Trends in Comparative Endocrinology and Neurobiology (H. Vaudry, 
E.W. Roubos, L. Schoofs, G. Flik, D. Larhammar eds.), 2005a, Ann NY Acad Sci, 
1040, pp. 249-252.
Calle M, Corstens GJ, Wang L, Kozicz T, Denver RJ, Barendregt HP, Roubos EW. Evi-
dence that urocortin I acts as a neurohormone to stimulate alpha-MSH release in 
the toad Xenopus laevis. Brain Res 2005b; 1040: 14-28.
Calle M, Kozicz T, Linden E van der, Desfeux A, Veening JG, Barendregt HP, Roubos 
EW. Effect of starvation on Fos and neuropeptide immunoreactivities in the brain 
and pituitary gland of Xenopus laevis. Gen Comp Endocrinol 2006a; 147: 273-246.
Calle M, Wang LC, Kuijpers FJ, Cruijsen PMJM, Arckens L, Roubos EW. Brain-derived 
neurotrophic factor in the brain of Xenopus laevis may act as a pituitary neurohor-
mone together with mesotocin. J Neuroendocrinol 2006b; 18: 454-465.
Cannon WB. The wisdom of the body. 1932, New York, Norton, p. 24.
Carr JA. Novel effects of CRF on visuomotor behavior and autonomic function in an-
uran amphibians. Gen Comp Endocrinol 2005; 146: 28-35.
Carr JA, Brown CL, Mansouri R, Venkatesan S. Neuropeptides and amphibian prey-
catching behavior. Comp Biochem Physiol B Biochem Mol Biol 2002; 132: 151-162.
Chaillou E, Baumont R, Tramu G, Tillet Y. Effect of feeding on fos protein expression in 
sheep hypothalamus with special reference to the supraoptic and paraventricular 
nuclei: an immunohistochemical study. Eur J Neurosci 2000; 12: 4515-4524.
Chaki S, Kawashima N, Suzuki Y, Shimazaki T, Okuyama S. Cocaine- and amphet-
amine-regulated transcript peptide produces anxiety-like behavior in rodents. 
Eur J Pharmacol 2003; 464: 49-54.
Chao MV, Hempstead B. P75 and Trk: a two-receptor system. TINS 1995; 18: 321-326.
Chao MV. Neurotrophins and their receptors: a convergence point for many signalling 
pathways. Nat Rev Neurosci 2003; 4: 299-309.
Charles CJ, Rademaker MT, Richards AM, Yandle TG. Plasma urocortin 1 in sheep: 
Regional sampling and effects of experimental heart failure. Peptides 2006; Epub, 
ahead of print.
Chen AM, Perrin MH, Digruccio MR, Vaughan JM, Brar BK, Arias CM, Lewis KA, 
Rivier JE, Sawchenko PE, Vale WW. A soluble mouse brain splice variant of type 
2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates 
their activity. Proc Natl Acad Sci U S A 2005; 102: 2620-2625.
Chen R, Lewis KA, Perrin MH, Vale WW. Expression cloning of human corticotropin-
releasing-factor receptor. Proc Natl Acad Sci USA 1993; 90: 8967-8971.
References
158
Cheng ET, Utley DS, Ho PR, Tarn DM, Coan GM, Verity AN, Sierra DH, Terris DJ. 
Functional recovery of transected nerves treated with systemic BDNF and CNTF. 
Microsurgery 1998; 18: 35-41.
Chronwall BM, Sands SA, Cummings KC, Hagler KE, Norberg M, Morris SJ, Gary KA. 
Differential innervation of individual melanotropes suggests a role for nonsyn-
aptic inhibitory regulation of the developing and adult rat pituitary intermediate 
lobe. Synapse 1998; 28: 227-243.
Conner JM, Yan Q, Varon S. Distribution of brain-derived neurotrophic factor in the rat 
pituitary gland. Neuroreport 1996; 7: 1937-1940.
Conway KM, Gainer H. Immunocytochemical studies of vasotocin, mesotocin, and 
neurophysins in the Xenopus hypothalamo-neurohypophysial system. J Comp 
Neurol 1987; 264: 494-508. 
Corstens GJH, Roubos EW, Jenks BG, van Erp PEJ. Analysis of Xenopus melanotrope 
cell size and POMC gene expression. In: Trends in Comparative Endocrinology 
and Neurobiology (H. Vaudry, E.W. Roubos, L. Schoofs, G. Flik, D. Larhammar 
eds.), 2005, New York: Ann NY Acad Sci, 1040, pp. 269-272.
Corstens GJH. Cellular and molecular aspects of Xenopus melanotrope cell function-
ing. Radboud University Nijmegen, PhD thesis, 2006, pp. 60-74.
Coste SC, Quintos RF, Stenzel-Poore MP. Corticotropin-releasing hormone-related pep-
tides and receptors: emergent regulators of cardiovascular adaptations to stress. 
Trends Cardiovasc Med 2002; 12: 176-182.
Crespi EJ, Denver RJ. Ontogeny of corticotropin-releasing factor effects on locomotion 
and foraging in the Western spadefoot toad (Spea hammondii). Horm Behav 2004; 
46: 399-410.
Crespi EJ, Vaudry H, Denver RJ. Roles of corticotropin-releasing factor, neuropeptide 
Y and corticosterone in the regulation of food intake in Xenopus laevis. J Neuroen-
docrinol 2004; 16: 279-288.
Dall-Vechia SE, Lambert PD, Couceyro PC, Kuhar MJ, Smith Y. CART peptide im-
munoreactivity in the hypothalamus and pituitary in monkeys: analysis of ul-
trastructural features and synaptic connections in the paraventricular nucleus. J 
Comp Neurol 2000; 416: 291-308.
Dall-Vechia SE, Smith Y, Kuhar MJ. CART peptide-immunoreactive projection from 
the nucleus accumbens targets substantia nigra pars reticulata neurons in the rat. 
J Comp Neurol 2001; 434: 29-39.
Danger JM, Guy J, Benyamina M, Jégou S, Leboulenger F, Coté J, Tonon MC, Pelletier 
G, Vaudry H. Localization and identification of neuropeptide Y (NPY)-like im-
munorecativity in the frog brain. Peptides 1985; 6: 1225-1236.
Dautzenberg FM, Dietrich K, Palchaudhuri MR, Spiess J. Identification of two cortico-
tropin-releasing factor receptors from Xenopus laevis with high ligand selectivity: 
unusual pharmacology of the type 1 receptor. J Neurochem 1997; 69: 1640-1649.
Dautzenberg FM, Wille S, Lohmann R, Spiess J. Mapping of the ligand-selective do-
main of the Xenopus laevis corticotropin-releasing factor receptor 1: implications 
for the ligand-binding site. Proc Natl Acad Sci USA 1998; 95: 4941-4946.
References
159
Dautzenberg FM, Py-Lang G, Higelin J, Fischer C, Wright MB, Huber G. Different 
binding modes of amphibian corticotropin-releasing factor 1 and 2 receptors: evi-
dence for evolutionary differences. J Pharmacol Exp Ther 2001; 296: 113-120.
Dautzenberg FM, Higelin J, Brauns O, Butscha B, Hauger RL. Five amino acids of the 
Xenopus laevis CRF (corticotropin-releasing factor) type 2 receptor mediate dif-
ferential binding of CRF ligands in comparison with its human counterpart. Mol 
Pharmacol 2002; 61: 1132-1139.
de Fanti BA, Martinez JA. Central urocortin activation of sympathetic-regulated en-
ergy metabolism in Wistar rats. Brain Res 2002; 930: 37-41.
de Rijk EPCT, Jenks BG, Wendelaar Bonga SE. Morphology of the pars intermedia and 
the melanophore-stimulating cells in Xenopus laevis in relation to background ad-
aptation. Gen Comp Endocrinol 1990; 79: 74-82.
de Rijk EPCT, van Strien FJC, Roubos EW. [125I]Bolton-Hunter neuropeptide-Y-binding 
sites on folliculo-stellate cells of the pars intermedia of Xenopus laevis: a combined 
autoradiographic and immunocytochemical study. Endocrinology 1991; 128: 735-
740.
de Rijk EPCT, van Strien FJC, Roubos EW. Demonstration of coexisting catecholamine 
(dopamine), amino acid (GABA), and peptide (NPY) involved in inhibition of 
melanotrope cell activity in Xenopus laevis: a quantitative ultrastructural, freeze-
substitution immunocytochemical study. J Neurosci 1992; 12: 864-871.
de Souza EB. Corticotropin-releasing factor receptors: physiology, pharmacology, bio-
chemistry and role in central nervous system and immune disorders. Psychoneu-
roendocrinology 1995; 20: 789-819.
Dierickx K, Vandesande F. Immuno-cytochemical demonstration in the external region 
of the amphibian median eminence, of separate vasotocinergic and mesotociner-
gic nerve fibres. Cell Tiss Res 1977; 177: 47-56.
Donaldson CJ, Sutton SW, Corrigan MH, Lewis KA, Rivier JE, Vaughan JM, Vale WW. 
Cloning and characterization of human urocortin. Endocrinology 1996; 137: 2167-
2170.
Dotman CH, Maia A, Jenks BG, Roubos EW. Sauvagine and TRH differentially stimu-
late proopiomelanocortin biosynthesis in the Xenopus laevis intermediate pituitary. 
Neuroendocrinology 1997; 66: 106-113.
Douglass J, McKinzie AA, Couceyro P. PCR differential display identifies a rat brain 
mRNA that is transcriptionally regulated by cocaine and amphetamine. J Neurosci 
1995; 15: 2471-2481.
Dun SL, Chianca DA Jr, Dun NJ, Yang J, Chang JK. Differential expression of cocaine- 
and amphetamine-regulated transcript-immunoreactivity in the rat spinal pre-
ganglionic nuclei. Neurosci Lett 2000; 294: 143-146.
Ebbesson SOE. Morphology of the spinal cord. In: Frog Neurobiology (R. Llínás, W. 
Precht eds.), 1976, Berlin-Heidelberg-New York, Springer-Verlag, pp. 679-706.
Elias CF, Lee CE, Kelly JF, Ahima RS, Aschkenasi C, Couceyro PR, Kuhar M, Saper 
CB, Elmquist JK. Leptin activates hypothalamic CART neurons projecting to the 
spinal cord. Neuron 1998; 21: 1376-1385.
References
160
Elias CF, Lee CE, Kelly JF, Ahima RS, Kuhar M, Saper CB, Elmquist JK. Characterisa-
tion of CART neurons in the rat and human hypothalamus. J Comp Neurol 2001; 
432: 1-19.
Elmquist JK, Elias CF, Saper CB. From lesions to leptin: hypothalamic control of food 
intake and body weight. Neuron 1999; 22: 221-232.
Ewert JP, Buxbaum-Conradi H, Dreisvogt F, Glagow M, Merkel-Harff C, Rottgen A, 
Schurg-Pfeiffer E, Schwippert WW. Neural modulation of visuomotor functions 
underlying prey-catching behavior in anurans: perception, attention, motor per-
formance, learning. Comp Biochem Physiol A Mol Integr Physiol 2001; 128: 417-461.
Fasolo A, Andreone C, Vandesande F. Immunohistochemical localization of cortico-
tropin-releasing factor (CRF)-like immunoreactivity in the hypothalamus of the 
newt, Triturus cristatus. Neurosci Lett 1984; 49: 135-142.
Fuxe K, Rivera A, Jacobsen KX, Hoistad M, Leo G, Horvath TL, Staines W, de la Calle 
A, Agnati LF. Dynamics of volume transmission in the brain. Focus on catechol-
amine and opioid peptide communication and the role of uncoupling protein 2. J 
Neural Transm 2005; 112: 65-76.
Galas L, Lamacz M, Garnier M, Roubos EW, Tonon MC, Vaudry H. Involvement of 
extracellular and intracellular calcium sources in TRH-induced alpha-MSH secre-
tion from frog melanotrope cells. Mol Cell Endocrinol 1998; 138: 25-39.
Galas L, Lamacz M, Garnier M, Roubos EW, Tonon MC, Vaudry H. Involvement of 
protein kinase C and protein tyrosine kinase in thyrotropin-releasing hormone-
induced stimulation of alpha-melanocyte-stimulating hormone secretion in frog 
melanotrope cells. Endocrinology 1999; 140: 3264-3272. 
Galas L, Vaudry H, Braun B, Van den Pol N, de Lecca L, Sutcliffe JG, Chartrel N. Immu-
nohistochemical localization of hypocretin/orexin-related peptides in the central 
nervous system of the frog Rana ridibunda. J Comp Neurol 2001; 429: 242-252.
Givalois L, Arancibia S, Alonso G, Tapia-Arancibia L. Expression of BDNF and its re-
ceptors in the median eminence cells with sensitivity to stress. Endocrinology 2004; 
145: 4737-4747.
Glass MJ, Billington CJ, Levine AS. Opioids and food intake: distributed functional 
neural pathways? Neuropeptides 1999; 33: 360-368.
González GC, Lederis K. Sauvagine-like and corticotropin-releasing factor-like immu-
noreactivity in the brain of the bullfrog (Rana catesbeiana). Cell Tissue Res 1988; 253: 
29-37.
González A, Smeets WJAJ. Distribution of vasotocin- and mesotocin-like immunoreac-
tivities in the brain of the South African clawed frog Xenopus laevis. J Chem Neuro-
anat 1992; 5: 465-479.
González A, Muñoz A, Muñoz M, Marín O, Smeets WJAJ. Ontogeny of vasotocinergic 
and mesotocinergic systems in the brain of the South African clawed frog Xenopus 
laevis. J Chem Neuroanat 1995; 9: 27-40.
 Gosnell BA, Lipton JM. Opioid peptide effects on feeding in rabbits Peptides 1986; 
7: 745-747.
Hamel E, Beaudet A. Electron microscopic autoradiographic localization of opioid re-
ceptors in rat neostriatum. Nature 1984; 312: 155-157.
References
161
Hara Y, Ueta Y, Isse T, Kabashima N, Shibuya I, Hattori Y, Yamashita H. Increase of 
urocortin-like immunoreactivity in the rat supraoptic nucleus after dehydratation 
but not food deprivation. Neurosci Lett 1997; 229: 65-68.
Heinrichs SC, Richard D. The role of corticotropin-releasing factor and urocortin in the 
modulation of ingestive behavior. Neuropeptides 1999; 33: 350-359.
Henry BA, Rao A, Ikenasio BA, Mountjoy KG, Tilbrook AJ, Clarke IJ. Differential ex-
pression of cocaine- and amphetamine-regulated transcript and agouti related-
protein in chronically food-restricted sheep. Brain Res 2001; 918: 40-50.
Herckenham M. Mismatches between neurotransmitters and receptor localization: im-
plications for endocrine functions in brain. In: Volume transmission in the brain: 
novel mechanisms for neural transmission. (H. Fuxe, L.F. Agnati, eds.), 1991, Ra-
ven Press, Ltd., New York, pp. 63-87.
Hervant F, Mathieu J, Durand J. Behavioral, physiological and metabolic responses to 
long-term starvation and refeeding in a blind cave-dwelling (Proteus anguinus) 
and a surface-dwelling (Euproctus asper) salamander. J Exp Biol 2001; 204: 269-
281.
Hervant F, Renault D. Long-term fasting and realimentation in hypogean and epi-
gean isopods: a proposed adaptive strategy for groundwater organisms. J Exp Biol 
2002; 205: 2079-2087.
Hillebrand JJC, de Wied D, Adan RAH. Neuropeptides, food intake and body weight 
regulation: a hypothalamic focus. Peptides 2002; 23: 2283-2306.
Hoistad M, Samskog J, Jacobsen KX, Olsson A, Hansson HA, Brodin E, Fuxe K. Detec-
tion of beta-endorphin in the cerebrospinal fluid after intrastriatal microinjection 
into the rat brain. Brain Res 2005; 1041: 167-180.
Hopker VH, Amoureux MC, Varon S. NGF and BDNF in the anterior pituitary lobe of 
adult rats. J Neurosci Res 1997; 49: 355-363.
Horvath TL, Warden CH, Hajos M, Lombardi A, Goglia F, Diano S. Brain uncoupling 
protein 2: uncoupled neuronal mitochondria predict thermal synapses in homeo-
static centers. J Neurosci 1999; 19: 10417-10427.
Huang Y, Yao XQ, Lau CW, Chan YC, Tsang SY, Chan FL. Urocortin and cardiovascu-
lar protection. Acta Pharmacol Sin 2004; 25: 257-265.
Hurd Y-L, Fagergren P. Human cocaine- and amphetamine regulated transcript (CART) 
mRNA is highly expressed in limbic- and sensory-related brain regions. J Comp 
Neurol 2000; 425: 583-598.
Irmgard F, Ziegler H. Paradigmenbruch. Eine neue Wissenschaftsdisziplin entsteht: 
die Neuroendokrinologie. Das Ehepaar Scharrer entdeckt die sezernierenden ner-
venzellen. Biospektrum 2004; 5: 639-642.
Iversen S, Iversen L, Saper C. The autonomic nervous system and the hypothalamus. 
In: Principles of neural science (E.R. Kandel, J.H. Schwartz and T.M. Jessel eds.), 
2000, McGraw-Hill, New York, pp. 960-981.
Jansson A, Descarries L, Cornea-Herbert V, Riad M, Verge D, Bancila M, Agnati LF, 
Fuxe K. Transmitter-receptor mismatches in central dopamine, serotonin, and 
neuropeptide systems. Further evidence for volume transmission. In: The neural 
environment: brain homeostasis in health and disease (W. Walz ed.), 2002, Hu-
mana Press, Totowa, NJ, pp. 83-101.
References
162
James VH, Few JD. Adrenocorticosteroids: chemistry, synthesis and disturbances in 
disease. Clin Endocrinol Metab 1985; 14: 867-892.
Jenks BG, de Koning HP, Cruijsen PMJM, Mauger CM, Roubos EW, Tonon MC, Des-
rues L, Vaudry H. Analysis of inositol phosphate metabolism in melanotrope cells 
of Xenopus laevis in relation to background adaptation. Ann N Y Acad Sci 1993a; 
680: 188-198.
Jenks BG, Leenders HJ, Martens GJM, Roubos EW. Adaptation physiology: the func-
tioning of pituitary melanotrope cells during background adaptation of the am-
phibian Xenopus laevis. Zool Sci 1993b; 10: 1-11.
Jenks BG, Ouwens DTWM, Coolen MW, Roubos EW, Martens GJM. Demonstration 
of postsynaptic receptor plasticity in an amphibian neuroendocrine interface. J 
Neuroendocrinol 2002; 14: 843-845.
Jenks BG, Roubos EW, Scheenen WJJM. Ca2+ oscillations in melanotropes of Xenopus 
laevis: their generation, propagation and function. Gen Comp Endocrinol 2003; 131: 
210-219.
Johansen JE, Broberger C, Lavebratt C, Johansson C, Kuhar MJ, Hökfelt T, Schalling M. 
Hypothalamic CART and serum leptin levels are reduced in the anorectic (anx/
anx) mouse. Brain Res Mol 2000; 84: 97-105.
Johanson CE, Duncan JA, Stopa EG, Baird A. Enhanced prospects for drug delivery 
and brain targeting by the chorioid plexus-CSF route. Pharm Res 2005; 22: 1011-
1037.
Johnson AK, Gross PM. Sensory circumventricular organs and brain homeostatic path-
ways. FASEB J 1993; 7: 678-686.
Jones DNC, Kortekaas R, Slade PD, Middlemiss DN, Hagan JJ. The behavioral effects 
of corticotropin-releasing factor-related peptides in rats. Psychopharmacology 1998; 
138: 124-132.
Kalin NH, Shelton SE, Davidson RJ. Cerebrospinal fluid corticotropin-releasing hor-
mone levels are elevated in monkeys with patterns of brain activity associated 
with fearful temperament. Biol Psychiatry 2000; 47: 579-585.
Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum 
brain-derived neurotrophic factor levels in major depressed patients. Psychiatry 
Res 2002; 109: 143-148.
Kastin AJ, Akerstrom V. Differential interactions of urocortin/corticotropin-releasing 
hormone peptides with the blood-brain barrier. Neuroendocrinology 2002; 75: 367-
374.
Kastin AJ, Pan W, Akerstrom V, Hackler L, Wang C, Kotz CM. Novel peptide-peptide 
cooperation may transform feeding behavior. Peptides 2002; 23: 2189-2196.
Kicliter E. Some telencephalic connections in the frog, Rana pipiens. J Comp Neurol 1979; 
185: 75-86.
Kidane A, Van Dooren S, Kuipers-Kwant FJ, Roubos EW, Jenks BG. Analysis of pre- 
and post-synaptic signalling in a neuroendocrine interface of Xenopus laevis. Ab-
stracts 4th Dutch Endo-Neuro-Psycho meeting, Doorwerth, 2005, p. 75.
References
163
Kimmel HL, Gong W, Vechia SD, Hunter RG, Kuhar MJ. Intra-ventral tegmental area 
injection of rat cocaine- and amphetamine-regulated transcript peptide 55-102 in-
duces locomotor activity and promotes conditioned place preference. J Pharmacol 
Exp Ther 2000; 294: 784-792.
Kokaia Z, Bengzon J, Metsis M, Kokaia M, Persson H, Lindvall O. Coexpression of 
neurotrophins and their receptors in neurons of the central nervous system. Proc 
Natl Acad Sci USA 1993; 90: 6711-6715.
Kolk SM, Kramer BMR, Cornelisse LN, Scheenen WJJM, Jenks BG, Roubos EW. Multi-
ple control and dynamic response of the Xenopus melanotrope cell. Comp Biochem 
Physiol B Biochem Mol Biol 2002; 132: 257-268.
Kononen J, Sonia S, Persson H, Honkaniemi J, Hökfelt T, Pelto-Huikko M. Neurotroph-
ins and their receptors in the rat pituitary gland: regulation of BDNF and trkB 
mRNA levels by adrenal hormones. Brain Res Mol Brain Res 1994; 27: 347-354. 
Kórösi A, Schotanus S, Olivier B, Roubos EW, Kozicz T. Chronic ether stress-induced 
response of urocortin 1 neurons in the Edinger-Westphal nucleus in the mouse. 
Brain Res 2005; 1046: 172-179.
Kórösi A, Veening JG, Kozicz T, Henkens M, Dederen J, Groenink L, Gugten J van 
der, Olivier B, Roubos EW. Distribution and expression of CRF receptor 1 and 2 
mRNAs in the CRF over-expressing mouse brain. Brain Res 2006; 1072: 46-54.
Koylu EO, Couceyro PR, Lambert PD, Ling ND, de Souza EB, Kuhar MJ. Immunohis-
tochemical localization of novel CART peptides in rat hypothalamus, pituitary 
and adrenal gland. J Neuroendocrinol 1997; 9: 823-833.
Koylu EO, Couceyro PR, Lambert PD, Kuhar MJ. Cocaine- and amphetamine-regu-
lated transcript peptide localization in the rat brain. J Comp Neurol 1998; 391: 115-
132.
Kozicz T, Yanaihara H, Arimura A. Distribution of urocortin-like immunoreactivity in 
the central nervous system of the rat. J Comp Neurol 1998; 391: 1-10.
Kozicz T, Arimura A, Maderdrut JL, Lázár G. Distribution of urocortin-like immuno-
reactivity in the central nervous system of the frog Rana esculenta. J Comp Neurol 
2002; 453: 185-198.
Kozicz T. Neurons colocalizing urocortin and cocaine and amphetamine-regulated 
transcript immunoreactivities are induced by acute lipopolysaccharide stress in 
the Edinger-Westphal nucleus in the rat. Neuroscience 2003; 116: 315-320.
Kozicz T, Kórösi A, Korsman C, Tilburg-Ouwens DTWM, Groenink L, Veening JG, 
Gugten J van der, Roubos EW, Olivier B. Urocortin expression in the Edinger-
Westphal nucleus is down-regulated in transgenic mice over-expressing neuronal 
corticotropin-releasing factor. Neuroscience 2004; 123: 589-594.
Krahn DD, Gosnell BA, Levine AS, Morley JE. Behavioral effects of corticotropin-re-
leasing factor: localization and characterization of central effects. Brain Res 1988; 
443: 63-69.
Kramer BMR, Welting J, Berghs CAFM, Jenks BG, Roubos EW. Functional organiza-
tion of the suprachiasmatic nucleus of Xenopus laevis in relation to background 
adaptation. J Comp Neurol 2001; 432: 346-355.
References
164
Kramer BMR, Cruijsen PMJM, Ouwens DTWM, Coolen MW, Martens GJM, Roubos 
EW, Jenks BG. Evidence that brain-derived neurotrophic factor acts as an auto-
crine factor on pituitary melanotrope cells of Xenopus laevis. Endocrinology 2002; 
143: 1337-1345.
Kramer BMR, Claassen IEWM, Westphal NJ, Jansen M, Tuinhof R, Jenks BG, Rou-
bos EW. Alpha-melanophore-stimulating hormone in the brain, cranial placode 
derivatives, and retina of Xenopus laevis during development in relation to back-
ground adaptation. J Comp Neurol 2003; 456: 73-83.
Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jen-
sen PB, Madsen OD, Vrang N, Larsen PJ, Hastrup S. Hypothalamic CART is a 
new anorectic peptide regulated by leptin. Nature 1998; 393: 72-76.
Kuhar MJ, Dall-Vechia SE. CART peptides: novel addiction- and feeding-related neu-
ropeptides. Trends Neurosci 1999; 22: 316-320.
Kuhar MJ, Yoho LL. CART peptide analysis by Western blotting. Synapse 1999; 33: 163-
171.
Kuhar MJ, Adams LD, Hunter RG, Dall-Vechia SE, Smith Y. CART peptides. Reg Pept 
2000; 89: 1-6.
Kuhar MJ, Adams S, Dominguez G, Jaworski J, Balkan B. CART peptides. Neuropep-
tides 2002; 36: 1-6.
Kuriyama G, Takekoshi S, Tojo K, Nakai Y, Kuhar MJ, Osamura RY. Cocaine-and am-
phetamine-regulated transcript peptide in the rat anterior pituitary gland is local-
ized in gonadotrophs and suppresses prolactin secretion. Endocrinology 2004; 145: 
2542-2550.
Lamacz M, Hindelang C, Tonon MC, Vaudry H, Stoeckel ME. Three distinct thyro-
tropin-releasing hormone-immunoreactive axonal systems project in the median 
eminence-pituitary complex of the frog Rana ridibunda. Immunocytochemical evi-
dence for co-localization of thyrotropin-releasing hormone and mesotocin in fi-
bers innervating pars intermedia cells. Neuroscience 1989; 32: 451-462.
Lambert PD, Couceyro PR, McGirr KM, Dall-Vechia SE, Smith Y, Kuhar MJ. CART 
peptides in the central control of feeding and interactions with neuropeptide Y. 
Synapse 1998; 29: 293-298.
Larsen PJ, Seier V, Fink-Jensen A, Holst JJ, Warberg J, Vrang N. Cocaine- and amphet-
amine-regulated transcript is present in hypothalamic neuroendocrine neurons 
and is released to the hypothalamic-pituitary portal circuit. J Neuroendocrinol 2003; 
15: 219-226.
Lázár G, Tóth P, Csank Gy, Kicliter E. Morphology and location of tectal projection 
neurons in frogs: a study with HRP and cobalt filling. J Comp Neurol 1983; 215: 
108-120.
Lázár G, Maderdrut JL, Merchenthaler I. Some enkephalinergic pathways in the brain 
of Rana esculenta: an experimental analysis. Brain Res 1990; 521: 238-246.
Lázár G, Liposits Z, Tóth P, Trasti SL, Maderdrut JL, Merchenthaler I. Distribution of 
galanin-like immunoreactivity in the brain of Rana esculenta and Xenopus laevis. J 
Comp Neurol 1991; 310: 45-67.
References
165
Lázár G, Maderdrut JL, Trasti SL, Liposits Z, Tóth P, Kozicz T, Merchenthaler I. Distri-
bution of pro-neuropeptide Y-derived peptides in the brain of Rana esculenta and 
Xenopus laevis. J Comp Neurol 1993; 327: 551-571.
Lázár G. Peptides in frog brain areas processing visual information. Microsc Res Techn 
2001; 54: 201-219.
Lázár G, Maderdrut JL, Merchenthaler I. Distribution of melanin-concentrating hor-
mone-like immunorecativity in the central nervous system of Rana esculenta. Brain 
Res Bull 2002; 57: 401-407.
Lázár G, Calle M, Roubos EW, Kozicz T. Immunohistochemical localization of cocaine- 
and amphetamine-regulated transcript peptide in the central nervous system of 
the frog Rana esculenta. J Comp Neurol 2004; 477: 324-339.
Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, 
Gulyas J, Fisher W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW. Identification 
of urocortin III, an additional member of the corticotropin-releasing factor (CRF) 
family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 2001; 98: 
7570-7575.
Lightman SL. The neuroendocrine paraventricular hypothalamus: receptors, signal 
transduction, mRNA and neurosecretion. J Exp Biol 1988; 139: 31-49.
MacMillan SJA, Mark MA, Duggan AW. The release of beta-endorphin and the neuro-
peptide-receptor mismatch in the brain. Brain Res 1998; 794: 127-136.
Malagon MM, Ruiz-Navarro A, Torronteras R, Gracia-Navarro F. Effects of ovine CRF 
on amphibian pituitary ACTH and TSH cells in vivo: a quantitative ultrastructural 
study. Gen Comp Endocrinol 1991; 83: 487-497.
Marín O, Smeets WJAJ, González A. Do amphibians have a true locus coeruleus?. Neu-
roReport 1996; 7: 1447-1451.
Marín O, González A, Smeets WJAJ. Basal ganglia organization in amphibians: effer-
ent connections of the striatum and the nucleus accumbens. J Comp Neurol 1997; 
380: 23-50.
Marín O, Smeets WJAJ, González A. Basal ganglia organization in amphibians: Che-
moarchitecture. J Comp Neurol 1998; 392: 285-312.
Martens GJ, Herbert E. Polymorphism and absence of Leu-enkephalin sequences in 
proenkephalin genes in Xenopus laevis. Nature 1984; 310: 251-254.
McAllister AK, Katz LC, Lo DC. Neurotrophins and synaptic plasticity. Annu Rev Neu-
rosci 1999; 22: 295-318.
Merchenthaler I, Maderdrut JL, Lázár G, Gulyas J, Petrusz P. Immunocytochemical 
analysis of proenkephalin-derived peptides in the amphibian hypothalamus and 
optic tectum. Brain Res 1987; 416: 219-227.
Merkle S, Hanke W. Long-term starvation in Xenopus laevis Daudin II. Effects on sev-
eral organs. Comp Biochem Physiol 1988; 90: 491-495.
Milán JF, Puelles L. Patterns of calretinin, calbindin, and tyrosine-hydroxylase expres-
sion are consistent with the prosomeric map of the frog diencephalon. J Comp 
Neurol 2000; 419: 96-121.
Miranda LA, Affanni JM. Thyrotropin-releasing hormone immunoreactivity in the 
brain and pituitary during Bufo arenarum development. Int J Dev Neurosci 2000; 
18: 47-52.
References
166
Momose K, Inui A, Asakawa A, Ueno N, Nakajima M, Fujimiya M, Kasuga M. Intra-
cerebroventricularly administered corticotropin-releasing factor inhibits food in-
take and produces anxiety-like behavior at very low doses in mice. Diabetes Obes 
Metab 1999; 1: 281-284.
Montgomery NM, Fite KV. Organization of ascending projections from the optic tec-
tum and mesencephalic pretectal gray in Rana pipiens. Visual Neurosci 1991; 7: 459-
478.
Morin SM, Ling N, Liu XJ, Kahl SD, Gehlert DR. Differential distribution of urocortin- 
and corticotropin-releasing factor-like immunoreactivities in the rat brain. Neuro-
science 1999; 92: 281-291.
Morin LP, Shivers KY, Blanchard JH, Muscat L. Complex organization of mouse and 
rat suprachiasmatic nucleus. Neuroscience 2006; 137: 1285-97.
Mosconi G, Carnevali O, Facchinetti F, Neri I, Polzonetti-Magni A. Opioid peptide 
modulation of stress-induced plasma steroid changes in the frog Rana esculenta. 
Horm Behav 1994; 28: 130-138.
Muñoz A, Muñoz M, González A, ten Donkelaar HJ. Spinal ascending pathways in 
amphibians: cells of origin and main targets. J Comp Neurol 1997; 378: 205-228.
Neary JT, Wilczynski W. Autoradiographic demonstration of hypothalamic efferents 
in the bullfrog, Rana catesbeiana. Anat Rec 1977; 187: 665-669.
Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K, Kilts CD, Loos-
en PT, Vale W. Elevated concentrations of CSF corticotropin-releasing factor-like 
immunoreactivity in depressed patients. Science 1984; 226: 1342-1344.
Nicholson C, Tao L. Hindered diffusion of high molecular weight compounds in brain 
extracellular microenvironment measured with integrative optical imaging. Bio-
phys J 1993; 65: 2277-2290. 
Nieuwenhuys R, Opdam P. Structure of the brainstem. In: Frog Neurobiology (R. 
Llinás, W. Precht eds.), 1976, Berlin-Heidelberg- New York, Springer-Verlag, pp. 
811-855.
Nieuwenhuys R. Chemoarchitecture of the brain. Springer, Berlin, 1985.
Noga O, Englmann C, Hanf G, Grutzkau A, Seybold J, Kunkel G. The production, 
storage and release of the neurotrophins nerve growth factor, brain-derived neu-
rotrophic factor and neurotrophin-3 by human peripheral eosinophils in allergics 
and non-allergics. Clin Exp Allergy 2003; 33: 649-564.
Ohata H, Suzuki K, Oki Y, Shibasaki T. Urocortin in the ventromedial hypothalamic 
nucleus acts as an inhibitor of feeding behavior in rats. Brain Res 2000; 861: 1-7.
Olivereau M, Vandesande F, Boucique E, Ollevier F, Olivereau JM, Immunocytochemi-
cal localization and spatial relation to the adenohypophysis of a somatostatin-like 
and a corticotropin-releasing factor-like peptide in the brain of four amphibian 
species. Cell Tissue Res 1987; 247: 317-324.
Olivereau M, Olivereau JM. Immunocytochemical localization of a galanin-like pep-
tidergic system in the brain of two urodele and two anuran species (Amphibia). 
Histochemistry 1992; 98: 561-566.
Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brain-derived neuro-
trophic factor across the blood-brain barrier. Neuropharmacology 1998; 37: 1553-
1561.
References
167
Pan W, Akerstrom V, Zhang J, Pejovic V, Kastin AJ. Modulation of feeding-related pep-
tide/protein signals by the blood-brain barrier. J Neurochem 2004; 90: 455-461.
Pang PK, Sawyer WH. Renal and vascular responses of the bullfrog (Rana catesbeiana) 
to mesotocin. Am J Physiol 1978; 235: 151-155.
Paredes A, Romero C, Dissen GA, DeChiara TM, Reichardt L, Cornea A, Ojeda SR, 
Xu B. TrkB receptors are required for follicular growth and oocyte survival in the 
mammalian ovary. Dev Biol 2004; 267: 430-449.
Parkes DG, Weisinger RS, May CN. Cardiovascular actions of CRH and urocortin: an 
update. Peptides 2001; 22: 821-827.
Pasquier DA, Cannata MA, Tramezzani JH. Central connections of the toad neural lobe 
as shown by retrograde neuronal labeling: classical and new connections. Brain 
Res 1980; 195: 37-45. 
Perrin MH, Vale WW. Corticotropin releasing factor receptors and their ligand family. 
Ann N Y Acad Sci 1999; 885: 312-328.
Pierce TL, Wessendorf MW. Immunocytochemical mapping of endomorphin-2-immu-
noreactivity in rat brain. J Chem Neuroanat 2000; 18:181-207.
Potter HD. Structural characteristics of cell and fiber population in the optic tectum of 
the frog (Rana catesbiana). J Comp Neurol 1969; 136: 203-232.
Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K, Sawchenko PE, Vale WW. 
Distribution of corticotropin-releasing factor receptor mRNA expression in the 
rat brain and pituitary. Proc Natl Acad Sci USA 1994; 91: 8777-8781.
Post RM, Gold P, Rubinow DR, Ballenger JC, Bunney WE, Jr., Goodwin FK. Peptides in 
the cerebrospinal fluid of neuropsychiatric patients: an approach to central ner-
vous system peptide function. Life Sci 1982; 31: 1-15.
Radka SF, Holst PA, Fritsche M, Altar CA. Presence of brain-derived neurotrophic fac-
tor in brain and human and rat but not mouse serum detected by a sensitive and 
specific immunoassay. Brain Res 1996; 709: 122-301.
Rennels ML, Blaumanis OR, Grady PA. Rapid solute transport throughout the brain 
via paravascular fluid pathways. Adv Neurol 1990; 52: 431-439.
Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesh JB, Gu-
lyas J, Rivier J, Vale WW, Sawchenko PE. Urocortin II: a member of the corticotro-
pin-releasing-factor (CRF) neuropeptide family that is selectively bound by type 
2 CRF receptors. Proc Natl Acad Sci USA 2001; 98: 2843-2848.
Risold PY, Fellmann D, Rivier J, Vale WW, Bugnon C. Immunoreactivities for antisera 
to three putative neuropeptides of the rat melanin-concentrating hormone pre-
cursor are coexpressed in neurons of the rat lateral dorsal hypothalamus. Neurosci 
Lett 1992; 136: 145-149.
Rivera A, Agnati LF, Horvath TL, Valderrama JJ, De la Calle A, Fuxe K. Uncoupling 
protein 2/3 immunoreactivity and the ascending dopaminergic and noradrener-
gic neuronal systems: relevance for volume transmission. Neuroscience 2006; 137: 
1447-1461.
Rodriguez EM. Design and perspectives of peptide secreting neurons. In: Hormones 
and behavior peptides (C.B. Nemeroff, A.J. Dunn eds.), 1984, Spectrum publica-
tions, New York, pp. 1-6.
References
168
Rothman RB, N Vu, H Xu, Baumann MH, Lu YF. Endogenous corticotropin releasing 
factor regulates adrenergic and opioid receptors. Peptides 2002; 23: 2177-2180.
Roubos EW, van der Wal-Divendal RM. Ultrastructural analysis of peptide-hormone 
release by exocytosis. Cell Tissue Res 1980; 207: 267-275.
Roubos EW. Background adaptation by Xenopus laevis: a model for studying neuronal 
information processing in the pituitary pars intermedia. Comp Biochem Physiol A 
Physiol 1997; 118: 533-550.
Roubos EW, Scheenen WJJM, Jenks BG. Neuroendocrinology – from concepts and com-
plexity to integration- the Xenopus pars intermedia. In: Perspective in Compara-
tive Endocrinology: Unity and Diversity (H.J.T. Goos, R.K. Rastogi, H. Vaudry, R. 
Pierantoni eds.), 2001 , Monduzzi Editore, Bologna, pp. 465-472.
Roubos EW, Scheenen WJJM, Cruijsen PMJM, Cornelisse LN, Leenders HJ, Jenks BG. 
New aspects of signal transduction in the Xenopus laevis melanotrope cell. Gen 
Comp Endocrinol 2002; 126: 255-260.
Roubos EW, Scheenen WJJM, Jenks BG. Neuronal, neurohormonal, and autocrine con-
trol of Xenopus melanotrope cell activity. In: Trends in Comparative Endocrinol-
ogy and Neurobiology (H. Vaudry, E.W. Roubos, L. Schoofs, G. Flik, D. Larham-
mar eds.), 2005, Ann NY Acad Sci, 1040, 172-183.  
Sánchez-Camacho C, Pena JJ, González, A. Catecholaminergic innervation of the sep-
tum in the frog: a combined immunohistochemical and tract-tracing study. J Comp 
Neurol 2003; 455: 310-323.
Sapolsky RM. Stress and the autonomic nervous system. In: Why zebras don’t get 
ulcers. The acclaimed guide to stress, stress-related diseases, and coping (W.H. 
Freeman ed.), 1994, Henry Holt and Company, LLC, New York, pp. 19-36.
Scalia F, Gallousis G, Roca S. Differential projections of the main and the accessory 
olfactory bulb in the frog. J Comp Neurol 1991; 305: 443-461.
Scharrer E. Die Lichtempfindlichkeit blinder Elritzen (Untersuchungen über das 
Zwischenhirn der Fische). Z Vgl Physiol 1928; 7: 1-38.
Scheenen WJJM, Yntema HG, Willems PH, Roubos EW, Lieste JR, Jenks BG. Neuro-
peptide Y inhibits Ca2+ oscillations, cyclic AMP, and secretion in melanotrope cells 
of Xenopus laevis via a Y1 receptor. Peptides 1995; 16: 889-895.
Schmidt ED, Roubos EW. Morphology and dynamics of nonsynaptic release sites of 
the Caudo-Dorsal Cells of Lymnaea stagnalis. In: Neurobiology: Molluscan Mod-
els. Mon Roy Neth Acad Arts Sci (H.H. Boer, W.P.M. Geraerts and J. Joosse, eds.), 
1987, North-Holland Publishing Company, Amsterdam, Oxford, New York, pp. 
89-94.
Schmitt FO. Molecular regulators of brain function: a new view. Neuroscience 1984; 13: 
991-1001.
Schwartz MW, Woods SC, Porte D, Seeley RJ, Baskin DG. Central nervous system con-
trol of food intake. Nature 2000; 404: 661-671.
Schwartz WJ, Reppert SM. Neural regulation of the circadian vasopressin rhythm in 
cerebrospinal fluid: a pre-eminent role for the suprachiasmatic nuclei. J Neurosci 
1985; 5: 2771-2778.
Secor SM. Physiological responses to feeding, fasting and estivation for anurans. J Exp 
Biol 2005; 208: 2595-2608.
References
169
Shapiro HH, Wilk MB. An analysis of variance test for normality. Biometrika 1965; 52: 
591-611.
Shi SR, Chaiwun B, Young L, Cote RJ, Taylor CR. Antigen retrieval technique utilizing 
citrate buffer or urea solution for immunohistochemical demonstration of andro-
gen receptor in formalin-fixed paraffin sections. J Histochem Cytochem 1993; 41: 
1599-1604. 
Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato 
M, Watanabe H, Shinoda N, Okada S, Iyo M. Alterations of serum levels of brain-
derived neurotrophic factor (BDNF) in depressed patients with or without anti-
depressants. Biol Psychiatry 2003; 54: 70-75.
Shioda S, Nakai Y, Iwai C, Sunayama H. Co-existence of TRH with mesotocin in the 
same axon terminals of the bullfrog pars nervosa as revealed by double labeling 
immunocytochemistry. Neurosci Lett 1989; 98: 25-28.
Siegel GJ. Neuropeptide functions and regulations. In: Basic Neurochemistry: Molecu-
lar, Cellular and Medical Aspects (G.J. Siegel, B.W. Agranoff, R.W. Albers, S.K. 
Fisher, M.D. Uhler, eds.), 1999, 6th edition, II, Lippincott Williams & Wilkins. 
Skelton KH, Owens MJ, Nemeroff CB. The neurobiology of urocortin. Regul Pept 2000; 
93: 85-92.
Smith MA, Makino S, Kim SY, Kvetnansky R. Stress increases brain-derived neuro-
tropic factor messenger ribonucleic acid in the hypothalamus and pituitary. Endo-
crinology 1995; 136: 3743-3750.
Smith Y, Kieval J, Couceyro PR, Kuhar MJ. CART peptide-immunoreactive neurons in 
the nucleus accumbens in monkeys: ultrastructural analysis, colocalization stud-
ies, and synaptic interactions with dopaminergic afferents. J Comp Neurol 1999; 
407: 491-511.
Somogyvari-Vigh A, Kastin AJ, Liao J, Zadina JE, Pan W. Endomorphins exit the brain 
by a saturable efflux system at the basolateral surface of cerebral endothelial cells. 
Exp Brain Res 2004; 156: 224-230.
Spiess J, Villareal J, Vale WW. Isolation and sequence analysis of a somatostatin-like 
polypeptide from ovine hypothalamus. Biochemistry 1981; 20: 1982-1988.
Spina M, Merlo-Pich E, Chan RK, Basso AM, Rivier J, Vale WW, Koob GF. Appetite-
suppressing effects of urocortin, a CRF-related neuropeptide. Science 1996; 273: 
1561-1564.
Stanley BG, Leibowitz SF. Neuropeptide Y injected in the paraventricular hypothala-
mus: a powerful stimulant of feeding behavior. Proc Natl Acad Sci USA 1985; 82: 
3940-3943.
Stanley SA, Small CJ, Murphy KG, Rayes E, Abbot CR, Seal LJ, Morgan DG, Sunter 
D, Dakin CL, Kim MS, Hunter R, Kuhar M, Ghatei MA, Bloom SR. Actions of 
cocaine- and amphetamine-regulated transcript (CART) peptide on regulation of 
appetite and hypothalamo-pituitary axes in vitro and in vivo in male rats. Brain Res 
2001; 893: 186-194.
Stenzel-Poore MP, Heldwein KA, Stenzel P, Lee S, Vale WW. Characterization of the 
genomic corticotropin-releasing factor (CRF) gene from Xenopus laevis: two mem-
bers of the CRF family exist in amphibians. Mol Endocrinol 1992; 6: 1716-1724.
References
170
Stevens CW, Pezalla PD, Yaksh TL. Spinal antinociceptive action of three representa-
tive opioid peptides in frogs. Brain Res 1987; 402: 201-203.
Stevens CW, Pezalla PD. Endogenous opioid system down-regulation during hiberna-
tion in amphibians. Brain Res 1989; 494: 227-231.
Swanson LW, Sawchenko PE, Rivier J, Vale WW. Organization of ovine corticotropin-
releasing factor immunoreactive cells and fibres in the rat brain: immunohisto-
chemical study. Neuroendocrinology 1983; 36: 165-186.
Sweep CGJ, Boomkamp MD, Barna I, Logtenberg AW, Wiegant VM. Vasopressin en-
hances the clearance of β-endorphin immunoreactivity from rat cerebrospinal 
fluid. Acta Endocrinologica (Copenh) 1990; 122: 191-200.
Suda T, Kageyama K, Sakihara S, Nigawara T. Physiological roles of urocortins, human 
homologues of fish urotensin I, and their receptors. Peptides 2004; 25: 1689-1701.
ten Donkelaar HJ. Anurans. In: The Central Nervous System of Vertebrates (R. Nieu-
wenhuys, H.J. ten Donkelaar, C. Nicholson eds.), 1998, Vol. 2, Springer.
Thim L, Nielsen PF, Judge ME, Andersen AS, Diers I, Egel-Mitani M, Hastrup S. Puri-
fication and characterization of a new hypothalamic satiety peptide cocaine and 
amphetamine-regulated transcript (CART), produced in yeast. FEBS Lett 1998; 
428: 263-268.
Tonon MC, Leroux P, Stoeckel ME, Jégou S, Pelletier G, Vaudry H. Catecholaminergic 
control of alpha-melanocyte-stimulating hormone (alpha-MSH) release by frog 
neurointermediate lobe in vitro: evidence for direct stimulation of alpha-MSH re-
lease by thyrotropin-releasing hormone. Endocrinology 1983; 112: 133-141.
Tonon MC, Burlet A, Lauber M, Cuet P, Jégou S, Gouteux L, Ling N, Vaudry H. Immu-
nohistochemical localization and radioimmunoassay of corticotropin-releasing 
factor in the forebrain and hypophysis of the frog Rana ridibunda. Neuroendocrinol-
ogy 1985; 40: 109-119.
Tonon MC, Cuet P, Lamacz M, Jégou S, Cote J, Gouteaux L, Ling N, Pelletier G, Vaudry 
H. Comparative effects of corticotropin-releasing factor, arginine vasopressin, and 
related neuropeptides on the secretion of ACTH and alpha-MSH by frog anterior 
pituitary cells and neurointermediate lobes in vitro. Gen Comp Endocrinol 1986; 61: 
438-445.
Tonosaki Y, Cruijsen PMJM, Nishiyama K, Yaginuma H, Roubos EW. Regulation of 
α-MSH release from the pituitary pars intermedia of Xenopus laevis in a cold en-
vironment. In: Perspective in Comparative Endocrinology: Unity and Diversity 
(H.J.T. Goos, R.K. Rastogi, H. Vaudry, R. Pierantoni eds.), 2001 , Monduzzi Edi-
tore, Bologna, pp. 821-826
Tonosaki Y, Cruijsen PMJM, Nishiyama K, Yaginuma H, Roubos EW. Low temperature 
stimulates alpha-melanophore-stimulating hormone secretion and inhibits back-
ground adaptation in Xenopus laevis. J Neuroendocrinol 2004; 16: 894-905.
Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors 
and stress. J Psychosom Res 2002; 53: 865-871.
Tuinhof R, de Rijk EPCT, Wismans RG, Smeets WJAJ, Roubos EW. The role of hypo-
thalamic nuclei in the dopaminergic control of background adaptation in Xenopus 
laevis. Ann N Y Acad Sci 1993a; 680: 486-488.
References
171
Tuinhof R, Laurent FY, Ebbers RG, Smeets WJAJ, Van Riel MC, Roubos EW. Immuno-
cytochemistry and in situ hybridization of neuropeptide Y in the hypothalamus of 
Xenopus laevis in relation to background adaptation. Neuroscience 1993b; 55: 667-
675.
Tuinhof R, Artero C, Fasolo A, Franzoni MF, ten Donkelaar HJ, Wismans RGP, Roubos 
EW. Involvement of retinohypothalamic input, the suprachiasmatic nucleus, the 
magnocellular nucleus and the locus coeruleus in neural control of melanotrope 
cells of Xenopus laevis: a retrograde and anterograde tracing study. Neuroscience 
1994a; 61: 411-420.
Tuinhof R, González A, Smeets WJAJ, Roubos EW. Neuropeptide Y in the developing 
and adult brain of the South African clawed toad Xenopus laevis. J Chem Neuroanat 
1994b; 7: 271-283.
Tuinhof R, Ubink R, Tanaka S, Atzori C, van Strien FJC, Roubos EW. Distribution of 
pro-opiomelanocortin and its peptide end products in the brain and hypophysis 
of the acquatic toad, Xenopus laevis. Cell Tissue Res 1998; 292: 251-265.
Turnbull AV, Rivier C. Corticotropin-releasing factor (CRF) and endocrine responses 
to stress: CRF receptors, binding protein, and related peptides. Proc Soc Exp Biol 
Med 1997; 215: 1-10.
Ubink R, Jenks BG, Roubos EW. Physiologically induced Fos expression in the hypo-
thalamo-hypophyseal system of Xenopus laevis. Neuroendocrinology 1997; 65: 413-
422. 
Ubink R, Tuinhof R, Roubos EW. Identification of suprachiasmatic melanotrope-in-
hibiting neurons in Xenopus laevis: a confocal laser-scanning microscopy study. J 
Comp Neurol 1998; 397: 60-68.
Ubink R, Buzzi M, Cruijsen PMJM, Tuinhof R, Verhofstad AA, Jenks BG, Roubos EW. 
Serotonergic innervation of the pituitary pars intermedia of Xenopus laevis. J Neu-
roendocrinol 1999; 11: 211-219.
Uchiyama M, Konno N. Hormonal regulation of ion and water transport in anuran 
amphibians. Gen Comp Endocrinol 2006; Epub ahead of print.
Vale WW, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypotha-
lamic peptide that stimulates secretion of corticotropin and beta-endorphin. Sci-
ence 1981; 213: 1394-1397.
Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, Perrin M, Vale 
WW, Sawchenko PE. Distribution of mRNAs encoding CRF receptors in brain 
and pituitary of rat and mouse. J Comp Neurol 2000; 428: 191-212.
van Vossel-Daeninck J, Dierickx K, Vossel van A, Vandesande F. Electron microscopic 
immunocytochemical demonstration of separate vasotocinergic and mesotociner-
gic nerve terminals in the median eminence of the frog hypophysis. Cell Tiss Res 
1979; 204: 29-36.
Vandesande F, Dierickx K. Immunocytochemical demonstration of separate vasotocin-
ergic and mesotocinergic neurons in the amphibian hypothalamic magnocellular 
neurosecretory system. Cell Tissue Res 1976; 175: 289-296.
Vaudry H, Trochard MC, Leboulenger F, Vaillant R. Control of pituitary secretion of 
melanotropin in an anuran amphibian by thyrotropin releasing factor (TRH). 
Study in vitro. C R Acad Sci Hebd Seances Acad Sci D 1977; 284: 961-965.
References
172
Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turn-
bull AV, Lovejoy D, Rivier C. Urocortin, a mammalian neuropeptide related to 
fish urotensin I and to corticotropin-releasing factor. Nature 1995; 378: 287-292.
Verburg-van Kemenade BM, Jenks BG, Driessen AG. GABA and dopamine act directly 
on melanotropes of Xenopus to inhibit MSH secretion. Brain Res Bull 1986; 17: 697-
704. 
Verburg-van Kemenade BML, Jenks BG, Cruijsen PMJM, Dings A, Tonon MC, Vaudry 
H. Regulation of MSH release from the neurointermediate lobe of Xenopus laevis 
by CRF-like peptides. Peptides 1987a; 8: 1093-1100.
Verburg-van Kemenade BML, Jenks BG, Visser TJ, Tonon MC, Vaudry H. 1987. Assess-
ment of TRH as a potential α-MSH-release stimulating factor in Xenopus laevis. 
Peptides 1987b; 8: 69-76.
Verhaert P, Marivoet S, Vandesande F, De Loof A. Localization of CRF immunoreactiv-
ity in the central nervous system of three vertebrate and one insect species. Cell 
Tissue Res 1984; 238: 49-53.
Vicentic A, Dominguez G, Hunter RG, Philpot K, Wilson M, Kuhar MJ. Cocaine- 
and amphetamine-regulated transcript peptide levels in blood exhibit a diurnal 
rhythm: regulation by glucocorticoids. Endocrinology 2004; 145: 4119-4124.
Vicentic A, Hunter RG, Kuhar MJ. Effect of corticosterone on CART peptide levels in 
rat blood. Peptides 2005; 26: 531-533.
Vigh B, Manzano e Silva MJ, Frank CL, Vincze C, Czirok SJ, Szabo A, Lukats A,  Szel 
A. The system of cerebrospinal fluid-contacting neurons. Its supposed role in the 
nonsynaptic signal transmission of the brain. Histol Histopathol 2004; 19: 607-628. 
Vigh-Teichmann I, Vigh B. The infundibular cerebrospinal-fluid contacting neurons. 
Adv Anat Embryol Cell Biol 1974; 50: 1-91.
Volkoff H, Peter RE. Effects of CART peptides on food consumption, feeding and asso-
ciated behavior in the goldfish, Carassius auratus: actions on neuropeptide Y- and 
orexin A-induced feeding. Brain Res 2000; 887: 125-133.
Volkoff H, Peter RE. Characterization of two forms of cocaine- and amphetamine-reg-
ulated transcript (CART) peptide precursosrs in goldfish: molecular cloning and 
distribution, modulation of expression by nutritional status, and interaction with 
leptin. Endocrinology 2001; 142: 5076-5088.
Volkoff H, Peter RE. Effects of lipopolysaccharide treatment on feeding of goldfish: 
role of appetite-regulating peptides. Brain Res 2004; 998: 139-147.
Vrang N, Larsen PJ, Clausen JT, Kristensen P. Neurochemical characterization of hy-
pothalamic cocaine-amphetamine-regulated transcript neurons. J Neurosci 1999; 
19: 1-8.
Wang C, Mullet MA, Glass MJ, Billington CJ, Levine AS, Kotz CM. Feeding inhibition 
by urocortin in the rat hypothalamic paraventricular nucleus. Am J Physiol Regul 
Integr Comp Physiol 2001; 280: 473-480.
Wang LC, Meijer HK, Humbel BM, Jenks BG, Roubos EW. Activity-dependent dynam-
ics of coexisting brain-derived neurotrophic factor, pro-opiomelanocortin and α-
melanophore-stimulating hormone in melanotrope cells of Xenopus laevis. J Neu-
roendocrinol 2004; 16: 19-25.
References
173
Wang LC, Calle M, Roubos EW. Brain-derived neurotrophic factor in the hypothalamo-
hypophyseal system of Xenopus laevis. In: Trends in Comparative Endocrinology 
and Neurobiology (H. Vaudry, E.W. Roubos, L. Schoofs, G. Flik, D. Larhammar 
eds.), 2005a, Ann NY Acad Sci, 1040: pp. 512-514.
Wang LC, Humbel BM, Roubos EW. High-pressure freezing followed by cryosubstitu-
tion as a tool for preserving high-quality ultrastructure and immunoreactivity in 
the Xenopus laevis pituitary gland. Brain Res Prot 2005b; 15: 155-163.
Warburg MR. Hormonal effect on the osmotic, electrolyte and nitrogen balance in ter-
restrial Amphibia. Zool Sci 1995; 12: 1-11.
 Watanabe F, Oki Y, Ozawa M, Masuzawa M, Iwabuchi M, Yoshimi T, Nishiguchi 
T, Iino K, Sasano H. Urocortin in human placenta and maternal plasma. Peptides 
1999; 20: 205-209.
Weitemier AZ, Ryabinin AE. Lesions of the Edinger-Westphal nucleus after food and 
water consumption. Behav Neurosci 2005; 119: 1235-1243.
Westhoff G, Roth G. Morphology and projection pattern of medial and dorsal pallial 
neurons in the frog Discoglossus pictus and the salamander Pletodon jordani. J Comp 
Neurol 2002; 445: 97-121.
White JD, Kershaw M. Increased hypothalamic neuropeptide Y expression following 
food deprivation. Mol Cell Neurosci 1989; 1: 41-48.
Yamamoto H, Gurney ME. Human platelets contain brain-derived neurotrophic fac-
tor. J Neurosci 1990; 10: 3469-3478.
Yao M, Westphal NJ, Denver RJ. Distribution and acute stressor-induced activation of 
corticotrophin-releasing hormone neurons in the central nervous system of Xeno-
pus laevis. J Neuroendocrinol 2004; 16: 880-893. 
Zhao L, Donaldson CJ, Smith GW, Vale WW. The structures of the mouse and human 
urocortin genes (Ucn and UCN). Genomics 1998; 50: 23-33.
Zoli M, Torri C, Ferrari R, Jansson A, Zini I, Fuxe K, Agnati LF. The emergence of the 
volume transmission concept. Brain Res Rev 1998; 26: 136-147.
Zoli M, Jansson A, Sykova E, Agnati LF, Fuxe K. Volume transmission in the CNS and 
its relevance for neuropsychopharmacology. Trends Pharmacol Sci 1999; 20: 142-
150.

Summaries
                                 
Summary (English)
Samenvatting (Nederlands)
Sommario (Italiano)
Sumario (Español)
Schematic Summary

Summaries
177
Summary 
The ability of organisms to respond and adapt to the ever changing environment 
is one of the most important requirements for their survival. In general, to adapt, 
many physiological processes such as feeding, growth, development, reproduction, 
hydromineral balance and metabolism have to be regulated and co-ordinated in an 
integrative way, so that they allow the organism’s body to function as one integrated 
unit. The main structures regulating these processes are the brain and the endocrine 
system. By communicating with each other, these systems transduce information about 
the environmental condition into meaningful physiological responses. Communication 
between the brain and the endocrine system occurs via the release of neurochemical 
messengers (neurotransmitters, hormones and neurohormones) that act via specific 
receptors to control the activity of target cells. This thesis is concerned with solving the 
question by what mechanisms the brain and endocrine system communicate to control 
physiological processes in an integrated, co-ordinated way. This has been done using 
two amphibian species particularly suited for this type of research, the green frog Rana 
esculenta and, especially, the South African clawed toad Xenopus laevis.
In Xenopus laevis, the role of the brain and the neuroendocrine system in the 
regulation of physiological processes has been studied in some detail. This animal is 
able to adapt its skin color to the color of the background. On a black background the 
endocrine melanotrope cells in the pituitary pars intermedia secrete α-melanophore-
stimulating hormone (α-MSH) that disperse melanin pigment in skin melanophore 
cell, resulting in skin darkening. On a white background, α-MSH release is blocked, 
and the animal appears white. The melanotrope cells are controlled by various 
neurochemical messengers. Messengers secreted by neurons in the magnocellular 
nucleus of the hypothalamus (Mg), such as corticotropin-releasing factor (CRF) and 
thyrotropin-releasing hormone (TRH), stimulate the melanotrope cells to secrete α-
MSH, whereas messengers from the suprachiasmatic nucleus (dopamine, neuropeptide 
Y and γ-aminobutyric acid) inhibit this release. In this thesis this animal model 
has been used to investigate the ways of release of different messengers (synaptic, 
neurohormonal, and ‘non-synaptic’ or by ‘volume transmission’) that are responsible 
for the co-ordination of distinct physiological processes. Emphasis has been put on the 
regulation of background adaptation, feeding, and stress adaptation, by the brain and 
by the hypothalamo-hypophyseal system. 
In Chapter 2 we have studied the presence in the X. laevis brain of cerebrospinal 
fluid-contacting neurons containing the stress-adaptation involved peptides CRF and 
urocortin 1 (Ucn1) and the opioid peptides β-endorphin, met-enkephalin (ENK) and 
endomorphin. We have observed liquor-contacting neurons in several brain areas, 
especially in the suprachiasmatic nucleus, which indicates that volume transmission 
plays a main role in this nucleus.
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Another way of communication is represented by the release of neurochemical 
messengers into the blood. This process of ‘neurosecretion’ of neurohormones is tested 
in Chapter 3 and Chapter 4 for brain-derived neurotrophic factor (BDNF) and Ucn1. In 
Chapter 3 the distribution of BDNF in the X. laevis brain and pituitary gland has been 
compared to the distribution of the classical amphibian neurohormone, mesotocin. 
BDNF, like mesotocin, is detected in neurons in the Mg that release both mesotocin 
and BDNF as neurohormones into the blood from their terminals in the pituitary 
neural lobe to stimulate α-MSH release from the melanotrope cells in the pituitary 
intermediate lobe. This is the first study reporting that the growth factor BDNF can act 
as a neurohormone and that mesotocin controls endocrine activity (Chapter 3). The 
actions of CRF and Ucn1 are mediated by the G-protein-coupled CRF receptor type 
1 (CRF1) and CRF receptor type 2 (CRF2). In Xenopus and in mammals, both CRF and 
Ucn1 have highest affinity for CRF1. In Chapter 5 we show the distribution of CRF1 in 
the X. laevis brain and pituitary, in relation to the presence of CRF- and Ucn1-positive 
neurons and their processes. In some cases synaptic communication, in others (where 
‘receptor mismatch’ appears) non-synaptic communication is postulated. Moreover, 
we reveal that the expression of CRF1 mRNA in the pituitary intermediate lobe is 
physiologically regulated by the background light condition, CRF1 being stronger 
expressed in white-adapted than in black-adapted animals. Chapter 6 deals with 
the regulation of another important physiological process, namely feeding activity. 
First, the distribution of cocaine and amphetamine-regulated transcript (CART), an 
established messenger in the regulation of feeding in mammals, is described in the 
brain and spinal cord of the hibernating frog R. esculenta, and compared to the CART 
distribution in the rat brain. The occurrence of CART-positive neuronal elements 
appears to be similar in both species, especially in relation to brain areas regulating 
feeding behavior. This observation strongly suggests that the CART system has been 
strongly preserved during evolution. Then, in Chapter 7, the distribution of CART 
is described in the brain of Xenopus and compared to its distribution in Rana and rat. 
Some particular differences in the olfactory and visual system of the two amphibian 
species have been found, probably related to their different feeding behaviors. In 
general, CART distribution in X. laevis is more similar to the rat than Rana.
In mammalian species, besides CART, also CRF and Ucn1 are important regulators 
of feeding-related processes. In Chapter 8, the hypothesis that in X. laevis, CRF and 
Ucn1 in the Mg are involved in the regulation of feeding-related processes is tested by 
looking at the effect of long-term starvation on the expression of the neuronal activity 
marker Fos, and on CRF- and Ucn1-expressions in different brain structures and in 
the pituitary gland. For comparison, CART, ENK and NPY, all implicated in feeding 
control, have been studied as well. Our data indicate first that indeed in X. laevis, CRF 
and Ucn1 in the Mg are involved in the regulation of feeding. Secondly, starvation has 
profound effects on the neurochemical contents of the Mg, as also CART and ENK in 
the Mg change their dynamics upon starvation. Moreover, we obtained indications 
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that in amphibians CART, ENK and NPY are involved in the regulation of feeding-
related processes, acting in distinct brain centres.
In conclusion, by the multiple action of a large variety of neuropeptides, some 
already known to be present in amphibians, some described in this thesis for the 
first time, evidence is presented that the Mg plays a central role in the control and 
co-ordination of different physiological processes such as background adaptation, 
hydromineral regulation, stress adaptation and feeding. These findings, especially 
with respect to the South African clawed toad Xenopus laevis, lead to a novel view on 
the integrative capabilities of the Mg of the hypothalamus and its neurohemal organ, 
the neural lobe of the pituitary gland. Moreover, deeper insight has been obtained in 
the various modes of communication underlying this integration. We propose that 
these principles of communication generally apply to the nervous system of animals 
and man.
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Samenvatting
Een van de belangrijkste vereisten voor een organisme om te overleven, is 
het vermogen om zich aan te passen aan en te reageren op de steeds wisselende 
uitwendige omstandigheden. In het algemeen gesproken, moeten voor aanpassing 
veel fysiologische processen, zoals eten, groei, ontwikkeling, voortplanting, water- en 
ionenhuishouding, en stofwisseling, op een gecoördineerde wijze worden gereguleerd 
zodat het lichaam als één goed geïntegreerde eenheid kan functioneren. De belangrijkste 
structuren die deze processen controleren, zijn de hersenen en het endocriene systeem. 
Door onderlinge communicatie zetten deze systemen informatie over de uitwendige 
omstandigheden om in betekenisvolle, fysiologische responsen. De communicatie 
tussen de hersenen en het endocriene systeem vindt plaats door de afgifte van 
neurochemische boodschappers (neurotransmitters, hormonen en neurohormonen) 
die via specifieke receptormoleculen de activiteit van hun doelwitorganen controleren. 
Dit proefschrift behandelt de vraag door welke mechanismen de hersenen en het 
endocriene systeem communiceren en zo fysiologische processen op een geïntegreerde 
wijze coördineren. Dit is gedaan door twee bij uitstek geschikte amfibieënsoorten te 
onderzoeken, namelijk de groene kikker, Rana esculenta en, vooral, de Zuid-Afrikaanse 
klauwpad, Xenopus laevis.
De rol van de hersenen en het neuroendocriene systeem in de regulatie van 
fysiologische processen in Xenopus laevis is redelijk bekend. Het dier kan zijn 
huidstint aanpassen aan de kleur van de achtergrond. Op een zwarte achtergrond 
geven de endocriene melanotrope cellen in de pars intermedia van de hypofyse α-
melanophore-stimulating hormone (α-MSH) af, dat de dispersie stimuleert van 
melanine pigmentkorrels in de huidmelanoforen, en dit leidt tot het zwart worden 
van de huid. Op een witte achtergrond is de afgifte van α-MSH geremd, waardoor 
het dier er wit uitziet. De melanotrope cellen worden gereguleerd door verscheidene 
neurochemische boodschappers. Boodschappers uit neuronen in de hypothalame 
magnocellulaire nucleus (Mg), zoals corticotropin-releasing factor (CRF) en thyrotropin-
releasing hormone (TRH), stimuleren de melanotrope cellen tot afgifte van α-MSH, 
terwijl boodschappers uit de suprachiasmatische nucleus (dopamine, neuropeptide 
Y en γ-aminoboterzuur) deze afgifte remmen. In het onderzoek dat in dit proefschrift 
staat beschreven, is dit diermodel gebruikt om de manieren te onderzoeken waarop 
deze verschillende boodschappers, die verantwoordelijk zijn voor de coördinatie van 
specifieke fysiologische processen, worden afgegeven (synaptisch, neurohormonaal, 
en ‘niet-synaptisch’ of door ‘volume transmissie’). Nadruk is gelegd op de regulatie 
van de achtergrondaanpassing, voedselopname en aanpassing aan stress, door de 
hersenen en het hypothalamus-hypofyse systeem. 
In Hoofdstuk 2 is de aanwezigheid onderzocht van neuronen in de hersenen 
van X. laevis die contact maken met de cerebrospinale vloeistof en peptiden bevatten 
die betrokken zijn bij de aanpassing aan stress: CRF, urocortine 1 (Ucn1) en de 
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opioïde peptiden β-endorfine, met-enkefaline (ENK) en endomorfine. Deze liquor-
contact-neuronen zijn in verscheidene hersengebieden aangetoond, vooral in de 
suprachiasmatische nucleus, wat aangeeft dat volumetransmissie in deze kern een 
belangrijke rol speelt.
Een andere vorm van communicatie is de afgifte van neurochemische boodschap-
pers aan het bloed. Dit proces van ‘neurosecretie’ van neurohormonen is onderzo-
cht in Hoofdstuk 3 and Hoofdstuk 4, voor brain-derived neurotrophic factor (BDNF) 
en Ucn1. In Hoofdstuk 3 is het voorkomen van BDNF in de hersenen en hypofyse 
van X. laevis vergeleken met het voorkomen van het klassieke amfibieën-neurohor-
moon, mesotocine. BDNF is, net als mesotocine, aangetroffen in neuronen in de Mg 
die vanuit hun axoneindigingen in de neurale lob van de hypofyse zowel mesotocine 
als BDNF als neurohormoon aan het bloed afgeven, en zo de afgifte stimuleren van 
α-MSH door de melanotrope cellen in de hypofyse-middenkwab. We tonen hier voor 
het eerst dat de groeifactor BDNF als een neurohormoon kan fungeren en dat mesoto-
cine endocriene activiteit kan controleren (Hoofdstuk 3). De acties van CRF en Ucn1 
worden gemediëerd door een aan een G-eiwit gekoppelde CRF type 1-receptor (CRF1) 
en een CRF type 2-receptor (CRF2). In Xenopus en in zoogdieren, vertonen zowel CRF 
als Ucn1 de sterkste affiniteit voor CRF1. In Hoofdstuk 5 beschrijven we de verdeling 
van CRF1 in de hersenen en hypofyse van X. laevis, in relatie tot de aanwezigheid van 
CRF- en Ucn1-positieve neuronen en hun uitlopers. In sommige gevallen stellen we 
het voorkomen voor van synaptische communicatie, in andere (waar ‘receptor mis-
match’ optreedt) van niet-synaptische communicatie. Bovendien wordt getoond dat 
de expressie van CRF1 mRNA in de hypofyse-middenkwab fysiologisch wordt geregu-
leerd door de conditie van achtergrondbelichting, waarbij CRF1 sterker tot expressie 
komt in wit-aangepaste dan in zwart-aangepaste dieren. Hoofdstuk 6 behandelt de 
regulatie van een ander belangrijk fysiologisch proces, namelijk van voedselopname-
activiteit. Allereerst is het voorkomen van ‘cocaine en amfetamine-gereguleerd tran-
script’ (CART), een bekende boodschapper bij de regulatie van voedselopname door 
zoogdieren, beschreven in de hersenen en het ruggenmerg van de overwinterende 
kikker R. esculenta, en vergeleken met het vorkomen van CART in de hersenen van de 
rat. De aanwezigheid van CART-positieve neuronale elementen blijkt in beide soorten 
sterk overeen te komen, vooral met betrekking tot hersengebieden die betrokken zijn 
bij de regulatie van voeding. Deze waarneming suggereert dat het CART-systeem ge-
durende de evolutie sterk is geconserveerd. Vervolgens is in Hoofdstuk 7 de verdeling 
van CART in de hersenen van Xenopus beschreven, in vergelijking met de verdeling 
in Rana en in de rat. Er zijn daarbij tussen de twee amfibieënsoorten enige opvallende 
verschillen gevonden in het olfactorische en het visuele systeem, die waarschijnlijk te 
maken hebben met hun verschillen in eetgedrag. In het algemeen lijkt het voorkomen 
van CART in X. laevis meer op dat van CART in de rat dan in Rana.
In zoogdieren zijn, naast CART, ook CRF en Ucn1 belangrijke regulatoren van 
voedingsprocessen. In Hoofdstuk 8 is de hypothese onderzocht dat CRF en Ucn1 in de 
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Mg van X. laevis betrokken zijn bij de controle van voedingsprocessen, door het effect te 
onderzoeken van langdurig hongeren op de expressie van de neuronale activiteitsmarker 
Fos, en op de expressie van CRF en Ucn1 in verschillende hersenstructuren en in de 
hypofyse. Ter vergelijking zijn ook CART, ENK en NPY bestudeerd omdat ze ook bij 
voedingsregulatie lijken te zijn betrokken. De resultaten wijzen er allereerst op dat 
CRF en Ucn1 in de Mg van X. laevis inderdaad een rol spelen in voedingscontrole. Ten 
tweede blijkt hongering duidelijke effecten te hebben op de neurochemische inhoud 
van de Mg, aangezien ook CART en ENK in de Mg van dynamiek veranderen als 
gevolg van hongering. Bovendien zijn aanwijzingen verkregen dat CART, ENK and 
NPY betrokken zijn bij de controle van voedingsprocessen in amfibieën, en daarbij in 
verschillende hersencentra werkzaam zijn.
Samengevat, zijn er sterke aanwijzingen verkregen dat de Mg een centrale rol 
speelt - door de multiple werking van een grote variëteit aan neuropeptiden waarvan 
sommige reeds in amfibieën bekend waren maar andere hier voor het eerst zijn 
aangetoond - bij de controle en coördinatie van verschillende fysiologische processen 
zoals achtergrondaanpassing, water- en ionenhuishouding, aanpassing aan stress, 
en voedselopname. Deze vindingen, en in het bijzonder die in de Zuid-Afrikaanse 
klauwpad Xenopus laevis, leiden tot een nieuwe opvatting over de integratieve 
capaciteiten van de Mg in de hypothalamus en het neurohemale orgaan, de neurale 
lob van de hypofyse. Bovendien is meer inzicht verkregen in de uiteenlopende wijzen 
waarop deze integratie is gebaseerd. We stellen voor dat deze communicatieprincipes 
algemeen geldig zijn voor het zenuwstelsel en endocriene systeem van mens en dier.
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Sommario
Uno dei requisiti principali per la sopravvivenza di un organismo é la capacitá di 
rispondere ed adattarsi ad un ambiente in continuo cambiamento. 
Generalmente, per ottenere un adattamento completo, molti processi fisiologici 
come ad esempio l’ alimentazione, la crescita, lo sviluppo, la riproduzione, l’ equilibrio 
idrominerale ed il metabolismo, devono essere regolati e coordinati in modo integrato, 
al fine di permettere all’ organismo il funzionamento come un’ unica unitá. 
Le strutture principali che si occupano di regolare tali processi sono il cervello 
ed il sistema endocrino. Questi due sistemi, comunicando reciprocamente l’ uno con 
l’ altro, trasmettono informazioni riguardanti le condizioni dell’ambiente esterno all’ 
organismo, trasformandole in importanti risposte fisiologiche. La comunicazione 
tra questi sistemi avviene tramite la secrezione di messaggeri neuronali (quali 
neurotrasmettitori, ormoni e neuro-ormoni), i quali attivando specifici recettori 
cellulari, controllano l’ attivitá dei loro target. 
Questa tesi si occupa di risolvere la domanda riguardo a quali meccanismi ven-
gono utilizzati dal cervello e dal sistema endocrino per comunicare e coordinare i vari 
processi fisiologici in una maniera integrata e coordinata. Tale obbiettivo é stato rag-
giunto usando come modello animale due specie di anfibi particolarmente adatti per 
questo tipo di ricerca, la rana Rana esculenta e piú in particolare la rana artigliata Sud 
Africana Xenopus laevis. Il ruolo del cervello e del sistema endocrino nella regolazione 
dei diversi processi fisiologici é stato studiato in dettaglio nell’ anuro Xenopus laevis. 
Questo modello animale é in grado di adattare il colore della pelle al colore dell’ am-
biente esterno. Se posto in uno sfondo nero, le cellule endocrine melanotrope, situ-
ate nella parte intermedia della ghiandola pituitaria, secernono l’ ormone melanoci-
to stimolante (α-MSH), che a sua volta disperde il pigmento melanina nelle cellule 
melanofore situate nella pelle, avendo come risultato finale lo scurimento della pelle 
dell’ animale. Se posto in uno sfondo bianco, la secrezione di α-MSH viene bloccata, e 
l’animale di conseguenza si schiarisce. Le cellule melanotrope sono controllate da nu-
merosi messaggeri neuronali. Alcuni di questi messaggeri neuronali, come ad esempio 
il fattore di rilascio della corticotropina (CRF) ed il fattore di rilascio della tireotropina 
(TRH), sono secreti da neuroni situati nel nucleo magnocellulare dell’ ipotalamo (Mg), 
i quali stimolano la secrezione di α-MSH. Altri messaggeri neuronali situati nel nucleo 
suprachiasmatico (come ad esempio la dopamina, il neuropeptide Y e l’ acido-γ-am-
minobutirrico), invece inibiscono il rilascio di α-MSH. In questa tesi questo modello 
animale é stato usato per studiare i diversi tipi di secrezione di messaggeri neuronali 
(sinaptica, neurosecrezione, e ‘non-sinaptica’ o ‘volume transmission’) responsabili per 
la coordinazione di diversi processi fisiologici. Enfasi é stata posta su come il cervello 
ed il sistema ipotalamo-ipofisario regolino il processo di adattamento all’ambiente es-
terno, all’ alimentazione e allo stress. 
Nel Capitolo 2 é stata studiata la presenza nel cervello dell’ anfibio X. laevis di 
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neuroni che contattano il liquido cerebrospinale, positivi ai neuropeptidi coinvolti 
nella regolazione dello stress CRF ed Urocortina 1 (Ucn1)e agli oppioidi endogeni b-
endorfina, met-enchefalina (ENK) ed endomorfina. 
Neuroni che contattano il liquido cerebrospinale sono stati osservati in varie aree 
del cervello, in particolare nel nucleo suprachiasmatico, indicando un ruolo importante 
di quest’area nel processo di volume transmission.
Un altro modo di comunicazione é rappresentato dalla secrezione di messaggeri 
neuronali nel sistema circolatorio. Questo processo di ‘neuro-secrezione’ é stato testato 
per due peptidi: brain-derived neurotrophic factor (BDNF) ed Ucn1, rispettivamente 
nei Capitoli 3 e 4. Nel Capitolo 3 la distribuzione del BDNF nel sistema nervoso centrale 
e nella ghiandola pituitaria dell’ anfibio X. laevis e’stata descritta paragonandola alla 
distribuzione del classico neuro-ormone negli anfibi: la mesotocina. Il BDNF, come 
la mesotocina, é presente nei neuroni nell’ Mg, i quali a loro volta secernono dai loro 
terminali nervosi, situati nella pars nervosa, mesotocina e BDNF come neuro-ormoni 
nella circolazione sanguigna, stimolando a loro volta il rilascio di α-MSH dalle cellule 
melanotrope nella ghiandola pituitaria. Questo é il primo studio che sostiene il ruolo 
del BDNF come neuro-ormone, ed il ruolo della mesotocina nel controllo dell’ attivitá 
endocrina (Capitolo 3).
Le azioni del CRF e dell’ Ucn1 vengono mediate da due recettori accoppiati alla 
proteina G, il recettore per il CRF di tipo 1 (CRF1) ed il recettore per il CRF di tipo 2 
(CRF2). Nello Xenopus e nei mammiferi, entrambi CRF ed Ucn1 hanno alta affinitá per il 
CRF1. Nel Capitolo 5 si é descritta la distribuzione del CRF1 nel sistema nervoso centrale 
e nella ghiandola pituitaria in relazione alla presenza di neuroni e fibre positive al CRF 
ed all’ Ucn1. In alcuni casi nella tesi si parla di comunicazione sinaptica, in altri (dove 
esiste un mismatch di recettori e peptide) il tipo di comunicazione non-sinaptica viene 
postulata. Inoltre l’ espressione nel lobo intermedio dell’ ipofisi dell’ mRNA per il CRF1 
si dimostra essere regolata in maniera fisiologica dalla luce dell’ ambiente esterno, 
rivelando un’elevata espressione del CRF1 in animali adattati ad uno sfondo bianco, 
piuttosto che ad uno sfondo nero. 
Il Capitolo 6 si occupa di un altro importante processo fisiologico, l’ alimentazione. 
In primo luogo si é descritta la distribuzione nel cervello e nella corda spinale della 
rana Rana esculenta, di “cocaine and amphetamine-related transcript” (CART), un 
importante peptide che regola l’ alimentazione nei mammiferi; in un secondo tempo 
la distribuzione di CART é stata paragonata tra anfibio e ratto. Questo studio ha 
evidenziato l’ esistenza in certe aree del cervello, di elementi neuronali positivi a 
questo peptide simili fra le due specie, specialmente in relazione alle aree cerebrali che 
controllano l’ alimentazione. Questa osservazione suggerisce che il sistema di CART 
sia stato preservato durante l’ evoluzione. 
In seguito nel Capitolo 7 si é descritta la distribuzione di CART nel cervello di X. 
laevis, paragonandola alla distribuzione nella Rana e nel ratto. Alcune differenze sono 
state osservate nel sistema olfattivo e visivo tra le due specie di anfibi, probabilmente 
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relazionate ai loro diversi comportamenti nelle modalitá di alimentazione. In generale, 
la distribuzione di CART in X. laevis é piú simile al ratto che alla Rana.
Nei mammiferi, oltre CART, anche CRF ed Ucn1 sono importanti peptidi che 
regolano i processi fisiologici dell’alimentazione. Nel Capitolo 8 si é testata l’ipotesi 
che in X. laevis , CRF ed Ucn1 nell’ Mg siano coinvolti nella regolazione dei meccanismi 
fisiologici relazionati all’alimentazione, osservando l’ effetto di tre mesi senza cibo 
sull’espressione dei neuropeptidi CRF, Ucn1 e del marker di attivitá neuronale Fos, in 
diverse aree del cervello e nella ghiandola pituitaria. 
Come paragone é stata studiata anche la distribuzione dei peptidi CART, ENK ed 
NPY, anch’essi coinvolti nella regolazione dell’alimentazione.
I risultati mostrano che in X. leavis, CRF e Ucn1 nell’ Mg sono coinvolti nella 
regolazione dell’alimentazione. Inoltre si é dimostrato che la deprivazione di cibo ha 
profondi effetti nel contenuto neurochimico dell’Mg, dato che anche CART ed ENK 
nell’ Mg cambiano la loro dinamica. Inoltre si é potuto evidenziare che negli anfibi 
CART, ENK ed NPY sono coinvolti nella regolazione dell’ alimentazione, agendo in 
diverse aree del cervello.
In conclusione, tramite l’ azione multipla di vari neuropeptidi, alcuni giá descritti 
negli anfibi, altri evidenziati in questa tesi per la prima volta, si dimostra un ruolo 
centrale dell’ Mg nel controllo e nella coordinazione di diversi processi fisiologici quali, 
l’ adattamento ad uno sfondo diverso, la regolazione idrominerale, l’ adattamento allo 
stress e l’alimentazione. Questi risultati ottenuti principalmente in X. laevis, portano ad 
una nuova visione delle capacitá integrative dell’ Mg dell’ipotalamo e del suo organo 
neuroemale, il lobo neurale della ghiandola pituitaria. Inoltre si sono ottenute maggiori 
informazioni sulle varie modalitá di comunicazione che supportano questo importante 
processo di integrazione. Proponiamo che questi principi di comunicazione si possano 
applicare al sistema nervoso di altri animali e dell’ uomo in generale.
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Sumario
La habilidad de los organismos de responder y de adaptarse a un ambiente en 
cambio continuo es uno de los requisitos para la supervivencia. En general, para 
adaptarse, muchos procesos fisiológicos como la alimentación, el crecimiento, el 
desarrollo, la reproducción, el balance hidromineral y el metabolismo tienen que ser 
regulados y coordinados de una forma integrada, para permitir al cuerpo del mismo 
organismo funcionar como una unidad integrada. Las estructuras principales que 
regulan estos procesos fisiológicos son el sistema nervioso y el sistema endocrino. 
Comunicándose entre ellos, estos dos sistemas trasforman la información recibida 
del ambiente externo en una respuesta fisiológica significativa. La comunicación 
entre el sistema nervioso y endocrino ocurre mediante la secreción de mensajeros 
neuroquímicos (neurotransmisores, hormonas y neurohormonas) que actúan sobre 
receptores específicos para controlar la actividad de las células que tienen como 
objetivo. Esta tesis se ocupa principalmente de resolver la pregunta sobre cuales son los 
mecanismos que el sistema nervioso y el sistema endocrino utilizan para comunicarse 
y coordinarse de una manera integrada para controlar varios procesos fisiológicos. Este 
objetivo se ha desarrollado utilizando como modelo animal dos especies de anfibios 
apropiados para este tipo de investigación: la rana verde Rana esculenta y en especial, 
el sapo Sur Africano Xenopus laevis.
En Xenopus laevis, el papel que juegan el cerebro y el sistema neuroendocrino en 
la regulación de varios procesos fisiológicos ha sido estudiado en detalle. Este animal 
es capaz de adaptar el color de su piel al color del fondo en el que se encuentra. En 
un fondo de color negro las células melanotropas ubicadas en la parte intermedia 
de la glándula pituitaria segregan la hormona a-melanofora estimulante (α-MSH) 
que a su vez propaga el pigmento melanina en las células melanoforas en la piel, 
resultando en el oscurecimiento de la piel del animal. En un fondo de color blanco, la 
secreción de α-MSH está bloqueada, y la piel del animal se vuelve de color blanco. Las 
células melanotropas estan controladas por varios mensajeros quimicos. La secreción 
de mensajeros por parte de neuronas que se localizan en el núcleo magnocelular 
del hipotálamo (Mg), como por ejemplo factor liberador de corticotropina (CRF) y 
hormona liberadora de tirotropina (TRH), estimulan las células melanotropas en la 
secreción de α-MSH mientras que mensajeros del núcleo supraquiasmático (como 
dopamina, neuropéptido Y y ácido γ-aminobutírico) inhiben este tipo de secreción. En 
esta tesis, este modelo animal ha sido utilizado para investigar las diferentes maneras 
de secreción (sináptica, neurohormonal, y ‘no-sináptica’o ‘volume transmission’) 
para diferentes mensajeros responsables para la coordinación de distintos procesos 
fisiológicos. Se ha puesto énfasis en la regulación por parte del sistema nervioso y 
del sistema hipotálamo-hipófisis de la adaptación a fondos diferentes, del proceso de 
alimentación y de la adaptación al estrés.
En el Capitulo 2 se ha estudiado en el cerebro de X. laevis la presencia de neuronas 
Summaries
190
que contactan el líquido cefalo raquidiano (CSF) positivas a los péptidos relacionados 
al estrés CRF y urocortina 1 (Ucn1) y a los péptidos opioides b-endorfina, met-
enkefalina (ENK) y endomorfina. Neuronas que contactan el CSF han sido observadas 
en distintas áreas del cerebro, en particular en el núcleo supraquiasmático, indicando 
un importante papel para este núcleo en el proceso de volume transmission. 
Otra forma de comunicación está representada por la secreción de mensajeros 
neuroquímicos en la sangre. Este proceso de neurosecreción de neurohormonas ha 
sido testado en el Capitulo 3 y en el Capitulo 4 para factor neurotrófico derivado 
del cerebro (BDNF) y Ucn1. En el Capitulo 3 la distribución de BDNF en el cerebro 
y glándula pituitaria de X. laevis ha sido comparada a la distribución de mesotocina, 
la clásica neurohormona conocida en los anfibios. BDNF y mesotocina se encuentra 
en neuronas en el Mg que a su vez secretan juntas como neurohormonas en la sangre 
mesotocina y BDNF desde los terminales neuronales ubicados en el lóbulo neural 
de la glándula pituitaria para estimular la secreción de α-MSH desde las células 
melanotropas de la glándula pituitaria. Este es el primer estudio que presenta la acción 
de BDNF como neurohormona y el control por parte de la mesotocina de la actividad 
endocrina (Capitulo 3).
Las acciones de CRF y Ucn1 están mediadas por dos receptores acoplados 
a proteína G: CRF receptor de tipo 1 (CRF1) y CRF receptor de tipo 2 (CRF2). En 
Xenopus y en los mamíferos, ambos CRF y Ucn1 tienen alta afinidad para CRF1. En 
el Capitulo 5 se ha mostrado la distribución del CRF1 en el cerebro y en la pituitaria 
de X. laevis, en relación a la presencia de neuronas y fibras positiva a CRF y Ucn1. En 
algunos casos se ha postulado comunicación de tipo sinaptico, en otros (donde no hay 
correspondencia entre la distribución del receptor y del mensajero) se ha postulado 
una comunicación no-sinaptica o ‘volume transmission’. Además, se ha descubierto de 
que la expresión de mRNA para CRF1 en la parte intermedia de la glándula pituitaria 
esta fisiológicamente controlada por la condición de luz del fondo, demostrando que 
CRF1 está mayormente expresado en animales adaptados a un fondo blanco (WA) 
con respecto a animales adaptados a un fondo negro (BA). El Capitulo 6 trata de la 
regulación de otro importante proceso fisiológico, la alimentación. Se ha descrito la 
distribución de cocaína y tránscrito regulado por cocaína y anfetaminas (CART), un 
establecido mensajero en la regulación de la alimentación en mamíferos, en el cerebro 
y espina dorsal de la rana hibernante R. esculenta, y se ha hecho una comparación con la 
distribución de CART en el cerebro de la rata. La ocurrencia de elementos neuronales 
positivos a CART es similar en ambas especies, especialmente con relación a las áreas 
del cerebro que controlan la alimentación. Esta observación sugiere que el sistema de 
CART ha sido preservado durante la evolución. Consecutivamente en el Capitulo 7, se 
ha descrito la distribución de CART en el cerebro de X. laevis, y se ha comparado con la 
distribución en Rana y en rata. Algunas diferencias particulares se han encontrado en 
el sistema olfativo y visual de las dos especies de anfibios, probablemente relacionadas 
con la distinta manera de alimentarse. En general, la distribución de CART es más 
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similar a la distribución en rata que en Rana. 
En los mamíferos, a parte de CART, también CRF y Ucn1 son factores importantes 
en la regulación de procesos relacionados a la alimentación. En el Capitulo 8 se ha 
estudiado la hipótesis de que en X. laevis CRF y Ucn1 en el Mg estan implicadas 
en la regulación de procesos relacionados a la alimentación mirando al efecto de la 
privación de comida por largo tiempo (tres meses) sobre la expresión del marcador de 
actividad neuronal Fos, y la expresión de CRF y Ucn1 en distintas áreas del cerebro y 
en la glándula pituitaria. Como comparación se han estudiado también otros péptidos 
como CART, ENK y NPY, implicados en el control de la alimentación. Los datos 
obtenidos indican primero de que en X. laevis CRF y Ucn1 en el Mg están implicados 
en la regulación de la alimentación. Secundariamente, el régimen de hambre tiene 
profundos efectos en el contenido neuroquímico del Mg, ya que también CART, ENK 
y NPY cambian su dinámica en el Mg. Además, se han obtenido indicaciones de que en 
anfibios CART, ENK y NPY están implicados en la regulación de procesos relacionados 
a la alimentación, actuando en diferentes áreas del cerebro.
En conclusión, con la múltiple acción de varios neuropéptidos, algunos ya 
conocidos por la existencia en anfibios y otros descritos en esta tesis por primera 
vez, se han presentado en esta tesis evidencias sobre el papel central del Mg en el 
control y coordinación de diferentes procesos fisiológicos como la adaptación al 
fondo, la regulación hidromineral, la adaptación al estrés y la alimentación. Estos 
descubrimientos, en especial relacionados con X. laevis, llevan a una nueva visión de 
las capacidades de integración del Mg del hipotálamo y su órgano neurohemal, la 
parte neural de la glándula pituitaria. Además, se han obtenido conocimientos más 
profundos sobre las distintas modalidades de comunicación a la base de este proceso 
de integración. Se propone que estos principios de comunicación se aplican al sistema 
nervioso de otros animales y del hombre también.
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Schematic summary
In this summary we display the results of the thesis research in a synthetic, 
abbreviated way. The reason to do this is that it will enable the reader to get a quick 
impression of an essential part of the thesis contents without reading the detailed 
data. This type of formulation gives an idea of the correlation between two parameters 
in connection with a given implication, even if a causal relation between the two 
parameters has not yet been established. 
In the following paragraphs, with the help of some abbreviations and symbols, 
the results described in the various chapters of the thesis will be described in “one-
liners”.
Chapter 2 
Observation: END in LCN @ SC ∩ PVN ∩ VH
 ENK in LCN @ SC ∩ TP
 EM in LCN @ SC
 CRF in LCN @ SC ∩ PVN
 Ucn1 in LCN@ Mg
Conclusion: SC, Mg, TP, PVN and VH are possible sites of neurochemical messenger 
release into the CSF
Chapter 3
Observation: BDNF, mesotocin @ Mg
 <BDNF, mesotocin> @ pit (in the same axon terminal type)
 ↑ Mesotocin ⇒ ↑ α-MSH 
Conclusion: BDNF can be released as a neurohormone
Chapter 4
Observation: CRF, Ucn1@ Mg ∩ pit
 ↑ Ucn1 ⇒ ↑ α-MSH 
Conclusion: Ucn1 can be released as a neurohormone
Chapter 5
Observation: CRF1@ brain ∩ pit
 ↑ CRF1@ pit ⇔ ↑ white (skin color of the animal)
Conclusion: CRF1 is present in Xenopus and is physiologically regulated 
Chapter 6
Observation: CART @ (brain Rana)
Conclusion: CART@ (brain Rana) ≈ CART@ (brain rat)
Summaries
194
Chapter 7
Observation: CART@ (brain Xenopus)
Conclusion: CART@ (brain Rana) ≈ CART@ (brain Xenopus) ≅ CART@ (brain rat)
The distribution of CART in the two amphibian species is quite similar with some 
differences at the level of the olfactory and visual system, probably due to the different 
way these two species feed. These differences in the central distribution of CART are 
not present between Xenopus and rat. 
Chapter 8
Observation: ↑ starvation⇒ ↑CRF, ↓Ucn1, ↓CART, ↓ENK @ Mg
                      ↑ starvation⇒ ↓CART @ EW, Pit
                      ↑ starvation⇒ ↑NPY @ SC
                      ↑ starvation⇒ ↓NPY @ VM
Conclusions: Several peptides are implicated in the regulation of feeding-related 
processes, and starvation has a profound effect on the dynamics of peptides in the 
Mg.
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Abbreviations for X. laevis brain areas
Accumbens (Acc)
Amygdala pars lateralis (Apl)
Amygdala pars medialis (Apm)
Anterior commissure (ac)
Anterior thalamic nucleus (A)
Anterodorsal tegmental nucleus (Ad)
Anteroventral tegmental nucleus (Av)
Central canal (cc)
Central grey (cg)
Central thalamic nucleus (C)
Cerebellum (Cb)
Cerebral aqueduct (aq)
Cochlear nucleus (LL)
Corpus geniculatum thalamicum (Cp)
Cuneate nucleus (Nc)
Descending spinal trigeminal tract (Vd)
Diagonal band of Broca (DB)
Dorsal horn (dh)
Dorsal pallium (dp)
Edinger-Westphal nucleus (EW)
Fourth ventricle (4th)
Glomerular layer (gl)
Gracile nucleus (Gn)
Infundibular recess (ir)
Infundibulum (inf)
Inner nuclear layer of the retina (inl)
Interpeduncular nucleus (Ip)
Isthmic nucleus (Is)
Laminar nucleus of the torus semicircularis (lt)
Lateral funiculus (lf)
Lateral hypothalamic area (LH)
Lateral septum (ls)
Lateral ventricle (lv)
Latero-dorsal pallium (Lpd)
Latero-ventral pallium (Lpv)
Locus coeruleus (Lc)
Magnocellular nucleus, dorsal part (Mgd)
Magnocellular nucleus, medial part (Mgm)
Magnocellular nucleus, ventral part (Mgv)
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Medial olfactory tract (mot)
Medial septum (ms)
Median eminence zona externa (ze)
Median eminence zona interna (zi)
Motor nucleus of the trigeminal nerve (Vm)
Neuropil of Bellonci (B)
Nucleus ambiguus (amb)
Nucleus habenularis dorsalis (Hd)
Nucleus habenularis ventralis (Hv)
Nucleus motorius nervi trigemini (Vm)
Nucleus motorius nervi vagi (Xm)
Nucleus motorius of the facial and gp nerve (IX)
Nucleus of Bellonci (NB) 
Nucleus of the oculomotor nerve (III)
Nucleus of the solitary tract (sol)
Nucleus posteroventralis tegmenti (Pv)
Nucleus reticularis medius (Rm)
Olfactory bulb, internal granule cells (igl)
Olfactory bulb, mitral cells (ml)
Olfactory nerve (olfn)
Optic chiasm (oc)
Optic nerve (on)
Optic ventricle (OV)
Paraventricular organ (NPv, NPV)
Periventricular layers (pvl)
Pituitary pars distalis (pd)
Pituitary pars intermedia (pi)
Pituitary pars nervosa (pn)
Posterior commissure (pc)
Posterior entopeduncular nucleus (epp)
Posterior thalamic nucleus (P)
Posterior tubercle (TP)
Post-olfactory eminence (pe)
Preoptic area (Poa)
Raphe nuclei (r)
Saccular nucleus (sa)
Striatum (Str)
Suprachiasmatic nucleus (SC)
Tectal layers (6-9)
Tectum mesencephali (tect)
Tegmentum mesencephali (tegm)
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Third ventricle (3rd)
Torus semicircularis (Tor)
Ventral horn (vh)
Ventral hypothalamic nucleus (VH)
Ventrolateral thalamic nucleus, dorsal part (VLd)
Ventrolateral thalamic nucleus, ventral part (VLv)
Ventromedial thalamic nucleus (VM)
Abbreviations for Rana esculenta brain areas
Accessory olfactory bulb (aob)
Anterior amygdaloid area (aa)
Anterior thalamic nucleus (A)
Anterodorsal tegmental nucleus (ad)
Anteroventral tegmental nucleus (av)
Basal optic nucleus (bon)
Bed nucleus of the stria terminalis (bst)
Central amygdala (cea)
Central canal (cc)
Central gray (cg)
Central thalamic nucleus (C)
Cerebellum (cer)
Cerebral aqueduct (aq)
Cochlear nucleus (cn)
Commissural nucleus of the torus semicircularis (cot)
Corpus geniculatum thalamicum (Cg)
Cuneate nucleus (nucleus cuneatus) (nc)
Descending spinal trigeminal tract (dst)
Diagonal band of Broca (d)
Distal lobe of the hypophysis (DL)
Dorsal habenula (dH)
Dorsal horn (dh)
Dorsal hypothalamic nucleus (dHy)
Dorsal pallium (dp)
Dorsal root (dr)
Edinger-Westphal nucleus (EW)
Ependyma (ep)
Fourth ventricle (4th)
Ganglion cell layer of the retina (gcl)
Glomerular layer of the olfactory bulb (gl)
Granular layer of the cerebellum (gr)
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Inferior reticular nucleus (ire)
Infundibular recess (IR)
Infundibulum (inf)
Inner nuclear layer of the retina (inl)
Inner plexiform layer of the retina (ipl)
Internal granular layer of the olfactory bulb (ig)
Interpeduncular nucleus (ip)
Isthmic nucleus (in)
Isthmic reticular nucleus (ir)
Laminar nucleus of the torus semicircularis (lt)
Lateral amygdala (la)
Lateral forebrain bundle (lfb)
Lateral funiculus of the spinal cord (lf)
Lateral geniculate complex (lgc)
Lateral hypothalamic nucleus (lHy)
Lateral pallium (lp)
Lateral septum (ls)
Lateral thalamic neuropil (ltn)
Lateral thalamic nucleus, anterior division (La)
Lateral thalamic nucleus, posterodorsal division (Lpd)
Lateral thalamic nucleus, posteroventral division (Lpv)
Lateral ventricle (lv)
Lateral vestibular nucleus (lvn)
Layer of rods and cones (lrc)
Magnocellular nucleus of the torus semicircularis (mt)
Magnocellular preoptic nucleus (mg)
Medial amygdala (mea)
Medial pallium (mp)
Medial septum (ms)
Mitral cell layer (ml)
Motor facial nucleus (mVII)
Motor nucleus of the glossopharyngeal nerve (IX, X)
Motor trigeminal nucleus (mV)
Neural lobe of the hypophysis (NL)
Neuropil of Bellonci (npB)
Nucleus ambiguus (amb)
Nucleus of Bellonci (nB)
Nucleus of the accessory nerve (XI)
Nucleus of the hypoglossal nerve (XII)
Nucleus of the medial longitudinal fasciculus (nflm)
Nucleus of the oculomotor nerve (III)
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Nucleus of the trochlear nerve (IV)
Nucleus profundus mesencephali (pm)
Optic chiasm (oc)
Optic nerve (on)
Optic tectum (tec)
Optic tract (ot)
Optic ventricle (ov)
Outer nuclear layer of the retina (onl)
Outer plexiform layer of the retina (opl)
Pallidum (pal)
Posterior commissure (pc)
Posterior entopeduncular nucleus (epp)
Posterior funiculus of the spinal cord (pf)
Posterior preoptic nucleus (pp)
Posterior tegmental nucleus (pd)
Posterior thalamic nucleus (P)
Posterior tubercle (tp)
Posteroventral tegmental nucleus (pv)
Post-olfactory eminence (pe)
Pretectal gray (ptg)
Pretectal neuropil (Pn)
Pretoral gray (ptrg)
Principal nucleus of the torus semicircularis (pt)
Raphe nuclei (r)
Saccular nucleus (sa)
Solitary tract (fasciculus solitarius) (fs)
Spinal trigeminal nucleus (snV)
Striatum (str)
Superior olive (so)
Suprachiasmatic nucleus (sc)
Telencephalon (tel)
Third ventricle (3rd)
Torus semicircularis (ts)
Ventral funiculus (vf)
Ventral habenula (vH)
Ventral horn (vh)
Ventral hypothalamic nucleus (vHy)
Ventrolateral thalamic nucleus (VL)
Ventrolateral thalamic nucleus, dorsal part (VLd)
Ventrolateral thalamic nucleus, ventral part (VLv)
Ventromedial thalamic nucleus (VM)
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Abbreviations for the Schematic Summary
BDNF  brain-derived neurotrophic factor
CART  cocaine and amphetamine-regulated transcript 
CRF  corticotropin-releasing factor
CRF1  corticotropin-releasing factor receptor 1
CSF  cerebrospinal fluid
CSFcn  cerebrospinal fluid-contacting neuron(s)
END  β-endorphin
EM  endomorphin 
EW  Edinger-Westphal nucleus
LCN  liquor-contacting neurons
Mg  magnocellular nucleus
α-MSH α-melanophore-stimulating hormone
NPV  paraventricular organ
NPY  neuropeptide Y
Pit  pituitary gland
SC  suprachiasmatic nucleus
TP   posterior tubercle
Ucn1  urocortin 1
VH  ventral hypothalamic area
VM   ventromedial thalamic nucleus
Symbols
↑(A)  A increases
↓(A)  A decreases
(A) @ X A is present in X
A, B @ X A is present in X and B is present in X
<A, B> @ X A and B together are present in X
A @ X ∩ Y A is present in X and Y
≈  ‘similar’ distribution
≅  ‘very similar’ distribution
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